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Chapter 1 
Introduction 
partly based on: 
Are postoperative pain instruments useful for specific groups of vulnerable infants? 
Monique van Dijk, Jeroen W.B. Peters, Nancy J. Bouwmeester, Dick Tibboel 
Clin in Perinatology (2002) volume 29, issue 3 page 469-491. 
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1.1 Pain and pain management in neonates and infants 
Development of pain pathways and mechanism 
Since 1965, the most plausible theory about the mechanism of pain was proposed by 
Melzack and Wall. 1 They proposed that the substantia gelatinosa functioned as a gate 
control system that modulates the afferent stimuli before they influence the transmission 
cells, and that the gate control system was influenced by central neural modulators. Pain 
phenomena would be detennined by interactions among these systems. Numerous lines of 
evidence suggest that even in the human foetus, pain pathways as well as cortical and 
subcortical centres necessary for pain perception are well developed late in gestation. The 
neurochemical systems now known to be associated with pain transmission and modulation 
are intact and functional. In adults the cutaneous flexor reflex is correlated with sensory 
input and corresponds with pain perception. Similar thresholds are documented in 
neonates, but with thresholds much lower than in adults. The thresholds are even lower in 
pre term neonates less than 30 weeks and increases of these thresholds are correlated with 
postconceptional age2 Probably the immaturity of the segmental control mechanisms 
within the spinal cord and the absence of descending inhibitory pathways cause this. 
During the perinatal period a number of endogenous pain control systems is developing, 
which means that the nociceptive input becomes under more control with increasing 
postnatal age. From a bio-evolutionary perspective, neonates should experience pain. At 
birth, the in utero protection disappears and pain perception is essential for adaptive 
responses to tissue damage and life threatening events, just as in adults. As such, pain can 
be considered as "biologically meaningful" 3 
Effects of pain stimuli 
Already in 1984 Randich and Maixner4 demonstrated that systems controlling 
cardiovascular function are closely coupled to systems modulating the perception of pain. 
Surgical stress activates neural pathways to the hypothalamic area, which stimulates the 
secretion of pituitary hormones5 The release of stress hormones: catecholamines, 
corticosteroids, growth hormone and glucagon, stimulates a cascade of metabolic changes 
leading to the breakdown of protein, fat and carbohydrate stores. Although short periods of 
stress can be useful as preparation to " fight or flight ", a continuing release of stress 
products is harmful. It can lead to a catabolic situation, preventing repair of the injured 
tissues, and in some patients to multi-system organ failure.6·7 In neonates, metabolic 
stability is more difficult to maintain because of the greater heat loss due to a relatively 
greater surface area, much smaller reserves of protein, carbohydrate and fat, the 
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immaturity of metabolic enzymes and controlling systems, and the increased oxygen 
demand due to a higher metabolism. The metabolic vulnerability in neonates is associated 
. h d . h d 1 8 9 A ak . . . 10 Wit greater stress responses to surgery as compare Wit a u ts. · w e crrcumctswn, 
awake intubation 11 and tracheal suction, 12 are procedures documented to result in large 
fluctuations of transcutaneous p02, increases in heart rate, arterial blood pressure and 
intracranial pressure. 
Although more neonates and infants underwent major surgery during the last twenty years, 
as result of an increased knowledge and improved technical possibilities in paediatric 
surgery and anaesthesia, only a few studies investigated the effects of analgesia on 
surgical stress responses in this age group (Chapter 2). Anand and coworkers reported as 
first the effects of analgesia on surgical stress in premature neonates. Besides decreased 
stress responses, the most important result of adequate analgesia was the lower incidence of 
morbidity and mortality. 13 ' 14 Attenuation of the deleterious effects of pathologic stress 
responses by the use of various anaesthetic techniques has also been well demonstrated 
during minor surgery and invasive procedures. The use of local anaesthetics or opioids 
abolished the adverse effects during lower abdominal surgery, 15 circumcision, 16 and 
intubation. 17 These studies had a great impact on the next generation of caregivers. 
Surgical stress score 
In an attempt to evaluate the magnitude of surgical stress a scoring method was developed. 
The so-called surgical stress score (SSS) was based on the amount of blood loss, superficial 
dissection and visceral trauma, the site and duration of surgery, cardiac surgical factors and 
associated stress factors for surgical neonates (hypothemlia, prematurity, sepsis). 18 The SSS 
was found to predict minor, moderate and severe stress groups as measured by hormonal 
metabolic stress responses. Changes in plasma epinephrine, blood glucose and total 
gluconeogenic substrates at the end of surgery, and at 6 hrs postoperative produced the 
greatest discrimination between the tltree stress groups. Clinical outcome following surgery 
was also significantly different between the three stress groups as mentioned above. 
Sensitization 
Ongoing nociceptive stimuli, especially in preterm neonates, can result in sensitization. 19 
Peptides such as Substance P (SP), and excitatory amino acids (EAA) such as glutamate 
and aspartate, are released by repeated stimulation of A and C fibres. Interactions of SP 
and EAA influence the transmission of pain stimuli from the spinal cord to the brain, 
which is controlled by supraspinal systems. Ongoing painful stimuli (tissue damage, 
repeated heel lancing in the very low preterm neonates, nerve dysfunction, surgery) or an 
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insufficient supraspinal inhibition, as in case of premature neonates, can activate the 
NMDA receptor, which results in wind up in the spinal neurones and hypersensitivity. 
Ultimately the wind up may end in a so-called neuropathic pain state, such as spontaneous 
pain, hyperalgesia to a normal pain stimulus, or allodynia, where non-painful stimuli such 
as touch are painful. NMDA activity can be blocked by NMDA-receptor antagonists 
(ketamine, dextromethorphan),20·21 by peripheral or spinal nerve blocks with local 
anaesthetics and, to a lesser extent, by opioids. Low doses of morphine block the dorsal 
horn neuronal excitation in response to normal C fiber input, however, ten-fold higher 
doses of morphine are required once the reflex withdrawal is established. 22 
Hence, to guard against NMDA activity with all the consequences described earlier, 
nociceptive stimuli have to be blocked at an early stage. So prevention of pain is the best 
way of pain treatment, which can be attained by the use of pre-emptive analgesia. 
Analgesia after major surgery 
After major surgery pain has to be treated with opioids. This is necessary in adults, but 
also in neonates, infants and children. 
Opioids 
Opioids act differently in stressed and unstressed situations. Opioids given to unstressed 
subjects, stimulate secretion of corticotropin releasing factor (CRF) and increase plasma 
catacholamines. Noradrenergic transmission originating in the locus coeruleus is most likely 
to play the primary causal role in the expression of physical dependence on morphine. 23 
During pain and stress, opioids, and the endogenously released beta-endorphin, reduce the 
nociceptive input into the hypothalamus, lessen the CRF response and reduce the normal 
catecholamine rise?4 
As a consequence, in the clinical situation, to maintain homeostasis, the severity of 
experienced stress is determining for the need of opioids. This finding directly challenges 
the previous practice of providing minimal anaesthesia for neonates based on concerns 
about the respiratory and hemodynamic side effects of opioids25·26 
How to treat pain after major surgery in neonates and infants? 
The most popular opioid after major surgery is morphine. However, little is known about 
requirements and effects of analgesics in neonates and infants in the postoperative period. 
While insufficient analgesia can give rise to stress responses with an increased morbidity, 
as mentioned above, high doses of opioids will give an unwanted deep sedation with a 
possible need for prolonged mechanical ventilation and intensive care (Chapter 3). 
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Morphine 
Morphine, an alkaloid obtained from opium, is frequently used as a postoperative 
analgesic drug in neonates, infants and children. Morphine is mainly metabolized by the 
enzyme uridine diphospho-glucuronyl transferase, type 2B7 (UDGT2B7), into the active 
metabolite morphine-6-glucuronide (M6G) and into morphine-3-glucuronide (M3G) 27 28 
UDGT2B7 is found in the liver, kidney, intestines and other organs. Morphine and M6G 
have both analgesic and respiratory depressive effects. In some studies M6G in the same 
doses as morphine produced even a greater degree of analgesia,Z9•30 but the claim that 
M6G has less respiratory depression potential has not been proven.31 •32 M3G, however, 
does not hind to opioid receptors and may antagonize the antinociceptive effects as well as 
the ventilatory depression.33 A small part of morphine, depending on age, is metabolized 
by sulphation or is eliminated as free, unbound morphine. 3435 Most of the metabolites are 
eliminated by the kidney, a small part by biliary excretion. 
Although the analgesic effect is dependent on the concentrations of morphine and M6G at 
the 11-receptor iu the CNS, in clinical practice, morphine requirement is generally related 
to the plasma concentration. These concentrations, however, are not only depending on 
the administered dosage, but especially on pharmacokinetic factors such as administration 
route, clearance and volume of distribution34•36-46 
Age, hepatic and renal function and clinical state of the patient (cardiac function, septic 
condition) affect these latter two parameters. These data were investigated using a 
population based approach that included size as the primary covariate in an effort to 
disentangle age related factors from size related factors47 (Chapter 4). 
Besides pharmacokinetics, pharmacodynamics determines the effect of a drug. 
M . f th l 48 49 1' . f . 50 d aturallon o e centra nervous system, · ear 1er expenences o pam, an 
psychological factors (surrounding, social and cultural background)'1 may all effect 
pharmacodynamics. Analgesic morphine plasma concentrations in neonates and older 
children have been reported to range from 3.8 (± 2.5) to 125 (± 9) ng/ml34.40.S2-5S This wide 
variation is dependent on the pain stimulus or sedation end-point, differences in pain 
perception and pain assessment, and the variation in clinical state of the child (severe 
illness, type of surgery, mechanically ventilated, tolerance, etc.). For this reason we 
limited our study population to neonates and infants, stratified for age, admitted to the 
Surgical Intensive Care Unit following major non-cardiac surgery. A subanalysis was 
performed in the neonates (0-28 days of age), stratified for age inS 7 days and> 7 days, to 
provide more detailed information in this fast developing age group (Chapter 5). 
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Pain measurement instruments 
The advanced medical technology, necessary to keep premature and severely handicapped 
infants alive, has led to an increasing demand for measurement methods of sustained pain in 
these groups of children. Improvements in paediatric surgery, anaesthesia and intensive care 
resulted in an increasing number of surgical procedures in non-verbal children. Evaluation 
of the effect of analgesics is essential in daily clinical practice and has to be performed by 
validated pain measurements. The choice of an instrument for measuring pain in children is 
strongly dependent on the child's cognitive development. It is generally accepted that self-
report measures can not be obtained from children younger than 4 years of age. Observation 
of behaviour is, therefore, the most suitable method for evaluation of the child's pain. 
Another approach for measuring pain in infants consists of the registration of changes in 
physiological parameters, such as increments and variability in heart rate and blood pressure, 
lowering of respiration rate, palmar sweating, and increased levels of catecholamines. 
Multidimensional instruments are characterized by using both behavioural as well 
physiological indicators of pain. Although physiological and behavioural measures can give 
relevant information on the intensity of pain when self-report is not possible, these 
measures, taken separately, do not discriminate very well between pain and other reactions 
of stress, such as anxiety or hunger 5 6 In addition, most physiological measures require 
sophisticated equipment or invasive procedures, and are therefore only applicable in medical 
situations in which these are used routinely, such as in intensive care environments. 
An example of a multidimensional instrument is the COMFORT Scale (CS). The CS was 
originally designed to assess distress in infants in paediatric intensive care units. The scale 
consists of 6 behavioural items (alertness, calmness, respiratory response, movement, 
muscle tone, and facial tension) and 2 physiological items (heart rate, mean blood pressure). 
The raters observe the patient for two minutes. Each item can be scored on a 5-point rating 
scale.57•58 In the Sophia Children's Hospital the CS was introduced to develop a validated 
instrument for postoperative pain measurement in non-verbal children (Chapter 6). 
Evolution of pain management in the Sophia Children's Hospital 
Tilll987, in the Sophia Children's Hospital, surgical neonates and infants received 
morphine or paracetamol for postoperative pain on an intermittent basis (rectally, 
intravenously or intramuscularly). Pain prescriptions were ordered as needed, and nurses had 
to decide by personal interpretation how often analgesics were administered. In 1987, 
following the Royal Children's Hospital of Melbourne, the way of morphine administration 
in the PICU was changed into i.v. continuous morphine infusions. 59 Unfortunately, due to 
the lack of validated instruments for assessment of postoperative pain in non-verbal 
Introduction 
children, it was impossible at that time to test the difference between both ways of 
morphine administration. After the introduction of a validated pain score combined with 
an algorithm for pain management, pain management based on objective validated pain 
scores became daily standard care (Chapter 7). 
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Table I gives an overview of studies reporting requirements and plasma concentrations of 
morphine after non-cardiac surgery, with or without the use of a pain assessment scale. 
Need for a study 
The introduction of continuous morphine infusions about a decade ago without proper 
evaluation of its effects, together with the evolution of pain assessment instruments 
prompted us to design a study with the following research questions: 
I. How reliable, valid and feasible is the multidimensional COMFORT scale to assess 
postoperative pain in neonates and infants< 3 years of age? 
The clinical utility and validity of the CS as postoperative pain measurement was tested 
comparing the old and new way of morphine administration [intravenously, as 3-hourly 
intermittent boluses (IM) or as continuous infusion (CM)], in four developmentally 
relevant age groups < 3 years of age. The Visual Analogue Scale (VAS), developed as 
self-report measurement,61 was used as an observational instrument,62 to test the 
concurrent validity of the COMFORT scale. The VAS scores were assigned after the 2 
min of observation needed for the CS. Pain was indicated by VAS scores ~ 4. 
The COMFORT scale was adapted for the Netherlands and its behavioural part has been 
proven to be a valid instrument for measurement of postoperative pain in neonates and 
infants after major surgery63·64 (PhD thesis M. van Dijk). 
2. Is there an improved efficacy and safety of postoperative analgesia with continuous 
morphine infusions compared with intennittent doses, in neonates and infants after major 
surgery? 
1.2 Scope of this thesis 
Chapter 2 reports the efficacy of continuous morphine versus intermittent morphine 
through hormonal-metabolic responses (plasma concentrations of epinephrine, 
norepinephrine, insulin, glucose, lactate), and hemodynamic responses (heart rate, mean 
arterial pressure) to postoperative pain in children aged 0-3 years. Safety was determined 
by the incidence of respiratory depression, because this is the most dangerous 
complication of opioid therapy. 
Table 1 Overview of morphine requirements and plasma concentrations in te1m neonates and infants after non-cardiac surgery 
Age II Loading dose or Dosage M infusion Plasma concentration Pain score Time Reference 
single (ftg/kg/h) morphine (ng/ml) 
dose (ftglkg) 
Earlier studies 
1-7days 4 50 (L) 7-ll 18.9 (!5.0-29.0) median Buchholz60 At steady state Lynn et al. 37 
(range) 
31-90 days 6 50(L) 13-19 9.1 (6.5-14.5) median (range) Buchholz60 At steady state Lynn et al.37 
91-180 days 6 50 (L) 17-25 10.5 (7.0-22.0) median (range) Buchholz60 At steady state Lynn et al. 37 
180-380 days !0 50 (L) 25-35 10.0 (6.0-17.0) median (range) Buchholz60 At steady state Lynn et al. 37 
l-l8days 20 50 (L) 15 39.0 (23.0) mean (SD) Not At steady state Farrington 46 
standardized 
0 to 6 months 5 150 (S) 26.2 (22.5) mean (SD) Not 129 min after M Olkkola55 
standardized 
2-4 years 5 !50 (S) 3.8 (2.3) mean (SD) Not 189 min after M Olkkola55 
standardized 
Present study 
0-4 weeks 31 100 10.8 (1.4) mean (SD) 22.0 (15.1-29.5) median (IQR) CS (van Dijk)63 24 h after start of M Bouwmeester et al. 
4-26 weeks 32 100 15.7 (7.5) mean (SD) 7.4 (5.3-13.4) median (IQR) CS (van Dijk)63 24 h after start of M Bouwmeester eta!. 
26-52 weeks 16 100 16.7 (10.8) mean 6.4 (4.2-9.0) median (IQR) CS (van Dijk)63 24 h after start of M Bouwmeester et a!. 
(SD) 
1-3years 18 100 12.1 (3.5) mean (SD) 4.8 (3.7-56) median (IQR) CS (van Dijk)63 24 h after start of M Bouwmeester et al. 
M = mmphine; n =number; (L) = loading dose; (S) =single dose; SD =standard deviation; IQR = interquartile range; CS = COMFORT 
Score. 
Introduction 
Chapter 3 describes the effects of treatment (continuous morphine versus intermittent 
morphine) and the effects of age on morphine metabolism by analysis of plasma 
concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide and the 
ratios of M3G/M, M6G/M and M6G/M3G. 
Chapter 4 describes the developmental pharmacokinetics of morphine and its metabolites 
in neonates, infants and young children. In an effort to disentangle age-related factors 
from size-related factors, a population-based approach was used that included size as the 
first covariate. 
9 
Chapter 5 describes the age-related differences in morphine requirements and metabolism 
in the postoperative neonate. Neonates are defined as aged< 28 postnatal days. Dosage 
recommendations for postoperative morphine in neonates 0: 7 days and> 7 days of age are 
given. Further findings from this study suggest that neonates on mechanical ventilation 
have a slower morphine metabolism than non-ventilated neonates. 
Chapter 6 describes the efficacy of postoperative intermittent and continuous morphine 
through behavioural responses (VAS and COMFORT scale) to postoperative pain in 
children aged 0-3 years. The repeated COMFORT "behaviour" and VAS pain scores were 
compared between the two treatment groups. 
Chapter 7 describes the process of changing postoperative pain treatment in the surgical 
ICU of the Sophia Children's Hospital, from 1985 up to the present. The effects of the 
change from morphine as needed into morphine continuously, and the introduction of 
routine pain assessment with a validated pain scale, on morphine requirements and the 
duration of mechanical ventilation, are described in one diagnostic category of surgical 
neonates, i.e. neonates with oesophageal atresia with primary anastomosis. 
Chapter 8 contains a general discussion and options for future pain management. 
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Based on: 
Hormonal and metabolic stress responses after major surgery in children aged 0- 3 
years: a double-blind, randomized trial comparing the effects of continuous versus 
intermittent morphine 
N.J. Bouwmeester, K.J.S. Anand, M. van Dijk, W.C.J. Hop, F. Boomsma, and D. Tibboel 
British Journal of Anaesthesia 87 (3): 390-9 (2001) 
!6 Chapter 2 
2.1 Summary 
Children aged 0-3 years were stratified for age and randomised to receive either 
continuous morphine (C.M. 10 f!g kg·1 h-1) with three-hourly placebo boluses or 
intermittent morphine (I.M. 30 f!g kg· 1 every 3 h) with a placebo infusion for 
postoperative analgesia. Plasma concentrations of epinephrine, norepinephrine, insulin, 
glucose and lactate were measured before and at the end of surgery and 6, 12 and 24 h 
after surgery. Pain was assessed by validated pain scales [the COMFORT Score and 
visual analogue scale (VAS)] with the availability of additional morphine doses. Minor 
differences occurred between the randomised treatment groups, the oldest IM group (aged 
1-3 yr) having a higher blood glucose concentration (P = 0.003), mean arterial pressure (P 
= 0.02), and COMFORT score (P = 0.02) than the CM group. In the neonates, 
preoperative plasma concentrations of norepinephrine (P = 0.01) and lactate (P < 0.001) 
were significantly higher, while the postoperative plasma concentrations of epinephrine 
were significantly lower (P < 0.001) and plasma concentrations of insulin significantly 
higher (P < 0.005) than in the older age groups. Postoperative pain scores (P < 0.003) and 
morphine consumption (P < 0.001) were significantly lower in the neonates than in the 
older age groups. Our results show that continuous infusion of morphine does not provide 
any major advantages over intermittent morphine boluses for postoperative analgesia in 
neonates and infants. 
2.2 Introduction 
In adults, endocrine and metabolic responses to severe injury consist of a hypometabolic 
period, which lasts about 3 days, followed by a hypermetabolic period.1.2 As a result of 
this homeostatic disturbance, cellular dehydration, capillary leakage and organ 
dysfunction may occur, leading to a prolonged convalescence period3 Although this 
endocrine-metabolic response can be modified by surgical anaesthesia, important 
reductions in stress responses depend on the analgesic method in adult patients,'·'·' and in 
children7 Epidural anaesthesia was more effective in reducing surgical stress during low 
abdominal surgery than systemic opioids8 Diminished stress responses and improved 
postoperative outcomes were noted after high-dose opioids in neonates after cardiac 
surgery9 ·10 More recently, the use of i.v. opioids in non-surgical, mechanically ventilated 
neonates resulted in reduced physiological and behavioural measurements of pain and 
stress 11 •12 and was associated with fewer periods of hypoxaemia13 and improved 
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neurological outcomes. 14 Because of the lack of randomized controlled trials in neonates 
and infants, 15 little is known about the alterations in hormonal-metabolic stress responses 
caused by postoperative analgesia or postnatal age in patients undergoing non-cardiac 
surgery. 
This study was designed as a double-blind, randomized controlled trial to test the 
hypothesis that postoperative analgesia with continuous morphine infusions would 
provide improved analgesia with lower stress responses compared with intermittent doses. 
To obtain more information about physiological and behavioural responses after major 
surgery in young children, surgical stress was evaluated by measuring hormonal, 
metabolic, and haemodynamic variables and postoperative pain was assessed by 
behavioural responses [COMFORT and a visual analogue scale (VAS)] and by the 
amount of morphine used. The ontogeny of these responses is unknown because of the 
paucity of data beyond the neonatal age group. Therefore, we randomised the patients into 
four developmentally relevant age groups. 16 
2.3 Methods 
The study protocol was approved by the hospital medical ethical committee, and written 
consent was obtained from the parents. We included children aged 0- 3 yr, admitted to 
the paediatric surgical intensive care unit (PICU) after non-cardiac thoracic and 
abdominal surgery. Patients were excluded if they had received analgesic or sedative 
drugs < 6 h before surgery, if they were receiving neuromuscular blockade or if they 
suffered from hepatic, renal, or neurological disorders or altered muscle tone. Patients 
were stratified by age into four groups [group I, 0- 4 weeks (neonates); II, 4 weeks to 26 
weeks; Ill, 26- 52 weeks, IV, I - 3 yr] and were assigned randomly to receive i.v. either 
continuous morphine (CM) or intermittent morphine (IM). The pharmacists prepared all 
study drugs, and strata-specific schedules for randomisation, and the clinical staff were 
blinded to the study group allocation until the data collection was complete. 
Anaesthetic management was standardized. Anaesthesia was induced i.v. with 
thiopentone 3-5 mg kg-1 or by inhalation of halothane in oxygen. Fentanyl 5 ~g kg-1 was 
given before orotracheal intubation, which was facilitated with atracurium 0.5- l mg kg-1 
or suxamethonium 2 mg kg-1 Ventilation was controlled and anaesthesia was maintained 
with isoflurane 0.5 minimum alveolar concentration in 60 %nitrous oxide in oxygen or 
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air in oxygen. Perioperative fluids were standardized to maintain a glucose infusion rate 
between 4-6 mg kg-1 min-l Body temperature was kept within normal ranges. A 
peripheral artery was cannulated and the measured mean arterial blood pressure (MAP) 
and heart rate (HR) were used as preoperative baseline data. After the first arterial blood 
sample (baseline), patients received a second dose of fentanyl 5 !Lg kg -I before surgical 
incision. Additional doses of fentanyl2 11g kg-1 were administered when HR and/or MAP 
were 15 % above baseline value. At the end of surgery, the neuromuscular block was 
antagonized and the tracheal tube was removed. Mechanical ventilation was continued in 
patients who required ventilatory assistance after surgery. 
Directly after surgery, all patients received an i.v. loading dose of morphine (100 11g kg-1) 
followed by a morphine infusion of 10 11g kg-1 h-1 for children in the CM group, 
combined with three-hourly i.v. placebo (saline) boluses. Children in the IM group 
received a continuous placebo infusion (saline) combined with three-hourly i.v. doses of 
30 11g kg-l The first intermittent bolus (morphine or placebo) was given 3 h after surgery. 
Additional analgesia was given by the nurse when there were signs of pain, indicated by a 
VAS score~ 4. During the first hour after surgery, one-third of the loading dose of 
morphine could be repeated every 15 min, and thereafter morphine 5 11g kg-1could be 
given every 10 min if required. No other analgesic or sedative drugs were used. 
Arterial blood samples were taken after induction of anaesthesia, at the end of surgery and 
6, 12, and 24 h after surgery to determine plasma concentrations of epinephrine, 
norepinephrine, insulin, glucose and lactate. From 24 to 36 h after surgery, urine was 
collected for determination of the 3-methyl histidine/creatinine molar ratio (3MH/CR), a 
measure of protein breakdown. 
After surgery, the Surgical Stress Score (SSS) 17 was computed by the surgeon and 
anaesthetist. Nurses performed regular assessments before surgery (baseline) and every 3 
h up to 36 h after surgery. Nursing interventions included pain assessment using a VAS 
and the COMFORT scale,18 blood sampling (as indicated), giving the intermittent bolus 
(placebo or morphine), and then nursing as needed. Thus, hormonal and metabolic stress 
responses were measured as plasma concentrations at time points corresponding to trough 
plasma concentrations in the IM group. 
The SSS consists of seven items: amount of blood loss; site of surgery; amount of 
superficial trauma; extent of visceral trauma; duration of surgery; associated stress factors 
(hypothermia, localized or generalized infection and prematurity); and cardiac surgery. 17 
The total scores in this study (excluding cardiac surgery and prematurity < 35 weeks) 
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ranged from 3 to 24, and were used to classify the degree of surgical stress. 
The VAS, a horizontal continuous 10 em line with the anchor points 'no pain' on the left 
and 'extreme pain' on the right, was used as an observational instrument. VAS scores < 4 
indicate absent or mild pain and scores ~ 4 indicate moderate to severe pain, as noted 
from previous studies in children. 
The COMFORT scale 18 ' 19 was originally developed and validated to assess distress in 
children ventilated mechanically (0-18 yr). This scale consists of six behavioural items 
(alertness, calmness, respiratory response, movement, muscle tone and facial tension) and 
two physiological items (MAP and HR). For non-ventilated children, the respiratory 
response item was replaced by an assessment of crying, possible scores ranging from 1 
(no crying) to 5 (screaming). Total score ranges from 8 to 40. We have recently validated 
the COMFORT scale as a measure of postoperative pain in this age group20 
Plasma concentrations of epinephrine and norepinephrine were measured by HPLC using 
fluorimetric detection21 Plasma concentrations of insulin were measured using the Insulin 
IRMA CT kit (Medgenix). Standardized automated laboratory analysers measured plasma 
concentrations of glucose, lactate, total bilirubin and plasma and urinary creatinine. The 
concentration of urinary 3-methylhistidine was measured by ion exchange 
chromatography on an amino acid analyser. 
In previous studies, a SD of 0.6 nmollitre-1 was found for epinephrine and 1.4 nmollitre· 1 
for norepinephrine. 10 To detect differences between the group values for plasma 
epinephrine (0.24 nmollitre-1) and norepinephrine (0.56 nmollitre- 1) with a power of 80% 
at a two-sided alpha error of 0.05 would require 100 patients in each group. Repeated 
measurements analysis of variance (RmANOV A)22 was used to evaluate simultaneously 
the effects of treatment, age groups and time after surgery. Plasma concentrations before 
surgery and changes from baseline values directly after surgery were compared between 
age groups using one-way ANOV A. Comparison with baseline values within age groups 
was done by the paired t-test. In these analyses, all hormonal and metabolic data had to be 
transformed logmithmically in order to obtain approximately normal distributions. The 
postoperative time points (directly after surgery and 6, 12 and 24 h after surgery) at which 
individual plasma concentrations were highest were compared between age groups using 
the Kruskal-Wallis/Mann-Whitney test. The same tests were used to compare morphine 
consumption between groups. Correlation coefficients given are Spearman's. 
All enrolled patients were included in an intention-to-treat analysis. Nine patients dropped 
out during the study (five in CM, four in IM) because of the loss of arterial access (seven), 
the need for neuromuscular blockade (one) and one postoperative death 3 h after surgery. 
20 Chapter 2 
2.4 Results 
Table I shows the clinical and surgical characteristics of the enrolled patients according to 
their age categories and randomized treatment groups. 
A total of 204 patients were enrolled: 101 in the CM group and 103 in the IM group. The 
randomisation schedule was stratifred for age; other demographic and clinical variables 
were similar in the two randomised groups. Thirteen of the 35 neonates in CM (37%) 
were ventilated mechanically before surgery compared with six of the 33 in the IM group 
(18 % ). This difference was not significant. 
For various reasons, 23 patients needed mechanical ventilation before surgery, seven of 
them for acute inflammatory surgical complications. 
The median doses of fentanyl for age groups I, II, III and IV were 12, 12, 17 and 15 11g 
ki1, respectively. Fentanyl doses did not differ significantly between the two treatment 
groups in any of the age groups (all P > 0.14). The fentanyl dose correlated significantly 
with the duration of surgery (R = 0.43, P < 0.001). The age groups were similar with 
respect to SSS. 
Hormonal and metabolic stress responses 
Table 2 shows the median and interquartile range of the hormonal and metabolic variables 
before and after surgery (average of 6, 12 and 24 h after surgery) according to age and 
treatment. 
Overall, no significant differences in plasma concentrations were found between the 
randomized treatment groups (all analyses: P 2: 0.22). For glucose, a significant 
interaction was found between the effects of treatment and age (P = 0.04), indicating that 
the treatment difference was not the same in all age groups. Further analysis within each 
age group showed that blood glucose concentrations were lower in the CM group (16 %, 
P = 0.003) than in the IM group in the oldest age group (1-3 yr), although an opposite 
trend was noted amongst the neonates (CM > IM, P = 0.07). 
Figure 1 shows the geometric mean plasma concentrations with the SE for epinephrine, 
norepinephrine, insulin, glucose and lactate and the insulin/glucose ratio, for all patients, 
according to age, and at the various time points (before and at the end of surgery and 6, 12 
and 24 h after surgery). 
Table 1 Patient data [mean (range or SD)] and detail.<; ojsurge1y. CM = continuoU.\' mmphine; IM =intermittent morphine; n =number ofpatients. High abdominal 
surge~y comprised diaphragmatic hernia/paresis, duodenal atresia, subtotal pancreatectomy, Nissen jimdop!ication, hepatic and choledochal surge1y, 
( ad)rena! surgery, stomic pe1jOration. Supe~jicial surge1y comprised nefrectomy, ureter reimplantation, pyeloplasty,and operationsfor extrophy of the 
bladde1~ sacroteratoma, yolk sac tumour, pull-through, incarcerated hemia. Acute gastrointestinal surge1y comprised operations fOr atresia, malrotation, 
intussusception, necrotizing enterocolitis, meconium peritonitis and pe~fOration, and ileus surgery 
II (4a26 weeks) 1111 (26-52 weeks) 1 1v 11-3 rrl 
1M CM 1M CM 1M CM IM 
(11 = 35) (11 = 33) (11 = 32) (11 = 33) (11 = 16) (11 = 15) (n = 18) (11 = 22) 
Age (days) 8 3 97 101 267 254 632 639 
(range) (0-28) (0-17) (29-173) (30-179) (185-351) (180-330) (368-1070) (393-1067) 
Weight (kg) 3.1 (0.7) 2.9 (0.5) 4.9 (1.5) 4.6 (1.8) 6.9 (1.6) 7.3 (1.2) 11.1 (1.9) 11.1 (2.5) 
Males/females (n) 21/14 19/14 20/12 22/11 917 9/6 9/9 10/12 
Mechanical ventilation before surgery 13 6 4 
Total Surgical Stress Score 9.9 (2.8) 9.9 (2.9) 9.3 (3.3) 9.6 (2.5) 8.4 (3.I) 9.9 (2.7) 10.6 (2.9) IO.I (3.7) 
Generalized or localized infection 5 6 I 1 I 
Surgical procedures 
Congenital diaphragmatic hernia 9 4 
Trachea-oesophageal atresia/TOP 6 9 
Bronchopulmonary (lobectomy, 1 2 I I 5 
pneumectomy, cyst) 
Cardiac (Blalock, vessel loop) I 2 
Nissen fundoplication 2 2 2 2 4 
Gastroschisis 1 1 
Acute gastrointestinal I5 15 l1 5 5 2 3 2 
Colonic pull-through I 2 
Closure of entero/colostoma 7 9 I 3 1 4 
Rehbein's procedure I 4 4 1 3 
Colon interposition 3 
Urological (ncfrcctomy, 1 I 2 I 2 
pyeloplasty, reimplantation, 
bladder augmentation) 
Miscellaneous (diaphragma paresis, tumour, I 2 7 7 5 3 2 7 
teratoma, cyst, pancreatectomy, choledochal 
atresia) 
Site of surgery 
Thoracic 5 8 6 4 2 5 
Abdominal high/low 16/12 61!7 6/I9 8/I9 817 3110 6/3 511I 
Thoracic combined with abdominal 2 3 2 
Superficial 1 2 I I 3 
Table 2 Honnonal and metabolic variables before and after surge!)' (average of 6, 12 and 24 h after surge!)'), according to age and treatment. All values are median 
interquartile range). CM =continuous m01phine; IM = intermittent nw1phi11e; n =number of patients. 
A e roup 
I (neonates, 0- 4 weeks) II (4 weeks- 26 weeks) III (26 weeks- 52 weeks) IV= I -3years 
CM 
" 
IM 
" 
CM 
" 
IM 
" 
CM 
" 
IM 
" 
CM 
" 
IM 
" Epinephlinc (nmolli!Te ) 
before surgery 0.1 (0.03-0.36) 34 0.11 (0.04-0.33) 32 0.07 (0.02-0.2) 29 0.10 (0.05-0.22) 32 O.I 1 (0.05-0.3416 0.16 (0.08-0.37) I 5 0.19 (0.04-0.29) 18 0.10 (0.05-0.65) 21 
after surgery 0.14 (0.05-0.28) 33 0.06 (0.03-0.29) 30 0.56 (0.31-0.97) 27 0.57 (0.36-0.97) 26 1.02(0.6-1.81) 15 1.05 (0.67-1.67) I4 1.42 (0.94-2.02) 15 1.93 (1.43-2.55) 17 
Norepinephrine (nnJOllitre· 1) 
before surgery 1.6 (.98-3.2) 34 1.6 (0.9-2.6) 32 1.1 (0.6-0.9) 29 0.9 (0.6-1.8) 32 !.() (0.6-1.9) 16 1.0 (0.7-1.8) 15 0.8 (0.5-1.5) I8 1.0 (0.4-2.3) 21 
after surgery 2.6 (1.8-4.2) 33 2.1 (1.3-3.2) 30 2.7 (2.0-3.7) 27 2.6 (2.0-4.4) 26 2.6 (1.7-2.9) 15 2.6 (1.7-3.1) 14 2.4 (1.5-2.9) I5 2.3 (1.8-3.6) 17 
Insulin (mU litre. 1) 
before surgery 5.0 (5.0-8.0) 31 5.0 (5.0-7.5) 29 5.0 (5.0-8.0) 3I 5.0 (5.0-5.8) 32 5.0 (5.0-5.0) 16 5.0 (5.0-9.0) 15 5.0 (5.0-7.0) 18 5.0 (5.0-6.0) 22 
after surgery 13.8 (9.4-17.1) 32 12.0 (8.5-19.6) 28 11.0 (8.7-14.3) 27 8.3 (6.0-12.2) 25 7.0 (5.7-11.3) 15 9.7 (7.5-12.6) 14 6.7 (5.3-!0.D) 15 10.0 (6.8-12.8) 17 
Glucose (mrnollitrc· 1) 
before surgery 5.5 (3.9-7.1) 35 5.7 (3 9-7.1) 32 5.8 (4.5-6.8) 31 5.6 (4.5-6.3) 32 4.5 (4.I-5.8) 16 5.6 (4.6-6.2) 15 4.5 (3.9-5.5) IH 4.9 (3.7-6.0) 22 
after surgery 5.8 (5.2-6.7) 34 5.I (4.5-6.7) 31 6.3 (5. I -6.5) 27 5.6 (5.1 -7.0) 25 5.8 (5.5-6.3) 15 6.3 (5.7-6.6) 14 5.9 (4.4-6.3) 15 6.7 (5.8-7.1) 18 
Lactate (mmollitre. 1) 
before surgery 1.9 (1.3-2.7) 35 2.1 (1.3-2.8) 3I 1.2 (1.0-1.4) 29 1.1 (0.8-1.3) 32 1.2 (0.9-1.5) 16 1.0 (0.9-1.5) 15 1.2 (0.8-1.5) 17 1.1 (0.8-1.3) 22 
after surgery 1.5 (1.2-1.8) 32 1.5 (1.2-2.2) 29 1.2 (0.8-1.4) 25 1.0 (0.8-1.3) 24 0.9 (0.8-1.0) 15 0.8 (0.8-1.0) 14 0.9 (0.8-1.0) 15 0.9 (0.7-1.0) 17 
Insulin/glucose ratio (Umol. 1) 
before surgery 1. I (0.8-2.5) 3I l. I (0.8-1.6) 28 1.1 (0.9-1.5) 3I 1.0 (0.9-1.4) 32 1.2 (1.1-1.3) I6 1.1 (0.9-1.3) I5 1.2 (1.1-1.3) 18 1.1 (0.9-1.5) 22 
after surgery 2.2 (1.8-3.0) 34 2.3 (1.7-3.1) 33 1.9 (1.6-2.5) 29 1.6 (1.1-2.0) 30 1.2 (1.0-2.1) I5 1.5 (1.3-2.1) IS 1.4 (1.1-1.7) 18 1.4 (1.0-1.9) 21 
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Plasma concentrations of epinephrine before surgery were not significantly different 
between the age groups. The mean increase in plasma epinephrine concentration directly 
after surgery was significantly lower in the neonatal group than in the other age groups 
(1.6 vs 6- 8 times baseline value, P < 0.001), and no significant differences occuued 
between the older age groups. The mean values of the average postoperative plasma 
concentration of epinephrine (6, 12 and 24 h after surgery) were significantly lower in the 
neonatal group than in the older children (all P < 0.001). RmANOV A showed that 
postoperative decreases in plasma epinephrine differed significantly between the age 
groups (P < 0.001). In the neonates the mean plasma concentration of epinephrine had 
returned to the baseline value 6 h after surgery and was below the baseline value at later 
time points (P < 0.05). In the older age groups, mean values were still above baseline 24 
h after surgery (all P < 0.001). The highest plasma concentrations were mostly found 
directly after surgery in age groups I and III, and 6 h after surgery in age groups II and 
IV. Plasma epinephrine concentrations were not significantly different with respect to 
spontaneous or mechanical ventilation. 
Plasma norepinephrine concentrations at baseline were significantly higher in the 
neonates than in age group II (P = 0.01) and nearly so in comparison with age groups III 
and IV (both P = 0.06). The increases in plasma norepinephrine concentrations (6, 12 and 
24 h after surgery) compared with baseline values were significantly smaller in the 
neonates than in age groups II (P = 0.004) and III (P = 0.05). The mean average plasma 
concentration of norepinephrine (6, 12 and 24 h after surgery) showed no significant 
differences between age groups or assessment times. Only for the oldest age group was 
there a significant increase in plasma concentrations 6 h after surgery (P = 0.03). No 
significant differences were found between age groups regarding the time at which 
individual patients reached the highest plasma concentration. In all age groups, plasma 
concentrations of norepinephrine were still significantly above baseline values 24 h after 
surgery (all P < 0.001). Neonates who were ventilated mechanically showed significantly 
higher plasma concentrations of norepinephrine before operation compared with the non-
ventilated neonates (P = 0.02). This difference was not significant in the postoperative 
period. In patients of age group II ( 4 - 26 weeks) needing mechanical ventilation after 
surgery, there were significantly higher plasma concentrations of norepinephrine 
compared with the non-ventilated children of that age group (P = 0.02). 
Plasma insulin concentrations at baseline were not significantly different between the age 
groups; however, directly after surgery, plasma concentrations were significantly higher 
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in the neonates than in age group III (P = 0.002), and IV (P < 0.001). The average plasma 
concentration of insulin (6, 12 and 24 h after surgery) showed a significant correlation 
with age (r = -0.34, P = < 0.001). 
Plasma glucose concentrations before surgery were not significantly different between the 
age groups and they were generally highest directly after surgery in all age groups. 
RmANOV A of glucose plasma concentrations 6, 12 and 24 h after surgery showed a 
significant decrease after surgery (P < 0.001). At 24 h after surgery, mean plasma 
concentrations were not significantly different from baseline values in all age groups. 
The insulin/glucose ratio was not significantly different before operation, but showed 
significant differences after surgery between the age groups in their patterns of 
postoperative changes. There was a significant correlation (r = -0.45, P < 0.001) between 
age and insulin/glucose ratio 6, 12, and 24 h after surgery. At 24 h after surgery, the mean 
insulin/glucose ratio was still above baseline for all age groups. 
The mean plasma concentration of lactate at baseline was significantly higher in the 
neonates than in the other age groups (all P < 0.001). Highest concentrations were found 
directly after surgery with no significant difference in the change from baseline values 
between the age groups. In the neonatal group there was a significant decrease from 6 to 
24 h after surgery (P = 0.02). A similar effect was found in age group IV (P < 0.001), but 
tbere were no significant postoperative differences for age groups II and III. Mean plasma 
concentrations of lactate were significantly below baseline values 24 h after surgery (all P 
oo; 0.001). There was no significant difference in the minary 3-MH/Cr ratio (from 12 to 36 
h after surgery) between the randomized treatment groups or the age groups. 
Plasma concentrations of epinephrine (P = 0.01) and norepinephrine (P = 0.003) were 
significantly higher after upper abdominal surgery than after thoracic or superficial 
surgery. A repeated analysis that excluded the eight patients with "superficial" surgery 
(Table!) gave results similar to those in Table 3. In 14 patients (11 of them neonates) 
hormonal and metabolic stress responses may have been influenced by acute, 
inflammatory surgical complications. A repeated analysis that excluded the 14 patients 
with "localised or generalised infection" again gave results similar to those in Table 3. 
Significantly higher plasma concentrations of norepinephrine occurred after blood 
transfusion in neonates compared with neonates without transfusion at 6 (P = 0.01), 12 (P 
= 0.07) and 24 h (P = 0.03) after surgery. These differences were not found in the other 
age groups. 
Table 3 Comparison between continuous morphine (CM) and intermittent morphine (IM) by 
RmANOVA, while controlling for age group (1, II, III and IV), sampling time (6, 12 
and 24 h after surge1y) and preoperative (baseline) plasma concentration. Data are 
the ratio of geometric means (0"'11/IM). *Significant differences between the age 
groups: I, I.I2 (P = 0.07); II, 0.99 (P = 0.75); III, 0.96 (P = 0.57); IV, 0.84 (P = 
0.003). 
Variable Ratio (CMIIM) 95% CL p 
Epinephrine 1.08 0.81-1.44 0.59 
Norepinephrine !.05 0.91-1.20 0.51 
Insulin 0.92 0.81-1.05 0.22 
Glucose 0.98* 0.95-!.04 0.52 
Insulin/glucose ratio 0.97 0.86-1.08 0.55 
Lactate 0.98 0.90-1.07 0.67 
Blood pressure and heart rate 
RmANOV A showed that postoperative increases in MAP (3 - 36 h after surgery) from 
baseline values depended on age. Significantly greater increases in the IM group 
compared with the CM group were found in age group Ill [12.0 (SD 5.8) mm Hg, P = 
0.04] and within age group IV [10.6 ( 4.4) mm Hg, P = 0.02], but no significant 
differences were found in the other age groups. 
In the neonates, mean HR at baseline was significantly higher in the CM than in the IM 
group (P = 0.03). Increases in HR at the end of surgery or postoperatively were not 
significantly different between the two treatment groups. However, the change from 
baseline HR increased significantly with age (P = 0.002), with maximum values recorded 
6 h after surgery for all age groups. 
Pain assessment 
Postoperative pain scores, morphine consumption during the first 24 h after surgery and 
the number of patients needing postoperative mechanical ventilation during > 36 h after 
surgery are shown in Table 4. 
Mean VAS scores (3 - 36 h after surgery) were significantly different between the age 
groups hut not between the CM and IM groups. VAS scores generally declined with time 
after surgery. More than 24 h after surgery, the mean VAS was still significantly higher in 
age group II than in each ofthe other age groups (all P < 0.04). 
The mean VAS scores were significantly lower in the neonates (1.3) than in the three 
older age groups (2.4, 2.1, and 1.8 respectively) (all P < 0.003) and in group IV compared 
with group II (P < 0.001). VAS scores of~ 4 occmTed less frequently in neonates than in 
the older age groups (P < 0.002) and in group IV compared with age group II (P = 0.004). 
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The occurrence of VAS ;:> 4 was con-elated significantly with plasma concentrations of 
norepinephrine, but only in age groups III and IV at 6 h after surgery (both P < 0.05). 
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The mean COMFORT score (3 - 36 h after surgery) was significantly different between 
CM and IM only in age group IV (18.8 and 20.8, respectively), (P ~ 0.02). Overall the 
mean COMFORT score was significantly (P < 0.001) lower in the neonates (17.4) than in 
the older age groups (21.4, 20.6 and 19.8 respectively). Generally, the plasma 
concentrations of epinephrine and norepinephrine were weakly Co!Telated with 
COMFORT scores at the vatious time points. 
Morphine consumption (excluding the loading dose) during the first 24 h after surgery 
was significantly different between the age groups, but not between the CM and IM 
groups. The morphine consumption during the first 24 h after surgery was significantly 
lower in the neonatal group than in the age groups Il, III and IV, (all P < 0.001), and 
significantly higher in group II versus !V (P ~ 0.035). 
2.5 Discussion 
We present the first randomized, placebo-controlled trial that includes a double-blind 
assessment of the clinical and physiological effects of continuous vs intermittent 
morphine for postoperative analgesia in neonates and older infants. In addition, we report 
important differences between the different age groups that will allow deeper 
understanding of the ontogeny of hormonal-metabolic stress responses in early life. 
Although the post-neonatal period is associated with major changes in the regulation of 
the hypothalamic-pituitary-adrenal axis and the hypothalamic sympathetic outflows (via 
the posterior hypothalamic nuclei and locus coeruleus), the effect of these developmental 
events on the neuroendocrine responses to surgical stress remains unclear. 
On the basis of these data, we can reject our primary hypothesis that continuous infusions 
of morphine postoperatively produce improved postoperative analgesia and lower 
honnonal-metabolic responses. Although supplementary doses of morphine were used to 
treat clinical signs of distress after surgery, standard criteria were used for these 
treatments in the CM and !M groups. Clinical bias was eliminated by a double-blind study 
design and total morphine consumption was similar in the two randomized groups. The 
additional morphine doses were considered to be necessary for the patient's comfort and 
for ethical reasons. In infants aged 1-3 yr, greater degrees of stress were noted in the !M 
group than in the CM group, as noted by significant increases in postoperative 
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hyperglycaemia, mean arterial pressure and clinical assessment by the COMFORT score. 
Because these measurements were performed at the time of trough morphine 
concentrations for the JM group, these differences may have been caused by the relatively 
great plasma clearance of morphine in this age group23"25 Thus, it is likely that the longer 
duration of opioid effect after intennittent morphine boluses in the younger age groups 
resulted in clinical and physiological effects that were similar to those of a continuous 
infusion. 
Similar clinical trials in adult patients have reported conflicting results, suggesting 
super:ior26 equivocal27 or inferior28 clinical effects of continuous i. v. infusions vs 
intermittent doses of morphine for postoperative analgesia. To our knowledge, a similar 
clinical trial has not been reported in paediatric patients, although several studies 
comparing i.v. with epidural morphine analgesia have been reported29 
These data indicate that the pattern of surgical stress responses differs between neonates 
(postnatal age 0- 4 weeks) and older age groups. Robust developmental differences were 
found for the postoperative changes in hormonal-metabolic variables (plasma 
epinephrine, norepinephrine, insulin and lactate), cardiovascular responses (MAP and 
HR), behavioural variables used for pain assessment (VAS and COMFORT scores), and 
postoperative morphine consumption. 
Compared to previous data,30 the magnitude of postoperative epinephrine responses was 
reduced in these neonates because of the effective anaesthetic and analgesic regimens 
used in the present study, although the brief duration of this response was similar to those 
in previons data30 Neonates with complex congenital heart defects were able to mount 
greater epinephrine responses, 10 suggesting that neonates are capable of increasing their 
production of epinephrine depending on the level of surgical stress. Decreased plasma 
concentrations of epinephrine at the end of surgery and decreased postoperative VAS and 
COMFORT scores in the neonates compared with older infants suggest that the doses 
used for fentanyl anaesthesia during surgery and postoperative morphine analgesia were 
inadequate for the older infants 31 This is further corroborated by the greater amounts of 
additional postoperative morphine required by the older infants than by the neonates. 
These findings can be explained by developmental differences in pharmacokinetic and 
pharmacodynamic factors between neonates and older infants. In studies comparing the 
effect of i.v. opioids (fentanyl at a mean dose of 1.3 f!g kg-1 and morphine to a maximum 
of 0.2 mg kg-1) with spinal and extradural analgesia during major surgery in infants (0- 4 
yr), all methods gave adequate postoperative analgesia, but more effective suppression of 
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epinephrine and norepinephrine was found in the spinal and extradural groups8 In the 
present study, the mean plasma concentrations of epinephrine and norepinephrine were 
similar to those of the spinal and extradural groups, suggesting that the fentanyl doses 
were adequate even for high abdominal and thoracic surgery. Most full-term infants older 
than 4 weeks did not require mechanical ventilation, because they had opioid-induced 
ventilatory depression. 
In contrast with the neonates, the older age groups had plasma concentrations of 
epinephrine that remained increased during the first 24 h after surgery, which might have 
been a result of additional stress factors operative in older infants, such as their emotional 
reactions to a strange environment, hunger, and separation anxiety. Alternatively, greater 
catecholamine responses may have resulted from direct or reflex stimulation of the 
efferent nerves supplying the adrenal glands during upper abdominal surgery.32 
The significantly higher plasma concentrations of nor-epinephrine at baseline in the 
ventilated than in the non-ventilated neonates might be explained by the withdrawal of 
sedative and analgesic drugs before surgery (according to the study protocol) in a limited 
number of patients. 
Preoperative neonatal plasma concentrations of lactate were comparable with those in 
previous studies. 10 Baseline values of the present study are not quite comparable with 
published results8·10 because the first blood sampling in the present study occurred after 
the administration of fentanyl anaesthesia, whereas in the other studies baseline samples 
were drawn before analgesia. 
Neonates had lower pain scores and needed less morphine than older children, probably 
because of the increased morphine metabolism more than 4 weeks after birth, resulting 
from closure of the ductus venosus and maturation of hepatic enzymes.33·34 
We found no consistent correlation of physiological signals of acute pain (plasma 
concentration of epinephrine and norepinephrine) with behavioural pain scores (VAS and 
COMFORT scale). 
The results of the present study allow us to draw important clinical and physiological 
conclusions. We can resolve the clinical controversy regarding continuous vs intennittent 
morphine analgesia. We have shown that neonates and infants up to 1 yr of age can be 
given intermittent morphine doses, thereby avoiding the excessive fluid intake and the 
need of infusion equipment. Older infants (1-3 yr) may require either a continuous 
infusion or more frequent dosing regimens (every 1-2 h) or judicious increases in the 
intermittent doses used for postoperative morphine analgesia. 
Tablc4 
VAS score* 
Pustupemtive p!lin scores [mean (SD )], 11101phine conmmption in the flrst 24 h after surge1y (e).-duding loading dose), [median (interquartile IWJ!{e)], and 
number of patients ventilated mechanically> 36 h after surgery. The range of the visual analogue scale (VAS) i~· 1- 10 and that of the COMFORT Kore is 3 
- 24. *Average ~fvalua 3, 6, 9, /2, I 5, I 8, 21, 24, 27, 30, 33, and 36 h after surgery. CM = continuous 11101phine; J!vl = intermittent morphine; 11 = number 
of patients. 
Age gr~!P _______ _ _ 
I= Neonates (0- 4 weeks) II= 4 -26 weeks III= 26 - 52 weeks IV= l-3years 
----··-- -·- ----··----·-·- .. --. 
__________ , ______________ _ 
CM uiM nCM uiM 11CM niM II CM II 1M 
" 
_______ , ___ , __________________________________ ,,_, __ , ______________________ _ 
1.3 (0.8) 34 1.3 (0.5) 32 2.6 (0.8) 28 2.3 (0.9) 29 2.0 (0.8) 15 2.1 (0.8) 14 1.5 (1.2) 16 2.1 (1.2) 20 
COMFORTscore* 17.4(2.9) 31 17.3 (2.3) 28 21.8 (2.0) 26 21.0(3.1) 27 20.2(3.1) 15 21.2 (3.1) 12 18.7 (3.1) 15 2.1 (2.6) 17 
Morphine (Jlg kg- 1 h-1) 10.0 34 10.0 33 12.3 29 11.6 30 11.7 15 12.1 15 10.9 17 11.0 21 
(10.0-11.3) (10.0-10.5) (11.2-17.8) (10.2-14.8) (10.4-14.9) (10.2-15.2) (10.2-1 1.5) (10.0-15.4) 
Mechanical ventilation 26 15 4 7 0 1 2 2 
> 36 hours after 
surgery 
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In addition, we have documented significant differences in hormonal and metabolic stress 
responses, physiological variables, behavioural responses and morphine consumption 
between neonates and older infants. These differences may result from the developmental 
changes in opioid pharmacology that occur in early infancy. Either neonates are unable to 
mount robust behavioural responses to postoperative pain or they may need less morphine 
for satisfactory behavioural pain scores. It is also evident that neonates need analgesia 
and/or sedation during mechanical venti]ation in order to control catecholamine 
responses. In the different age groups between 4 weeks and 3 yr, we found similar 
patterns of hormonal-metabolic responses, behavioural responses and postoperative 
morphine consumption (although minor differences were found between infants aged 4-
26 weeks and 1-3 yr). 
We speculate that combined therapy with different classes of analgesic and sedative dmgs 
will provide more effective control of physiological and behavioural responses, especially 
in children 1-3 yr of age, who may have a high level of anxiety in the PICU. Further 
studies are needed to establish the efficacy and safety of such combinations. We strongly 
support the recent editorial calling for more randomized clinical trials to investigate 
analgesic regimens in young children, due to the absence of validated clinical protocols 
for infants undergoing surgery." Not only will these studies provide a scientific 
framework for the postoperative management of neonates and young infants, but they 
may also provide clues about the development of pain and stress-responsive systems in 
the developing brain. 
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3.1 Abstract 
Background 
To investigate clinical variables such as gestational age, sex, weight, the therapeutic 
regimens used, and mechanical ventilation, which might affect morphine requirements 
and plasma concentrations of morphine and its metabolites. 
Design 
Randomized double-blind study 
Setting 
Paediatric Surgical Intensive Care Unit 
Methods 
Neonates and infants stratified for age (group I, 0- 4 weeks (neonates); group II, 4- 26 
weeks; group Ill, 26 - 52 weeks; group IV, I - 3 yr), following abdominal or thoracic 
surgery, received morphine 100 ).lg kg·' after surgery, and were randomly assigned to 
either continuous morphine (CM, 10 ).lg kg.1h- 1) or intermittent morphine boluses (IM, 30 
).lg kg-1 every 3h). Pain was measured with the COMFORT behavioural scale and the 
Visual Analogue Scale. Additional morphine was administered on guidance of the pain 
scores. Morphine (M), morphine-3-glucuronide (M3G) and morphine-6-glucuronide 
(M6G) plasma concentrations were determined before, directly after, and at 6, 12 and 24 h 
after surgery. 
Results 
Multiple regression analysis of different variables revealed that age was the most 
important factor affecting morphine requirements and plasma morphine concentrations. 
Significantly fewer neonates required additional morphine doses as compared with all 
other age groups (P < 0.001). Method of morphine administration (intermittent vs. 
continuous) had no significant influence on morphine requirements. Neonates had 
significantly higher plasma concentrations ofM, M3G and M6G (all P < 0.001), and 
significantly lower M6G/M ratio (P < 0.03) than the older groups. The M6G/M3G ratio 
was similar in all age groups. 
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Conclusion 
Neonates require a narrower therapeutic window for postoperative morphine analgesia 
than older age groups, with no differences in the safety or effectiveness of intermittent 
doses compared to continuous infusions in any of these age groups. In infants > I month 
of age analgesia is achieved after morphine infusions ranging from I 0.9 to 12.3 ~g kg.1h-1 
at plasma concentrations of< 15 ng m1 - 1• 
3.2 Introduction 
Morphine is the most frequently used agent for postoperative analgesia in neonates, 
infants and children. 1·5 Therapeutic plasma concentrations of morphine depend on factors 
such as route of administration, total body clearance and volume of distribution, which 
are affected by the age, hepatic function, renal function and clinical condition of these 
patients. 6' 9 As a result of these factors, morphine pharmacokinetic studies have reported a 
noticeable variability between individual patients. 10 Wbile preterm neonates are regarded 
as a separate group with regard to serum half-life and morphine clearance, the distinction 
between term newboms and older infants is less clearly defined. 10 In addition, the 
pharmacodynamics of morphine may change rapidly during infancy, being influenced by 
d 11 h . f .. d 12-14 l. . f . '' II gen er, t e maturatiOn o · op101 receptors, ear 1er expenences o pam, as we as 
social and cultural factors16 
Despite the reported variability, most previous studies have investigated the effects of 
morphine only in 4- 20 patients within the different age groups, 10 thus precluding their 
ability to examine the effects of underlying clinical and demographic factors. 
We designed a prospective study including larger numbers of patients in each age group, 
enabling us to elucidate the impact of various clinical and demographic variables on both 
morphine requirements and morphine pharmacokinetics. In the same patient population, 
we have recently reported the effects of morphine administration on their hormonal and 
metabolic stress responses following major surgery. 17 
3.3 Methods 
After approval from the medical ethics committee for the Erasmus MC, Rotterdam, 
written consent was obtained from all parents. We included 204 children, aged 0 to 3 
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years, admitted to the paediatric surgical intensive care unit following non-cardiac 
thoracic and abdominal surgery. Patients were excluded if they had received morphine 
< 6 h prior to surgery, or suffered from hepatic, renal or neurologic disorders. Patients 
were stratified into four age groups: I) 0- 4 weeks, II) 4 to 26 weeks, Ill) 26 to 52 weeks, 
IV) I - 3 years. They were randomly assigned to receive either intravenous continuous 
morphine (CM) or intermittent morphine (IM). The pharmacist prepared all study drugs 
and strata-specific schedules for randomisation. For each age group the boxes with study 
drugs were numbered consecutively and used in sequence. Each included patient received 
a study number, consisting of a number of the age group (I to IV) and a sequence number 
(1 to 68). Anaesthetic management was standardized in all patients. Anaesthesia was 
induced with i. v. thiopentone 3 - S mg kg -I or, when i. v. induction was impossible, by 
inhalation of halothane in oxygen(< 5% of the patients). After the insertion of an i.v. 
line, the anaesthetic procedure was similar for all patients. Fentanyl S ~g kg-1 was given 
before orotracheal intubation, which was facilitated with atracurium 0.5- I mg kg-1 or 
suxamethonium 2 mg kg-1 Ventilation was controlled and anaesthesia was maintained 
with isoflurane 0.5 minimum alveolar concentration (MAC) in 60 % nitrous oxide in 
oxygen or air in oxygen. Perioperative fluids were standardized to maintain a glucose 
infusion rate between 4- 6 mg kg-1 min-1• Body temperature was kept within normal 
ranges. A peripheral artery was cannulated and the measured mean arterial blood pressure 
(MAP) and heart rate (HR) data served as preoperative baseline data. Patients received a 
second dose of fentanyl 5 ,ug kg-1 before surgical incision and additional doses of fentanyl 
2 ~g kg-1 when HR and/or MAP were 15% above baseline value. At the end of surgery, 
the neuromuscular block was antagonized and the tracheal tube was removed. Mechanical 
ventilation was continued in patients who required ventilatory assistance after surgery. 
The anaesthetist and the surgeon then jointly computed the Surgical Stress Score (SSS) to 
classify the degree of surgical stress. 18 This measure takes into account seven items: 
amount of blood loss, site of surgery; amount of superficial trauma, extent of visceral 
trauma, duration of surgery, associated stress factors (hypothermia, localized or 
generalized infection and prematurity), and cardiac surgery. The total scores in this study 
(excluding cardiac surgery and prematurity< 35 weeks) could range from 3 to 24. 
Directly after surgery all patients received an intravenous loading dose of morphine 
hydrochloride (100 ~g kg-1 in 2 min), followed by a morphine infusion of 10 11g kf 1 h-1 
for children in the CM group, combined with three-hourly intravenous placebo (saline) 
boluses. Children in the IM group received three-hourly intravenous morphine doses of 
30 ~g kg-1, combined with a continuous placebo infusion (saline). The amount of glucose 
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and the volume of fluid was the same in both treatment groups. The clinical staff were 
blinded to the study group allocation until data collection was complete. 
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The continuous infusion started within 30 min after the loading dose, the first intermittent 
bolus (morphine or placebo) was given 3 h after surgery. 
Pain was assessed by nurses trained in the use of the behavioural pm1 of the COMFORT 
Scale (CS), 19'20 of which total scores could range from 6 to 30, and the Visual Analogue 
Scale (VAS), ranging from 0 tolO. The modified CS counts six behavioural items: 
alertness, calmness, respiratory response (for mechanically ventilated children) or crying 
(for the non-ventilated children), movement, muscle tone, and facial tension20 VAS 
scores were taken after the 2-minute observation periods needed for the CS. Additional 
analgesia was given when there were signs of pain, indicated by VAS scores ;;:: 4. During 
the first hour after surgery, one-third of the loading dose of morphine could be repeated 
every 15 min, and thereafter morphine 5 11g kg-1 every 10 min if required. Nursing 
interventions included pain assessment, blood sampling and administration of intermittent 
bolus (placebo or morphine) medication, and then nursing as needed. No other analgesic 
or sedative dmgs were used. Arterial blood samples were taken after induction of 
anaesthesia (baseline), at the end of surgery, and at 6, 12, and 24 h after surgery to 
determine blood gas values and plasma concentrations of M, M3G and M6G. Respiratory 
depression was defined by the presence of apnoea or arterial PaC02 values :0: 7.3 kPa in 
spontaneously breathiug patients." Blood samples were taken at time points 
conesponding with trough plasma morphine concentrations in the IM group. 
Morphine and metabolite assay 
Sample preparation 
The blood samples (1.4 ml) were centrifuged at 3000 rpm for 10 min and the serum was 
stored at -20 'C until analysis. 
Serum aliquots (0.6 ml) were extracted with the Baker- !0 extraction system (Baker 
Chemicals, Deventer, the Netherlands) fitted with 1-ml disposable cyclohexyl cmridges 
(C6H6, Baker, cat.nr 7212-01). The extraction column was conditioned with two column 
volumes of methanol, two column volumes of water and I ml of 500 mM diammonium 
sulphate (pH= 9.3). The serum (0.6 ml) was diluted with 0.6 ml 500 mM diammonium 
sulphate (pH= 9.3) before it was brought on top of the extraction column. It was washed 
with 2 ml of 50 mM diammonium sulphate (pH= 9.3) after which it was allowed to dry 
for 15 seconds. The elution was canied out with 0.5 ml 0.01 M KH2P04 buffer, pH= 2.1, 
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containing 11 % acetonnitrile. From this elute 50 J.ll was injected on the analytical 
column. 
Chromatography 
The HPLC system comprised a Spectroflow 400 solvent delivery system (Kratos, 
Rotterdam, the Netherlands) equipped with a degasser (Separations, Hl-Ambacht, the 
Netherlands), a Marathon auto sampler (Separations, HI-Ambacht, the Netherlands), a 
Spectroflow 773 UV detector at 'A= 210nm (Separations, HI-Ambacht, the Netherlands), 
in sequence with an ESA electrochemical detector (ESA, Kratos, Rotterdam; present: 
Interscience, Breda, the Netherlands) equipped with an analytical cell (Model 5010). All 
compounds leave the UV detector chemically intact, and so the electrochemically active 
components can be oxidised in the electrochemical cell. This type of electrochemical cell 
contains two separate analytical cells, which makes it possible to create a small window 
of applied potential. The detector 2 potential was set at 0.4V, while the detector I 
potential was 0.3V. This minimizes interfering peaks because only compounds with an 
oxidation potential from 0.3 to 0.4V are recorded. Chromatographic separations were 
achieved using a Cp-Sper C8 column (250 x 4.6 mm) (Chrompack, Bergen op Zoom, the 
Netherlands). The mobile phase was a 0.01 M KH2P04 buffer, pH= 2.1, containing 11 % 
acetonnitri1e and 0.4 gil heptane sulphonic acid. 
Recovery and reproducibility 
For the measurement of M3G, M6G and morphine, the calibration samples contained all 
three compounds. In serum all calibration graphs (containing 6 data points) were linear: 
for M3G the concentrations ranged from 25- 580 ng/ml (r = 0.9992); for M6G from 5-
100 ng/ml (r = 0.9982) and forM, from 5- 90 ng/ml (r = 0.9963). The quantitation limit 
was 5 ng/ml forM and M6G and 25 ng/ml for M3G. However, in individual samples, the 
chromatogram allowed for a lower threshold. Using these values yes or no should have 
affected the mean plasma concentrations. As we used median values in this study, these 
are not affected by the values under the detection limit. In this concentration range, the 
intra- and inter-day precision were less than 10% for all compounds and the accuracy 
was about 5 %.2223 
Standardized automated laboratory analysers measured plasma concentrations of bilirubin 
and creatinine. 
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Statistical analysis 
Relations between age and the studied plasma concentrations (M, M3G and M6G) were 
investigated using AN OVA We applied multiple regression analysis to detennine the 
effects of the factors gestational age, sex, birth weight, study weight, preoperative and 
postoperative mechanical ventilation, preoperative plasma concentrations of creatinine 
and total bilirubin, SSS, location of surgery, morphine treatment, and a history of 
previous surgery, in addition to age on morphine requirements and plasma concentrations 
of morphine and its metabolites. In all analyses, the morphine and metabolite plasma 
concentrations were transformed logarithmically in order to approximate normal 
distributions. Relations between the various factors and the need (yes/no) for extra 
morphine were assessed by logistic regression analysis. 
All 204 patients were included in an intention-to-treat analysis. Seven had to be excluded 
from morphine data analysis (4 in CM, 3 in IM): five had detectable morphine plasma 
concentrations at baseline due to prior morphine administration (congenital diaphragmatic 
hernia, n = 4; meconium peritonitis, n = I), one patient died within 3 h after surgery 
(vessel loop and therapy resistant pulmonary hypertension, n = 1), and another patient 
required neuromuscular blockade after surgery (hemi-hepatectomy u = 1). Logistic and 
laboratory problems resulted in missing data for several of the 197 included patients. 
Spearman's rho was used for correlation coefficients and the other statistical tests used 
are given in the text. To control the a-error for the multiple statistical tests performed, the 
level of significance was set at P = 0.01, instead of the conventional P = 0.05. The power-
analysis for the comparative randomized trial was given in the original article. 17 In the 
present paper the effects of age and various other factors are investigated with respect to 
morphine requirements and plasma concentrations. With a study group of 200 infants 
correlations as small as r = 0.25 are detectable (alpha= 0.01) with a power greater than 
80%. 
3.4 Results 
Table l gives the clinical and surgical characteristics of the 197 enrolled patients stratified 
by age group and randomized treatment group (97 in the CM group and 100 in the IM 
group). 
Table 1 Patients data and details of surgery in 197 patients. 
I (neonates, 0-4 weeks) II ( 4-26 weeks) III (26-52 weeks) IV (1-3 years) 
CM IM CM IM CM IM CM IM 
(n) 31 32 32 33 16 14 18 21 
Age (days) 4 2 90 95 273 267 613 574 
(range) (0-28) (0-17) (29-173) (30-179) (185-351) (187-330) (368-1070) (393-1067) 
Study weight (kg) 3.2 (0.7) 2.9 (0.5) 5.0 (1.5) 4.7 (I 8) 6.9 (1.6) 7.3 (1.3) I 1.1 (1.9) 11.1 (2.5) 
Birth weight (kg) 3.1 (0.7) 2.9 (0.5) 2.9 (1.2) 2.7 (1.2) 2.7 (0.9) 2.6 ( 1.0) 2.7 (0.7) 3.1 (0.9) 
Gestational age (weeks) 38 (3) 38 (2) 37 (4) 37 (5) 37 (5) 37 (5) 38 (2) 38 (3) 
Boys/girls (n) 19112 18/14 20/12 22/11 9/7 9/5 9/9 9/12 
Plasma creatinine ().lmol r 1) 46 (22) 47 (25) 26 (18) 23 (14) 31 (36) 54 (45) 28 (36) 27 (16) 
Plasma total bilirubin (Jlmol r 1) 91 (67) 108 (56) 23 (39) 35 (55) 15 (31) 7 (3) 6 (2) 7 (3) 
Plasma bilirubin glucuronide (~unol r 1) 6 (4) 9 (8) 14 (26) 23 (42) 12 (32) 2 (1) 3 (I) 3 (I) 
Mechanical ventilation before surgery (n) 10 5 3 0 0 0 0 0 
Mechanical ventilation >24h post surgery (n) 22 14 4 7 0 I 2 2 
Surgical Stress Score 9.8 (2.9) 9.7 (2.8) 9.3 (3.3) 9.6 (2.5) 8.4(3.1) 10.0 (2.8) 10.6 (2.9) 9.8 (3.5) 
Type of Surgery (n): 
Thoracic I 8 6 4 0 2 5 
Thoracic combined with abdominal 0 2 0 0 0 0 3 2 
Abdominal high/low 19/11 7113 6/19 8/19 8/8 3/9 6/2 5/9 
Superficial 0 2 I 2 0 0 2 4 
CM:::: continuous morphine, IM =intermittent morphine. Age (days): median (range); 
(n) number ofpatients; other values are mean (SD ). 
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Patient characteristics and clinical variables within the four age groups were similar in the 
two randomized groups. Although the surgical procedures varied, the age and treatment 
groups had similar Surgical Stress Scores. 
Morphine requirements 
Overall, there were significant differences in the use of extra morphine between the age 
groups (P < 0.001), but not between the treatment groups. 
Table 2 shows the need for extra morphine as percentage of patients and the total 
requirement of morphine kg-1 h-1 (excluding the loading dose) in the four age groups. 
Only 38% of neonates (age group I) required additional morphine, a significantly lower 
percentage than in all older age groups. More infants aged 4 to 26 weeks (91 %of group 
II) required additional morphine than the children aged I to 3 years (72 % of group IV). 
Table 2 Morphine requirements for 24 hours after surgery 
Age group I II m IV 
(0-4 weeks) ( 4-26 weeks) (26-52 weeks) (1-3 yr) 
(n = 63) (n = 65) (11 = 30) (n = 39) 
No. of patients 
with extra morphine(%)* 24 (38) 59 (91) 26 (87) 28 (72) 
~Morphine maintenance dose 10.0 (10.0-10.7) 12.3 (10.6-16.6) 11.9 (10.4-15.3) 10.9 (10.0-14.3) !J-g kg-lh(l# 
Values are percentages, or median (interquartile range); (n) number of patients. 
*Age group I versus groups II, Ill and IV (P < 0.001); II versus IV (P = O.Oll) (X2 -test). 
#Age group I versus groups II, Ill and IV (P < 0.001) ANOVA. §Excluding the loading dose of 
IOO f1g kg 1 
Additional morphine 
Multiple logistic regression analysis of all variables, showed that age group, plasma 
concentrations of total bilirubin and the SSS were the most important factors affecting the 
need for additional morphine. The percentage of patients needing extra morphine was 
significantly higher in age group II than in group I (91 % vs. 38 %, P < 0.001). In all age 
groups, increases in plasma bilirubin concentrations reduced the need for extra morphine 
(P = 0.01), whereas a higher SSS increased the need for extra morphine (P = 0.007). 
During the first hour after the loading dose, the need for additional morphine was only 
related to age group. A significantly higher perc.entage of patients in group II than in 
group I (P = 0.01) needed extra morphine in this period. There was no consistency in the 
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need for extra morphine during the first hour after surgery and/or between the other time 
periods (1-6, 6- 12, 12- 18 and 18-24 h after surgery). Figure 1 shows the percentage of 
patients needing additional morphine during each of these periods. 
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Percentages of patients in all age groups (group I. 0-4 weeks, II. 4-26 weeks, III. 
26-52 weeks, IV.J-3 yr) needing additional morphine during the first 24 h after 
surgery (O-J h, 1-6 h, 6-12 h, 12-24 h). 
Morphine dosage kg'1 
The age group and type of morphine administration significantly affected the required 
morphine dosage kg·' day'1. However, inherent to the protocol design the dosage in the 
CM group was always 30 f.Lg kg·' higher than in the IM group. Disregarding this amount 
of 30 f.Lg kg' 1 in the CM group, the treatment groups did no longer differ from one 
another. Age group I needed significantly less morphine kg- 1 than the other age groups 
(AN OVA, P < 0.001) (Table 2). 
Morphine plasma concentrations 
Analysis of morphine plasma concentrations at 6 h after surgery revealed a significant 
difference between age gronps depending on the type of morphine administration. 
Therefore, the effect of age groups was evaluated within the treatment groups separately. 
The plasma concentrations at 12 and 24 h after surgery were no longer dependent on type 
of treatment. 
Table 3 Plasma concentrations of morphine, M3G and M6G at 6, 12 and 24 h after surgery, according to age and treatment group 
Age Groups 
I (neonates, 0~4 week.<t) II (4 -26 weeks) ill (26-52 weeks) IV (1-3 yr) 
CP time after CM 11 1M 
" 
CM 11 1M 
" 
CM 11 1M 11 CM 11 1M 
" (ng.mf 1) surgery (h) 
Morphine 6 25.0* 29 16.5* 28 8.5 28 5.7 27 8.6 14 2.9 14 5.2 18 1.0 17 
(14.3-32.0) (10.7-23.8) (5.0-10.9) (1.8-14.9) (4.7-20.0) (1.0-6.0) (4.2-6.5) (1.0-2.5) 
12 23.0''' 29 15.7* 28 7.9t 28 7.6;- 25 5.6 15 1.1 13 4.9 16 1.7 18 
(12.0-31.0) (9.6-22.8) (5.5-12.3) (2.0-17.8) (4.7-10.0) (1.0-12.7) (3.8-5.7) (1.0-5.0) 
24 22.0* 29 15.4* 25 7.4! 27 7.5t 24 6.4 15 1.0 13 4.8 17 2.3 17 
(15.1-29.5) (9.9-19.1) (5.3-13.4) (l.l-22.9) (4.2-9.0) (l.0-3.8) (3.7-5.6) (1.0-7.9) 
M3G 6# 106.oe 19 73.0§ 12 75.0! 26 67.5! 26 77.0 13 42.0 14 43.0 18 30.0 17 
(63.0-151.0) (39.3-87.8) (53.0-123.8) (40.0-101.5) (52.5-116.5) (22.1-75.8) (31.0-61.0) (16.7-55.0) 
12 l05.0* 19 73.5* 12 77.0 t 26 58.0 t 23 56.0 14 26.0 13 34.0 16 26.5 18 
(64.0-126.0) (48.0-123.8) (46.3-112.0) (28.0-77.0) (40.3-87.5) (22.5-54.0) (23.0-57.0) (21.3-80.3) 
24 90.0* 19 79.0* 11 54.5! 26 45.0! 24 46.0 14 31.0 13 39.0 l7 39.0 17 
(67.0-116.0) (46.0-131.0) (34.8-102.8) (30.5-69.0) (38.3-71.8) (19.8-37.5) (28.5-51.0) (18.3-69.0) 
M6G 6 17.0* 29 12.2* 29 11.8 t 29 8.8! 30 12.6 14 5.2 14 6.9 17 3.2 17 
(12.8-23.5) (8.9-16.0) (8.3-21.0) (6.0-14.7) (7.8-17.1) (3.7-11.1) (4.5-8.8) (2.1-6.1) 
12 18.6* 29 14.6* 29 12.6 t 29 10.8 t 27 7.8 15 4.9 13 6.2 15 4.9 17 
(14.5-21.6) (10.5-19.7) (7.9-16.4) (4.4-16.6) (5.9-12.1) (3.7-7.0) (4.5-8.1) (2.9-9.4) 
24 16.0* 29 13.2* 26 13.42! 27 7.lt 27 7.6 15 6.0 l3 6.8 16 5.5 16 
(12.6-21.6) (10.3-19.0) (7.0-17.5) (4.5-12.5) (6.1-10.9) (3.6-6.6) (4.8-1 0.6) (2.8-10.7) 
CM = continuous morphine; IM = inte1mittent mmphine; CP = concentration plasma; M3G = morphine~3~glucuronide; M6G = morphine-6-
glucuronide; n = number of patients. Data are median ( interquartile range). 
*Age group T higher than all other age groups (CM and IM) (P < O.OOI ); t II higher than IV (CM and IM) (P < 0.001), # CM higher than IM 
in all age groups (P < 0.007); §I higher than III and IV (CM and IM) (P < 0.003) (ANOVA) 
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Table 3 gives the plasma concentrations of morphine and its metabolites M3G and M6G, 
and the differences between age and treatment groups at 6, 12 and 24 b after surgery. 
Plasma levels were significantly higher in age group I than in the other groups, and in age 
group li versus group IV (Table 3). ANOV A showed that morphine plasma 
concentrations were significantly affected by the total morphine dose administered 
(P < 0.001). Plasma morphine levels in the CM neonatal group (at 12 and 24 h after 
surgery) were significantly correlated with plasma creatinine levels (r = 0,5, P = 0.01; 
r = OA, P = 0.04, respectively), and with plasma bilirubin levels (r = 0.6, P = 0.001). 
Morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) concentrations 
Difficulties in detection of M3G plasma concentrations in tbe neonatal group, because of 
disturbing spikes, resulted in many missing values (n = 32) for M3G in this age group. 
AN OVA of M3G and M6G plasma concentrations revealed that the age group and the 
administered dosage of morphine kg·' significantly affected these plasma levels (both P < 
0.001). 
Although plasma concentrations of M3G and M6G were higher in CM tban in lM, this 
difference was only significant for M3G at 6 h after surgery. M3G and M6G plasma 
concentrations were significantly higher in age group I than in the other age groups and in 
group li versus group IV at 12 and 24 h after surgery (all P < 0.001) (Table 3). M6G 
plasma concentrations correlated significantly with plasma creatinine only in the 
neonates, and only in CM at 12 and 24 h after surgery (r = 0.5, P = 0.01 and r = 0.5, 
P = 0.002, respectively). No such correlation was found for M3G. 
Figure 2abc shows the median plasma concentrations of M, M3G and M6G, in the four 
age groups for CM and lM at 6, 12 and 24 h after surgery. 
M3G/M and M6G/M ratios 
Table 4 gives the ratios of morphine and its metabolites at 24 h after surgery, and the 
significant differences between age groups. 
The M6G/M ratio showed only significant differences between age groups, not between 
the different treatments. The M6G/M ratio was lower in age group I than in all other age 
groups (Table 4). 
Morphine therapy in postoperative infants 
28 
~ 24 
l!l'l6h lii'i12h 024h I 20 
I :: 
E 
~ 8 
CM JM CM 1M CM 1M CM 1M 
Fig 2a Morphine plasma concentrations (median) in all age groups (group I. 0-4 weeks, 
II. 4 - 26 weeks, III. 26 - 52 weeks, IV I - 3 yr) at 6, !2 and 24 h after surgery. 
CM =continuous morphine, IM = intermittent morphine. 
~ 
" 5 
I 120 !ill6h ll'll2n D24h 
~ urn 
~ 80 
" • 60 l " 
~ " 
f 0 
2 CM 1M CM CM CM Thl 1M 1M 
n lU JV 
47 
Fig. 2b Morphine-3-glucuronide (M-6-G) plasma concentrations (median) in all age groups 
(group I. 0 - 4 weeks, II. 4 - 26 weeks, III. 26- 52 weeks, IV. I - 3 yr) at 6, 12 and 24 
h after surgery. CM =continuous morphine, IM = intennittent morphine. 
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Fig. 2c Morphine-6-glucuronide (M-6-G) plasma concentrations (median) in all age groups 
(group I. 0-4 weeks, II. 4- 26 weeks, III. 26-52 weeks, IV. 1- 3 yr) at 6, !2 and 24 h after 
surgery. CM = continuous morphine, IM = intennittent morphine 
Table 4 Morphine and morphine metabolite ratios at 24 h after surgery 
Age groups 
I (0-4 weeks) II (4-26 weeks) III (26-52 weeks) IV (1-3 yr) 
CM 1M n CM 1M n CM 1M n CM 1M n 
M3G/M ratio 5.2 7.0 28 8.6 9.6 47 8.0 15.7 27 9.1 16.7 34 
(2.9-11.6) (3.0-11.9) (7.8-10.3) (2.4-20.0) (5.5-14.5) (7.4-27.5) (5.0-11.0) (6.1-27.6) 
M6G/M ratio 0.8* Ll 52 1.5 1.9 50 1.5 3.4 28 1.4 2.5 32 
(0.5-1.7) (0.7-1.5) (1.2-2.1) (0.5-3.8) (0.9-2.3) (l.l-5.9) (1.0-2.1) (!.3-4.6) 
M6G/M3G 0.22 0.17 30 0.18 0.17 49 0.18 0.19 27 0.18 0.16 32 
ratio (0.16-0.23) (0.13-0.25) (0.15-0.23) (0.15-0.21) (0.15-0.19) (0.16-0.24) (0.16-0.22) (0.14-0.19) 
M =morphine; M3G= morphine-3-glucuronide; M6G = morphine-6-glucuronide; CM = continuous mmphine, IM = intermittent mmphine 
Values are median (interquartile range); n =number of patients. 
*Age group !versus groups III and IV (P < 0.003), group I versus II (P = 0.03), (CM and JM); ANOVA. 
Table 5 Data of 11 patients with respiratory insufficiency during the first 24 h after surgery 
Age CM/IM Diagnosis Complications Extra M Mean doscM RcMintubation Hours after Comments 
(days) Yes/No (!Jg kg'' h'') Yes/No surgery 
I IM Exstrophy of the Apnoea N 10 y 6 Bryant's traction 
bladder 
1M Jejunal atresia Apnoea N 10 y <4 30 min after M bolus 
2 IM Trachea-oesophageal Respiratory obstruction N 10 y 21 Failed exh1bation 
atresia 
3 1M Trachea-oesophageal Respiratory obstruction N 10 y 15 Failed extubation 
atresia 
4 IM Duodenal atresia pC02 I (8.9 and 8.3 kPa aL6 and 12 h post N 10 N Downs syndrome 
surgery) 
54 CM Neuroblastoma Apnoea y 10.2 y 6 
61 CM Ileus Apnoea y 22.2 y 6 High pain scores; I 00 )lg 
ki1extra Min 3 h 
78 IM Rehbein resection pC02 I (8.4 kPa at 6 h post surgery) y 10.7 N 
90 IM Nissen fundoplication In- and expiratory stridor 2 h post surgery y 10.4 y <4 
102 IM Bilobcctomy pC02 1' (7 .4 and 7.5 kPa at 6and 12 h post y 11.7 N Pneumonia 
surgery) 
831 CM Neuroblastoma Apnoea N 10 N 12 M stopped at 12 h post 
surgery 
CM::: continuous morphine; IM::: intermittent morphine; M::: morphine. 
Table 6 Overview of morphine requirements and plasma concentrations of morphine in neonates and infants after non-cardiac surgery in 
earlier studies and the present study 
Age 
Earlier studies: 
1-7days 
31-90 days 
91-180 days 
180-380 day,; 
1-18 days 
" 
4 
6 
6 
10 
20 
Loading dose or 
single dose (S) 
(~g kg'') 
50 
50 
50 
50 
50 
0 to 6 months 5 mean 150 (S) 
2-4 years 5 150 (S) 
Present study (CM group only): 
0-4 weeks 31 100 
1-6 months 32 toO 
6-12 months 
1-3 years 
16 
18 
100 
100 
Dosage M infusion 
(J.lg kg"l h"l) 
7-1 1 
13-19 
17-25 
25-35 
15 
10.8 (mean) 
15.7 (mean) 
16.7 (mean) 
12.1 (mean) 
Plasma concentration morphine 
(ng mr1) 
18.9 (15.0-29.0) median (range) 
9.1 (6.5-14.5) median (range) 
10.5 (7.0-22.0) median (range) 
10.0 (6.0-17.0) median (range) 
39.0 (23.0) mean (SD) 
26.2 (22.5) mean (SD) 
3.8 (2.3) mean (SD) 
22.0 (15.1-29.5) median (IQR) 
7.4 (5.3-13.4) median (IQR) 
6.4 (4.2-9.0) median (IQR) 
4.8 (3.7-56) median (lQR) 
M = mmphine; n =number of patients; SD =standard deviation; !QR = interquar!Ue range. 
Comments 
At steady state 
AL steady state 
129 min after M dose 
189 min after M dose 
At 24 h after start ofM 
References 
Lynn et al. 24 
Lynn el al.24 
Lynn et al. 24 
Lynn et ai.N 
Farrington25 
Olkkola26 
O!kkola26 
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M6G!M3G-ratio 
Neither age group nor treatment at any time point had any significant effect on the 
M6G/M3G ratio (Table 4). 
Adverse effects 
Eleven spontaneous breathing patients (8 in IM, 3 in CM) had postoperative respiratory 
insufficiency, seven of them required intubation (5 in IM, 2 in CM). Details on age, 
treatment, surgical procedure, requirement of morphine and complications are given in 
Table 5. 
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Table 6 gives an overview of studies reporting requirements and plasma concentrations of 
morphine after non-cardiac surgery, including the present data24.26 
3.5 Discussion 
In this clinical study we investigated a) the effects of various variables on the morphine 
dose required in infants, and b) the age-related changes in morphine and metabolite 
concentration. Age was the most important factor differentiating dose requirements 
between neonates and infants older than 4 weeks. In a recent meta-analysis, a continuous 
infusion rate of 7 ~g kg'1 h-1 was calculated for term neonates, assuming a desired steady 
state plasma concentration of 15 ng rn1·1 for all ages27 Neonates in our current study 
received higher infusion rates and the concentrations are proportionally similar. Because 
more than 60 % of the neonates had adequate analgesia through the minimal dose of 10 
~g kg'1 h' 1 (concentration median 22 ng mr1), it is likely that a lower dose of morphine 
would have sufficed for the neonates. Significantly more morphine was used in the older 
children, with requirements ranging from (median) 10.9 to 12.3 ~g kg' 1 h-I Even with the 
additional morphine, the required dose was lower than the recommended dosage of 20 ~g 
kg·1 h-1 27.31 Remarkably, of the age groups older than 4 weeks, children aged l to 3 years 
needed the lowest dosage of morphine (NS). They also had the lowest plasma 
concentrations of morphine, which suggests that their clearance was the highest. 
Because concentration is directly proportional to dose, we need to determine clearance in 
order to predict dose. The wide range of neonatal plasma concentrations reported in the 
literature, was as expected, given the variability in interindividual clearance (Table 6). In 
our study, plasma concentrations of morphine in neonates (n = 63) provided adequate 
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analgesia between 15.4 (trough) and 22 ng ml-1, and in infants> 4 weeks (n = 134) 
between LO and 7.5 ng ml-1• These low plasma concentrations of morphine apparently 
produced effective analgesia, as evidenced by the low CS and VAS scores 
postoperatively. It seems that plasma concentrations as high as 15 ng mr1 are not 
necessary for adequate postoperative analgesia in infants> 4 weeks. Although at the time 
of surgery all patients had been without morphine therapy > 6 h , plasma morphine was 
still detectable in five neonates. This would indicate that clearance in this age group is 
low (approx. 9 ml ki1 min- 1) 9 Morphine plasma concentrations were significantly 
dependent on age, bearing in mind that patients with renal impairment were not included. 
Differences between treatment groups were only found at 6 h after surgery_ Extra 
morphine dosages, given in a nurse-controlled way, based on observational pain scores, 
resulted in similar plasma concentrations in CM and lM from 12 h after surgery. In the 
CM group we report median concentrations that decreased from 7.4 to 6.4 to 4.8 ng ml-1 
with increasing age. These data are consistent with an increase in plasma clearance over 
the age range investigated. 
Plasma concentrations of morphine which should produce effective analgesia in neonates 
and older children have been reported to range from 3.8 (± 2.5) to 125 (± 9) ng m]-126•32-34 
This wide range results from the various pain stimuli or sedation end-points, differences 
in pain perception and pain assessment, and variations in the children's clinical state 
(severe illness, mechanically ventilation, needing sedation or analgesia, tolerance, etc.). 
As reported earlier the relation between morphine requirement and plasma concentrations 
is also dependent on the type of surgery, which leads to different results after cardiac or 
non-cardiac surgery .6'34 
Morphine is mainly metabolised in the liver into M3G and M6G by urinediphosphate 
glucuronosyl transferase (UDG2B7). The kidneys excrete these metabolites, as well as a 
portion of the unchanged morphine. Developmental maturation, associated with 
increasing renal clearance and decreasing drug half-life, starts in the early neonatal period 
and goes on for two years. Using the% power model adult levels of clearance were 
reached at an earlier age, between 2 and 6 months.35 
High morphine plasma levels and low M3G- and M6G-morphine ratios, as were found in 
the neonates, might indicate a low glucuronidation capability. However, from 12 h after 
surgery the highest plasma concentrations of M3G and M6G were found in the neonates, 
signifying that they were able to glucuronidate morphine. Nevertheless, hepatic induction 
of these enzyme systems cannot be ruled out. The high plasma levels of morphine 
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metabolites in the neonates were due to a low renal function, which was confirmed by the 
significant correlation between serum creatinine and M6G in this age group. The 
decreased clearance of morphine explains its increased analgesic effect in neonates, 
contributed by the active metabolite M6G. While the M3G/M and M6G/M ratios 
increased with advancing age, indicating improved morphine metabolism, the M3G and 
M6G plasma concentrations decreased with advancing age, indicating improved renal 
excretion, as reported in other studies as wel!7 ·34•36•37 
In the present study plasma concentrations of morphine and morphine metabolites were 
not only significantly different between neonates (age group I) and the older children (age 
groups II, II and IV), but also between infants aged 4 to 26 weeks (group II, median age 3 
months) and 1 to 3 years (group IV, median age 20 months). The major changes in 
morphine metabolism and elimination apparently take place in the first 3 months after 
birth, only minor differences in morphine clearance are found after that age. The 
development of the glucuronidation capability and the renal function, might have resulted 
in lower plasma levels of morphine in the older children. Clinical effects, however, may 
be more dependent on the concentrations in brain tissue, receptor characteristics, 14 and 
other factors. 
Reported correlations between metabolite-morphine ratios and gestational age or birth 
weight are controversial. M3G/M and M6G/M ratios increased with increasing birth 
weighe738 and gestational age38 (glucuronidation capability increases), which was not 
found by Barrett et al39 The disparity in plasma morphine glucuronide ratios between the 
different studies could be due to the varying number of patients in the individual studies, 
differences in gestational age and study age, in detection limits of metabolites, and in the 
duration of morphine infusions and the time of sampling. Because M3G and M6G have 
long half-lives in neonates39 (impaired renal function), it is suggestive that in neonates the 
M6GIM and M3G/M ratios are increasing with increased periods of morphine infusion. 
In a review examining the effects of age, renal impairment and route of administration on 
morphine metabolism, Faura eta!. reported a consistently high correlation between M6G 
and M3G, with a ratio of about 15 % as well in neonates and children, as in adults7 
Across all studies the range of the ratios of metabolites to morphine was wide. However, 
there was almost complete overlap between children (> 1 month) and adults, but neonates 
( <l month) had discernibly lower ratios of both metabolites to morphine. Although the 
number of neonates and children was small compared with that of adults ( 49, 90 and 
1073, respectively), the ratio M3G/M6G remained constant in all subgroups analyzed 
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(including neonates, children and adults, patients with renal impairment, and different 
routes of administration). 
In the present study neonates differed significantly from the older children in median 
M6G/M ratio (P = 0.003), without significant differences between the three older age 
groups. The M6G/M3G ratio at 24 h after intravenous morphine was not significant! y 
different between the four different age groups from 0 to 3 years. 
Although the data are difficult to compare (median versus mean weighted values) both 
latter studies result in similar conclusions, i.e. A) neonates differ significantly from older 
patients (children and adults, respectively), having an immature morphine metabolism, B) 
children> I month metabolize morphine like older children, as presented in our study, 
and like adults,7 and C) the M6G/M3G ratio remains constant at all ages. 
Hartley reported decreasing M6G/M3G plasma ratios, although not significantly, with 
increasing birth weight. 37 The latter might suggest a differential development of enzymes 
(UDGT) for the formation of M3G and M6G. 
Recently it was shown that Uridine 5' -diphosphate-glucuronyltransferase-2B7 (UGT2B7) 
is responsible for the glucuronidation of morphine and is capable of catalyzing the 
glucuronidation of both the 3- and 6-hydroxyl moieties on these molecules 40'41 However, 
polymorphism in the coding sequence, as well as in the 5' -flanking region, may affect the 
rate of morphine glucuronidation and can result in individual differences. 42 
The SSS was developed as a measure of the severity of surgical stress. 18 Although in the 
present study the scores did not significantly differ between age or treatment groups, 
multiple regression analysis showed that they significantly influenced the dosage of 
morphine required. In the absence of other methods that can directly measure 
postoperative pain across different age groups, the SSS may help to assess the need for 
postoperative morphine. 
Eight of the II children who showed respiratory insufficiency belonged to the 1M 
treatment group. In most of these patients respiratory depression could not be attributed to 
the morphine therapy, but had to be considered as a complication of their surgical 
operation. 
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3.6 Conclusions 
Age is the most important factor in morphine dosage and morphine metabolism. 
In our previous study investigating the effect of CM and 1M on surgical stress responses 
in the same patient population, infants aged 1 - 3 yr in the 1M group showed greater stress 
than those in the CM group. 17 
Combining the results of both studies, we conclude that morphine given intermittently 
does not provide any clinical advantages and that a continuous morphine infusion is 
probably safer in neonates and more effective in older infants. 
By stratifying for age and carefully monitoring the children's behaviour, we were able to 
give more precise dosages for postoperative morphine after major non-cardiac surgery. 
We agree with the recommended dosage for continuous morphine infusions of 7 jJ.g kt 1 
h-1 in fullterm neonates 27 However, we would advise to start with an infusion rate of 15 
jJ.g kg-1 h-1 in infants > 4 weeks of age. Differences in developmental maturation between 
neonates and infants indicate the need for individual drug dosages. Increase of the 
infusion rates should only be based on pain scoring by trained nurses, in order to prevent 
overdosing with its associated risks. 
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Developmental pharmacokinetics of morphine and metabolites in neonates, 
infants and young children 
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4.1 Abstract 
Background 
Data concerning metabolism of morphine and its metabolites in young children are scant. 
Previous studies have not differentiated the effects of size from those related to age during 
infancy. 
Methods 
Postoperative children 0- 3 years were given an intravenous loading dose of morphine 
hydrochloride (I 00 [lg!kg in 2 min) followed by either an intravenous morphine infusion 
of 10 [lg!kg/h (n = 92) or 3-hourly intravenous morphine boluses 30 [lg!kg (n = 92). 
Additional morphine (5 11gikg) every 10 min was given if the Visual Analogue Pain Scale 
(VAS, 0- 10) score was 2: 4. Serum (0.6 nil) was sampled within 5 min of the loading 
dose and at 6, 12 and 24 h for morphine, morphine-3-glucuronide (M3G) and morphine-
6-glucuronide (M6G). The formation clearances of morphine base to its glucuronide 
metabolites as well as metabolite elimination clearances were estimated using non-linear 
mixed effects models. 
Results 
Population parameter estimates and their variability(%) for a one compartment, first 
order elimination model were as follows: volume of distribution 115 I (54), formation 
clearance to M3G 24.3 (91) 1/h, formation clearance to M6G 2.9 (87) 1/h, elimination 
clearance ofM3G 7.2 (65) 1/h, elimination clearance ofM6G 5.0 (76) 1/h; standardized to 
a 70 kg person using allometric ''4 power' models. Clearance by other routes contributed 
50% of total body clearance. The volume of distribution increased exponentially with a 
maturation half-life of 2 weeks from 72 l/70kg at birth; formation clearance to M3G and 
M6G increased with maturation half-life of 79 days from 5.2 and 0.6 l/h/70kg respectively 
at birth. Serum bilirubin concentration was inversely related to metabolite formation. 
Metabolite clearance increased with age (maturation half-life 131 days) with a time 
course similar to that described for glomerular filtration rate in infants. 
Conclusion 
M3G is the predominant metabolite of morphine in young children and total body 
morphine clearance is 87 % tbat of older children at 6 months. A mean steady-state serum 
concentration of 20 ng/nll can be achieved in children after non-cardiac surgery in an 
intensive care unit with a morphine hydrochloride infusion of 8.5 [lg/kglh at birth (term 
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neonates), 15 f!g/kg/h at 1 month, 22 f!g/kg/h at 3 months, 27 flg/kg/h at 12 months 
postnatal age and 25 f!g/kg/h for l - 3 year old children. 
4.2 Introduction 
Morphine is largely metabolized by uridine 5' -diphosphate glucuronosyltransferase 
UGT2B7 to morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G)1 In 
vitro studies using liver microsomes from fetuses aged 15 - 27 weeks indicated that 
morphine glucuronidation was approximately 10-20% of that seen with adult 
microsomes 23 Morphine glucuronidation has been demonstrated in premature infants as 
young as 24 weeks. Morphine clearance is reported as 23.6 (S.D. 8.5) ml/min/kg in 
infants and children greater than 11 days old4 Lynn et al5 report clearances (rnllmin/kg) 
greater than those of adults at 3 months of age. In a systematic review of morphine 
metabolism Faura et al 6 conclude that children older than 1 month metabolize morphine 
like adults. The use of the per kilogram size model (ml/min/kg) has confused 
interpretation of morphine developmental pharmacokinetics; an overestimation occurs as 
size decreases 7 Anderson et al8 corrected available clearance data from different age 
groups using a 'A power allometric size model to demonstrate that adult values for 
clearance are reached at about 6 months. 
We had the opportunity to examine morphine and metabolite serum concentrations in 
children 0 - 3 years old given either intermittent boluses or morphine infusion9 These 
data were investigated using a population based approach that included size as the 
primary covariate in an effort to disentangle age related factors from size related factors. 
4.3 Methods 
Patients and methods 
The study was approved by the hospital medical ethical committee and written consent 
obtained fi·om the parents of studied children. Children aged 0 to 3 years, admitted to the 
paediatric surgical intensive care unit following non-cardiac thoracic and abdominal 
surgery were considered for enrolment. Patients were excluded if they had received 
morphine within 6 h before surgery, or if they suffered from hepatic, renal or neurological 
disorders. Patients were randomly assigned to receive either intravenous morphine 
hydrochloride infusion or intennittent morphine hydrochloride boluses. The pharmacists 
62 Chapter 4 
randomised and prepared all study drugs. Clinical staff were blinded to the study group 
allocation. 
At the end of surgery, mechanical ventilation was continued in patients who required 
ventilatory assistance after surgery. Directly after surgery all patients were given an 
intravenous loading dose of morphine hydrochloride (100 J.lg/kg over 2 min), followed by 
either a morphine infusion of 10 J.lg/kglh combined with three-hourly intravenous placebo 
(saline) boluses or a continuous placebo infusion (saline) combined with three-hourly 
intravenous morphine hydrochloride boluses of 30 J.lg/kg. Additional morphine (5 J.lglkg 
every 10 min) was given if the Visual Analogue Pain Scale (VAS, 0- 10) scores were ::00 4. 
No other analgesic or sedative drugs were used. 
Arterial blood samples (1.4 ml) were taken after induction of anaesthesia (baseline), at the 
end of surgery, and at 6, 12, and 24 h after surgery to determine serum concentrations of 
morphine, M3G and M6G. 
Pain was assessed 3 hourly by nurses trained in the use of the behavioural part of the 
COMFORT Score10 and the VAS (0- 10). The VAS was measured after the 2 minutes of 
observation needed for the COMFORT Score. Nursing interventions included pain 
assessment, blood sampling and administration of intermittent bolus (placebo or 
morphine) medication. 
Morphine and metabolite assay 
Serum aliquots (0.6 ml) were extracted with the Baker-! 0 extraction system (Baker 
Chemicals, Deventer, the Netherlands) fitted with 1-ml disposable cyclohexyl cartridges 
(C6H6, Baker, cat.nr 7212-01). The extraction column was conditioned with two column 
volumes of methanol, two column volumes of water and I ml of 500 mM diammonium 
sulphate (pH= 9.3). The serum (0.6 ml) was diluted with 0.6 ml 500 mM diammonium 
sulphate (pH = 9.3) before it was brought on top of the extraction column. It was washed 
with 2 ml of SO mM diammonium sulphate (pH= 9.3) after which it was allowed to dry 
for 15 seconds. The elution was carried out with 0.5 ml 0.01 M KH2P04 buffer, pH= 2.1, 
containing 11 % acetonnitrile. From this elute 50 f!l was injected on the analytical 
column. The HPLC system comprised a Spectroflow 400 solvent delivery system (Kratos, 
Rotterdam, the Netherlands) equipped with a degasser (Separations, HI-Ambacht, the 
Netherlands), a Marathon auto sampler (Separations, HI-Ambacht, the Netherlands), a 
Spectroflow 773 UV detector at A.= 210nm (Separations, HI-Ambacht, the Netherlands), 
in sequence with an ESA electrochemical detector (ESA, Kratos, Rotterdam; present: 
Interscience, Breda, the Netherlands) equipped with an analytical cell (Model5010). All 
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compounds leave the UV detector chemically intact, and so the electrochemically active 
components can be oxidised in the electrochemical cell. This type of electrochemical cell 
contains two separate analytical cells, which makes it possible to create a small window 
of applied potential. The detector 2 potential was set at 0.4V, while the detector l 
potential was 0.3V. This minimises interfering peaks because only compounds with an 
oxidation potential from 0.3 to 0.4V are recorded. Chromatographic separations were 
achieved using a Cp-Sper C8 column (250 x 4.6 mm) (Chrompack, Bergen op Zoom, the 
Netherlands). The mobile phase was a 0.01 M KH2P04 buffer, pH= 2.1, containing 11% 
acetonnitrile and 0.4 g/1 heptane su1phonic acid. 
In serum all calibration graphs (containing 6 data points) were linear: for M3G the 
concentrations ranged from 25-580 ng/ml (r = 0.9992); for M6G from 5- 100 ng/ml 
(r = 0.9982) and forM, from 5 -90 ng/ml (r = 0.9963). On average, the quantitation limit 
was 5 ng/ml forM and M6G and 25 ng/ml for M3G. However, in individual samples, the 
chromatogram allowed for a lower threshold. In this concentration range, the intra-day 
precision was less than 10% for all compounds and the accuracy was about 5%1 1.1 2 
Standardised automated laboratory analysers measured serum concentrations of bi1imbin 
and creatinine. 
Morphine hydrochloride dose, and M3G and M6G concentrations were converted to 
anhydrous morphine base equivalents using a molecular weight of 285 for morphine, 322 
for morphine hydrochloride and 461 for the two glucuronide metabolites. 
Modelling 
Population parameter estimates 
Population parameter estimates were obtained using a non-linear mixed effects model. 
This model accounts for population parameter variability (between and within subjects) 
and residual variability (random effects) as well as parameter differences predicted by 
covariates (fixed effects). The population parameter variability in model parameters was 
modelled by a propm1ional variance model. The covariance between clearance, 
distribution volume and absorption half-life was incorporated into the model. A 
proportional term characterised the residual unknown variability for morphine. An 
additive and a proportional term characterised the residual unknown variability for M3G 
and M6G concentrations. The population mean parameters, between subject variance and 
residual variances were estimated using NONMEM version V release 1.1.13 Estimation 
used the first order conditional estimate method with the interaction option and ADV AN 
6 with Tol = 5. Convergence criterion was 3 significant digits. A Compaq Digital Fortran 
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Version 6.5 compiler with Intel Celeron 333 MHz CPU (Intel Corp., Santa Clara, CA) 
under MS Windows 1998 (Microsoft Corp., Seattle, WA) was used to compile 
NONMEM. 
Differential equations were used to describe the pharmacokinetics of morphine and its 
metabolites. 
CLT = CL2M3G + CL2M6G + CLEX 
dCSidt = (RA TEIN - CS x CLT) I V 
dM3Gidt = (CL2M3G x CS - CLM3G x CM3G) I V3M 
dM6Gidt = (CL2M6G x CS - CLM6G x CM6G) I V6M 
The model is shown in Figure 1. CLT is total body clearance, Vis the volume of 
distribution for morphine, CS is morphine serum concentration, CL2M3G is formation 
clearance to M3G, CL2M6G is formation clearance to M6G, CLM3G is the elimination 
clearance of M3G, CLM6G is the elimination clearance of M6G, VM is the volume of 
distribution of glucuronide metabolites, CLEX is unaccounted clearance, RA TEIN is the 
morphine infusion rate. 
The metabolite volumes of distribution (V3M, V6M) can not be identified with the 
current study design and were fixed at 23 and 30 l/70kg, based on a studies by Penson et 
al14 and Hanna et al15 in adults. 
G 0 1 I VM 'I~ CLM3G 
G0~0 
I ~~~CLM6G 
Figure 1 
b 
CLEX 
Pharmacokinetic Model. CLT is total body clearance, Vis the volume of 
distribution for morphine, CS is morphine serum concentration, CL2M3G is the 
formation clearance to M3G, CL2M6G is the formation clearance to M6G, 
CLMJG is the elimination clearance of M3G, CLM6G is the elimination clearance 
of M6G, VM is the volume of distribution of glucuronide metabolites, CLEX is 
unaccounted clearance, RATEIN is the morphine infusion rate. 
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Covariate Analysis 
The parameter values were standardized for a body weight of 70-kg using an allometric 
model'- 16 
P ) PWR P1 = "dx(W;IW,M 
where P, is the parameter in the ith individual, W, is the weight in the ith individual and 
P "d is the parameter in an individual with a weight W;~ct of 70 kg. The PWR exponent was 
0.75 for clearance and I for distribution volumes. 16' 19 
Exponential functions were applied to allow for age-related changes for the formation of 
metabolites (CL2M3G, CL2M6G), clearance of metabolites, unaccounted clearance and 
morphine volume of distribution (see Table 3b). e.g. 
CL2M3G = (CL2M3Gstd x (Wt/70/ 75) x ( 1 - jki x EXP(-PNA in days x Ln(2)/Tcl)) Vh 
CLM3G = (CLM3Gstd x (Wt/70/ 75) x (1- f3ifx EXP(-PNA in days x Ln(2)/Trf)) Vh 
CLEX = (CLEXstd x (Wt/70/ 75) x ( 1 - j]ex x EXP(-PNA in days x Ln(2)/Tex)) 1/h 
V = (Vstd x (Wt/70)) x (1 - j]vol x EXP(-PNA in days x Ln(2)/Tvol)) I 
~cl, ~rf, ~ex and ~vol are parameters estimating the fraction below CL2M3G, CLM3G, 
CLEX and V respectively at birth; Tel, Trf, Tex and Tvol describe the maturation half-
lives of the age-related changes ofCL2M3G, CLM3G, CLEX and V. 
The effect of altered renal function on CLM3G & CLM6G was modelled using an 
estimate of renal function in children older than one week of age. Renal function was 
standardised to a 40-year-old adult male with a creatinine clearance of 6 Vh and a 
creatinine of 85.947 mcmolll20 This empirical model used age (PNA) as a covariate to 
predict creatinine production rate with scaling constant (Kage) for age e.g. 
CLM3G =CLM3Gstd x (Wt/70;"75 x 85.947/creatinine x EXP(Kage x PNN365-40) 
Serum bilirubin (mcmol/1) was used as a marker of hepatic function and its effect on 
CL2M3G & CL2M6G was modelled with an exponential function with a scaling constant 
(Kbili) e.g. 
CL2M3G =CL2M3Gstd x (Wt/70;" 75 x EXP(bilirubin x Kbili) 
The quality of fit of the pharmacokinetic model to the data was assessed by visual 
examination of plots of observed versus predicted concentrations. Models were nested 
and an improvement in the objective function was referred to the Chi-squared distribution 
to assess significance e.g. an objective function change (OBJ) of 3.84 is significant at 
U= 0.05. 
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4.4 Results 
10 100 1000 10000 
Postnatal Age {days) 
Volume of distribution change with postnatal age. Individual predicted volumes, 
standardised to a 70-kg person, from the NONMEM post hoc step, are plotted 
against age. The solid line represents the non-linear relation benveen volume of 
distribution and age. 
The analysis comprised 184 subjects (1856 observations). The number of children given 
intermittent bolus and those given morphine infusion were the same (n = 92). There were 
106 boys and 78 girls. Mean (range) age and weight ofthe patients were 195 (0- 1070) 
days and 5.9 (1.9- 16.8) kg. Parameter estimates. standardised to a 70-kg. 40 year old 
person are shown in Table Ia. Metabolism by routes other than M3G and M6G was 
undetectable. Covariate analysis estimates are shown in table I b. The covariance ofthe 
pharmacokinetic parameters, expressed as the correlation of population parameter 
variability was low (table 2). Table 3a shows metabolite formation and clearance estimate 
changes with age. 
The volume of distribution of morphine increased exponentially with a maturation half-
life of 2 weeks from 72 !J70kg at birth (figure 2); formation clearance to M3G (figure 3a) 
and M6G (figure 3b) increased with a maturation half-life of78.7 days from 5.8 and 0.6 
!Jh/70kg at birth to predicted values of 25 and 3 1Jh/70kg at 3 years respectively. At 6 
months formation clearances were 87 % of those predicted in children at 3 years. 
Formation maturation of both metabolites was the same. The objective function was not 
improved by using individual maturation parameters for each metabolite. Serum bilirubin 
concentration was inversely related to metabolite formation clearances (figure 4). 
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Individual predicted formation clearances to M3G, standardised to a 70-kg 
person, from the NONMEM post hoc step, are plotted against age. The solid line 
represents the non-linear relation between clearance and age. 
0 
0 
0 0 
0 0 0 
0 
0 
0 
0 
0 0 
0 0 
0 0 
0 
10 100 1000 10000 
Postnatal Age (days) 
Individual predictedfonnation clearances to M6G, standardised to a 70-kg 
person, from the NONMEM post hoc step, are plotted against age. 
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Table la 
Parameter 
CLT 
CL2M3G 
CL2M6G 
CLM3G 
CLM6G 
CLEX 
v 
V3M 
V6M 
Chapter 4 
Pharmacokinetic parameter estimates. These estimates are standardised to a 70-kg 
person using an allometric size model; %CV is the coefficient of variation for the 
population parameter estimate. 
Estimate CV% 
52.3 
24.3 91 
2.9 87 
7.2 65 
5.0 76 
25.1 95 
115 54 
23 fixed 
30 fixed 
Err morphine (proportional) 0.38 
Err M3G (additive) ng/ml 3.4 
Err M3G (proportional) 0.36 
Err M6G (additive) ng/ml 0.46 
Err M6G (proportional) 0.30 
CLT =population estimate for CL (l/h/!70kg) in children, Vis the volume of distribution for 
morphine (1170kg), CL2M3G is formation clearance to M3G (Uh/70kg), CL2M6G isfonnation 
clearance to M6G (/lh/70kg), CLM3G is the clearance of M3G (/lh/70kg), CLM6G is the 
clearance of M6G (llh/70kg), CLEX is unaccounted clearance, Err is the residual error. 
The metabolite volumes of distribution (V3M, V6M) can not be identified with the current study 
design and were fixed at 23 and 30 l!70kg, based on a studies by Penson et al14 and Hanna et al15 
in adults. 
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50 100 150 200 
Bilirubin (mcmolll) 
Individual a posteriori Bayesian estimates for CL2M3G corrected for size and age 
plotted against serum bilirubin. Formation clearance decreases as serum bilirubin 
increases. 
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Table lb Covariate Models and Estimates for Pooled Population Parameters 
Parameter Estimate 
~vol 0.381 
Tvol 13.5 days 
~cl 0.793 
Tel 78.7 days 
~rf 0.789 
Trf 131 days 
~ex 0.739 
Tex 55.9 days 
Kage 0.0128 
Kbili -0.00195 
a) Volume of distribution 
V ~ (Vstd x (Wt/70)) x (I + j3vol x EXP(-PNA in days x Ln(2)/Tvol)) l 
j3vol is a parameter estimating the fraction below Vat birth, Tel describes the maturation 
half-life of the age-related change for V. PNA is postnatal age. 
b) Fonnation clearance 
CL2M3G ~ (CL2M3Gstd x (Wt/70;"75) x (1- j3cl x EXP(-PNA in days x Ln(2)/Tcl)) Uh 
CL2M6G ~ (CL2M6Gstd x (Wt/70;"75) x (I- j3cl x EXP(-PNA in days x Ln(2)/Tcl)) Uh 
j3cl is a parameter estimating the fraction below CL2M3G and CL2M6G at birth, Tel 
describes the maturation half-life of the age-related change for CLM3G and CL2M6G. 
c) Metabolite clearance 
CLM3G ~ (CLM3Gstd x (Wti70J" 75) x (1- j3rfx EXP(-PNA in days x Ln(2)1Trf)) 1/h 
CLM6G ~ (CLM6Gstd x (Wti70J" 75) x (1- j3rfx EXP(-PNA in days x Ln(2)!Trf)) 1/h 
CLEX ~ (CLEXstd x (Wt/70}'75 ) x (1- j3ex x EXP(-PNA in days x Ln(2)/Tex)) llh 
j3rf and j3ex are parameters estimating the fraction below CLM3G, CLM6G and CLEX at 
birth, Tif and Tex describe the maturation half-life of the age-related change for CLM3G, 
CLM6G and CLEX. 
d) Creatinine clearance40 in children older than one week of age. Creatinine clearance was 
standardised to a 40 year old person and centred about 85.947 mcmol!l. This empirical model 
used age (PNA) as a covariate to predict creatinine production rate with scaling constant 
(Kage) e.g. 
CLM3G ~ CLM3Gstd x (Wt/70}' 75 x 85.947/creatinine x EXP(Kage x PNA/365-40) 
e) Relationship of bilirubin to CL2M3G & CL2M6G 
CL2M3G ~ CL2M3Gstd x (Wt/70)'75 x EX?( bilirubin x Kbili) 
Kbili is a scaling factor 
Metabolite elimination clearance of M3G and M6G increased with a maturation half-life 
of 131 days from 1.53 and l.lllh/70kg at birth to predicted values of7.2 and 5l/h/70kg at 
3 years respectively (figure 5a & b). This maturation curve closely approximated that 
described for the maturation of glomerular filtration rate in infants. The effect of altered 
renal function on M3G elimination clearance is shown in figure 6. This effect appears 
minimal. 
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Table 2 Conelation of population pharmacokinetic parameter variability 
CL2M3G CL2M6G CLM3G CLM6G v 
CL2M3G I 
CL2M6G 0.65 l 
CLM3G 0.73 0.40 
CLM6G 0.388 0.76 0.64 
v 0.003 0.09 -0.21 -0.08 
Figures 7a, b & c demonstrate the quality of fit for pharmacokinetic data over the study 
time. The individual Bayesian predictions for serum concentration of morphine, M3G and 
M6G are compared to those observed. These predictions are based on maximum a 
posteriori Bayesian estimates of the parameters for each specific individual using their 
observed data. The fit is poorest for the prediction of serum metabolite concentration after 
the initial loading dose of morphine. The weighted residuals (WRES) for each subject 
with values for each subject joined by vertical bars are shown in Figure 8. This plot gives 
a good indication of which patient's data deviated in a particular direction. 
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figure Sb 
Individual a posteriori Bayesian estimates of CLM3G (A) are plotted against 
postnatal age. The dashed line represents the maturation of glomerular filtration 
rate (ml/min/1.73m2), scaled to overlie CLM3G maturation (data from 
Bergstein39). It closely approximates that of predicted CLM3G maturation. 
Individual a posteriori Bayesian estimates of CLM6G (B) are plotted against 
postnatal age. 
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Table 3a 
Age v 
days l/70kg 
0 71.9 
7 84.4 
30 105.6 
90 114.6 
180 !15 
365 !15 
!000 liS 
Table 3b 
PCA 
Weeks 
24-27 
28-31 
32-35 
36-39 
Table 3c 
Morphine base parameter estimate changes with age estimated in this current study 
CL2M6G CL2M3G CLM3G CLM6G CLEX CLT base 
l/h/70kg l/h/70kg l/h/70kg l/h/70kg l/h/70kg l/h/70kg 
0.6 5.2 1.5 l.l 6.6 12.4 
0.8 6.3 1.7 1.2 8.1 15.2 
1.2 9.7 2.4 1.6 12.3 23.2 
1.9 15.9 3.7 2.5 19 36.8 
2.5 20.8 5 3.5 23.1 46.4 
2 24 6.4 4.4 24.9 51.8 
3 24.8 7.2 5 25.1 52.9 
Morphine clearance changes with post conception age. Data taken from Scott et 
al?4 
Weight Clearance CLT std (CV%) 
Kg mllmin!kg l/h/70kg 
l.l 2.27 3.378 (47) 
1.4 3.21 5.07 (49) 
2.2 4.51 7.98(44) 
3.6 7.8 15.6 (32) 
Morphine sulphate clearance changes with postnatal age in term neonates. Data 
taken from Lynn et al5 and McRorie et al.27 *Weights are estimates only 
Age Weight* Clearance CLT std Weight Clearance CLT std 
Days Kg mllmin/kg l/h/70kg Kg ml!minlkg l/h/70kg 
Lynn et al McRorie et al 
0-7 3 9.8 18.7 (12.0-30.6) 3.2 5.5 10.6 (6.2-16.3) 
8-30 4 13.3 27.3 3.9 7.4 15.1 (6.9-38.4) 
31-90 5.6 23.9 53.4 (37.3-74.4) 4.3 10.5 22.0 (20.5-42.0) 
91-180 7.5 32.3 77.6 (44.5-125.2) 5.1 13.9 30.3 (18.2-52.6) 
181-365 8.5 38.1 94.5 (44.6-172.1) 7.2 21.7 51.6 (13 .7-68 .0) 
Adult4 70 22 92.4 (CV% 38) 
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Renal Function (l/h/70kg) 
The relationship of renal function to metabolite elimination clearance of M3G, 
corrected for size and age. 
4.5 Discussion 
Size has considerable impact on the estimation and interpretation of pharmacokinetic 
parameters in children7'8'21 and has been unaccounted for in paediatric morphine 
pharmacokinetic studies 5 •22-27 The impact of size is demonstrated in table 3b & 3c, where 
reported clearance estimates, standardised to a 70-kg person with an allometric "%power 
model", show that cleaxance is similar to adults within 6- 12 months. Size was the 
primary covariate used in our analysis of the effects of age and weight This deliberate 
choice was based on known biological principles. A great many physiological, structural 
and time related variables scale predictably within and between species with weight 
exponents of 0.75, I and 0.25 respectively. 17 We have used these "l/4 power models" in 
this current study rather than centred weight, or some other function of weight, because 
the "l/4 power models" have sound biological principles. West et ai18J 9 have used fractal 
geometry to mathematically explain this phenomenon. The% power law for metabolic 
rates was derived from a general model that describes how essential materials are 
transported through space-filled fractal networks of branching tubes18J 9 These design 
principles are independent of detailed dynamics and explicit models and should apply to 
virtually all organisms. By choosing weight as the primary covariate, the secondary 
effects of age could be investigated. We had no prior biological model for the effect of 
age on clearance or apparent volume, but assumed first order processes, which are 
common in biology. 
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Figures 7a, b & c demonstrate the quality of fit for phannacokinetic data over the 
study time period- a line connects each subject's data. The individual a posteriori 
Bayesian predictions/or serum concentration of morphine (A), M3G (B) and M6G 
(C) are compared to those observed. These predictions are based on maximum a 
posteriori Bayesian estimates of the parameters for each specific individual using 
their observed data. 
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The weighted residuals (WRES) for each subject with values for each subject 
joined by vertical bars are shown. 
The predominant metabolite was M3G. Formation clearance to M3G and M6G increased 
with maturation half-life of 79 days from 5.2 and 0.6 llh/70kg at birth to predicted adult 
values of 25 and 3 llh/70kg respectively. The total body clearance (CLT) was 87% that of 
older children by 6 months and 98 % that predicted in adults by I year. Morphine HCI 
CLT and its rate of maturation fall between those described by McRorie et al27 and those 
described by Lynn et al25 or Hunt et al. 28 when their estimates are standardised to a 70-kg 
person with a% power model (table 3c). Our estimates are for the anhydrous morphine 
base rather than sulphate or hydrochloride salts and were detennined using a population-
based analysis. Differences may be related tbe population studied and the nature of the 
illness within that population5 McRorie27 and Lynn25 determined clearance after infusion 
by dividing infusion rate in those patients whom achieved steady state concentration. 
Patients who did not achieve steady-state concentrations were excluded and it is unclear 
from their papers if the morphine salt used in the infusion and measured concentrations of 
morphine were corrected for molecular weight. 
There are few data concerning morphine metabolite formation or elimination clearance in 
neonates and children. Barrett et al29 studied the pharmacokinetics of morphine. M6G and 
M3G in 19 ventilated new-born infants (24- 41 weeks gestation) who were given 
diamorphine infusions. The authors made the assumption that 55 % of administered 
morphine is converted to M3G and 10 % to M6G, based on adult literature. 30 The CLT 
reported by Barrett et a!"9 (4.6 mlfminlkg. 7.21/h/70kg) is similar to that observed in the 
study by Scott eta! in premature neonates24 (Table 3b) and the CL2M3G (2.5 rnl/minlkg. 
4.0 l/h/70kg) is similar to that in our current study. We estimate a formation clearance 
contribution of 42 % for M3G in infants rather than 55 % in adults. Similarly, the 
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CL2M6G (0.46 ml!min/kg, 0.72l/hl70kg) is smaller than expected (0.63 llh/70kg) 
because of the smaller contribution from this metabolite (5% vs. 10 %). CLT observed in 
our current study in term neonates is 50 % greater than that described by others in 
premature neonates23'24 (4.6 ml/min!kg, 7.2l/hl70kg), consistent with intrauterine 
development of glucuronidation. 1 
The volume of distribution increased exponentially with a maturation half-life of 2 weeks 
from 721/70kg at birth to 115 (CV 54%) l/70kg at 6 months. Kart et al,4 in a literature 
review, were unable to discern age related changes in volume of distribution. However, 
the methods used in the literature to determine volume of distribution vary greatly and it 
is difficult to compare estimates. Individual studies such as that by Pokela et al31 report 
similar age-related changes to ours. The volume of distribution increased from 91 (S.D. 
28) 1!70kg in neonates 1 - 4 days old, 126 (S.D. 56) l/70kg at 8- 60 days and 168 (S.D. 
105) 1170kg at 61 - 180 days of age. 
The metabolite volumes of distribution in neonates and children are unknown. Penson et 
al 14 report a volume of distribution for M3G (V3M) of 23.1 l/70kg in adults. Adult 
estimates for the volume of distribution for M6G (V6M) are from 8.4 to 30 1!70kg. 15 ·32-34 
V6M is believed to be greater than V3M because of higher lipophilicity at physiological 
pH;35 consequently a V6M of 30 1170kg was empirically chosen. The goodness of fit was 
poorest for the prediction of serum metabolite concentration after the initial loading dose 
of morphine (figure 7) and may be attributable to fixing VM at a set value with no 
associated vaTiability. The CLM3G of 7.2 (CV 65 %) l/hl70kg is similar to that described 
by Penson32 (10.1, SD 2.9llh/70kg) in adults. Both M6G formation and clearance is 
reduced compared to adults. Penson14 and Lotsch34 report a CLM6G of 9.4, SD 2.8 
llh/70kg and 9.24, SD 1.68 llh/70kg respectively. These data suggest that both CL2M6G 
and CLM6G increase out of early childhood to approach those of adults. 
The morphine metabolites M3G and M6G are water-soluble compounds, enabling renal 
excretion. The time course of metabolite elimination clearance follows that of glomerular 
filtration rate (GFR), although clearance of M3G is greater (see figure 5). This may be 
attributable to renal tubular secretion3036·37 and non-renal elimination. 30.3 8 Glomerular 
filtration rate (GFR) changes are usually referenced to body surface area in children,39 a 
model that approximates the "3/4 power model" but uses 2/3 as the weight exponent. 
Attempts to use the Cockcroff and Gault models 40 to predict creatinine production rate 
failed. An empirical formula based on age to predict creatinine production was used. 
Creatinine production increased with age (Kage 0.0128) as opposed to adults in whom 
production decreases with age (Kage -0.014) 40 The increase in children is assumed to be 
a consequence of increasing muscle bulk with age as opposed to the decrease in muscle 
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bulk that occurs with age in adults. The maturation of GFR is determined by inulin 
clearance, but is commonly estimated by creatinine clearance. However, creatinine 
clearance (CrCl) may result in overestimation as GFR declines because of tubular 
secretion, changes in metabolic state altering creatinine production, and measurement 
errors at low concentrations significantly altering CrCl estimation. We demonstrated 
minimal effect attributable to altered renal function (based on creatinine production) 
because maturation of metabolite elimination clearance, which mirrored GFR maturation, 
was already accounted for. 
Serum bilirubin was used as a marker of hepatic function. This is a crude marker of 
hepatic function because serum concentrations are dependent on both formation and 
clearance of bilirubin. Bilirubin is metabolised in the liver by another 
glucuronosyltransferase, UGT1A1, and does not compete for the same metabolic pathway 
as morphine. 1 Activity of this enzyme also increases immediately after birth, reaching 
adult values around 3 to 6 months.41 It was possible to relate bilirubin (L;OBJ 50) to 
metabolite formation. Clearance was reduced from 24 llh/70kg when serum bilirubin is 5 
mcmolll to 17 llh/70kg when bilirubin is 180 mcmolll. 
Routes other than glucuronidation clear morphine in humans. Renal clearance of 
unmetabo1ised morphine contributes 19 % of CL T in infants younger than 3 months, 13 % 
in older infants and 11 % in adults 27 Sulphate metabolism for morphine is believed to be 
similar to that for acetaminophen and contributes approximately 6 l/h/70kg, a clearance 
that is the same for neonates and adults27.42 Faecal excretion and norrnorphine formation 
contribute minimally. We were unable to quantify these other routes in this current study 
and these clearances were accounted for by the CLEX parameter. CLEX contributed 4 7 % 
of CLT at 3 years while CL2M3G contributed 42% and CL2M6G 6 %, suggesting there is 
further gradual maturation of glucuronidation during childhood or adolescence before 
adult ratios of 35 %, 55% and 10% respectively are reached. 
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5.1 Abstract 
Objective 
To investigate age-related differences in morphine requirements and metabolism in full 
term neonates following major surgery. 
Design 
Randomized double-blind study 
Setting 
Paediatric Surgical Intensive Care Unit 
Patients and Interventions 
Sixty-eight neonates (52 aged,; 7 days, 16 aged> 7 days) following abdominal or 
thoracic surgery, received morphine 100 [!g/kg after surgery, and were randomly assigned 
to either continuous morphine (CM, 10 flg/kglh) or intermittent morphine boluses (!M, 30 
[!glkg/3 h). Pain was measured with the COMFORT behavioural scale and the Visual 
Analogue Scale. Additional morphine was administered on guidance of the pain scores. 
Morphine (M) and morphine-6-glucuronide (M6G) plasma concentrations were 
determined before, directly after, and at 6, 12 and 24 h after surgery. 
Results 
Neonates aged,; 7 days differed significantly from neonates > 7 days in morphine 
requirement [median 10 vs. 10.8 [!g/kg/h, (P < 0.001)], morphine plasma concentration 
[23.0 vs. 15.3 ng/ml, (P = 0.027)], and M6G/M ratio [0.6 vs. 1.5, (P = 0.018)]. Pain scores 
did not differ between age groups or morphine treatment groups. 
Neonates who were mechanically ventilated> 24 h (n = 37) had significantly higher 
morphine plasma concentrations than the spontaneously breathing neonates (n = 15) at 12 
and 24 h after surgery (29.1 vs. 13.1 ng/m1 and 26.9 vs. 12.0 ng/ml, respectively; both P < 
0.001). 
Morphine plasma concentrations were not correlated with effective analgesia or 
respiratory depression. Five neonates showed respiratory insufficiency, all on !M, 
however the difference between CM and IM was not significant. 
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Conclusion 
Neonates aged :S 7 days require significantly less morphine postoperatively than older 
neonates do. Mechanical ventilation decreases morphine metabolism and clearance. Both 
intravenous morphine regimens (CM and IM) were equally effective and safe. 
5.2 Introduction 
Although health care professionals become increasingly alert to pain management in 
neonates and infants,'·' adequate treatment of continuing pain is not guaranteed. We still 
do not know which morphine doses will provide sufficient analgesia after major surgery 
in newborn infants. Physiological alterations starting from birth, with improving hepatic 
and renal clearing capacity and changing volume of distribution, are likely to influence 
the efficacy and safety of morphine in the vulnerable neonate7 · 11 
Previously we investigated in infants of different ages (0-3 yr) tbe effects of two 
morphine administration regimens (continuous versus intermittent intravenously) on 
hormonal and metabolic stress responses and morphine requirement after major non-
cardiac surgery. 12 We concluded that age was the most important variable, because 
significant differences were found between neonates and older infants. Within the age 
groups, differences between the two methods of morphine administration were found only 
in the older age groups. 
In the present study we investigated the effect of developmental maturation on morphine 
metabolism in full term neonates after thoracic or abdominal surgery. We distinguished 
between neonates aged :S 7 days and> 7 days, because hepatic and renal physiology 
change prominently in the first week after birth. The analysis included a) age-related 
aspects, i.e. analgesia, morphine (M) need, morphine and morphine-6-glucuronide (M6G) 
concentrations; and b) effects of other clinical factors, i.e. apnoea, mechanical ventilation, 
intermittent versus continuous morphine. 
5.3 Materials and methods 
Sixty-eight neonates aged 0 to 4 weeks (gestational age 35-42 weeks and body weight 2 
1500 grams), admitted to the surgical intensive care unit following thoracic or abdominal 
surgery, were enrolled in this study. Neonates with neurological, renal, or hepatic 
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dysfunction, or with opioid therapy less than 6 h prior to surgery were excluded. The 
study protocol was approved by the Medical Ethics Committee of the Erasmus MC 
Rotterdam. Patients were enrolled only after informed consent had been obtained from the 
parents. 
Anaesthetic management was completely standardized. Anaesthesia was induced 
intravenously with thiopentone 3 - 5 mg/kg or by inhalation with halothane in oxygen. 
Fentanyl 5 )lg/kg was given before orotracheal intubation, which was facilitated with 
atracurium 0.5- 1 mg/kg or suxamethonium 2 mg/kg. Ventilation was controlled and 
anaesthesia was maintained with isoflurane 0.5 minimum alveolar concentration in 60% 
nitrous oxide in oxygen or air in oxygen. Perioperative fluids were standardized to 
maintain a glucose infusion rate between 4 - 6 mg/kg/min; body temperature was kept 
within normal ranges. A peripheral artery was cannulated, and the measured mean arterial 
blood pressure (MAP) and heart rate (HR) data served as preoperative baseline values. 
Patients received a second dose of fentanyl 5 )lg/kg before surgical incision. Additional 
doses of fentanyl 2 )lg!kg were administered when HR and/or MAP were 15% above 
baseline value. At tbe end of surgery, the neuromuscular block was antagonized and the 
tracheal tube was removed. Mechanical ventilation was continued in patients who 
required ventilatory support. 
The anaesthetist then computed the Surgical Stress Score (SSS) to classify the degree of 
surgical stress. 13 This measure takes into account seven items: amount of blood loss, site 
of surgery, amount of superficial trauma, extent of visceral trauma, duration of surgery, 
associated stress factors (hypothermia, localized or generalized infection and 
prematurity), and cardiac surgery. The total scores in this study (excluding cardiac 
surgery and prematurity < 35 weeks) could range from 3 to 24. 
All neonates received a dose of morphine hydrochloride 100 )lgikg at the end of surgery 
and were randomly allocated to equivalent doses of continuous morphine infusions (CM, 
10 )lgikg/h) or intermittent morphine boluses (IM, 30 )lgikg/3h), given intravenously. 
Pain was assessed by trained nurses before surgery and every 3 h for 24 h after surgery 
using the validated behavioural COMFORT scale (CS), (total scores range from 6 to 30) 
and the Visual Analogue Scale (VAS), ranging from 0 tolO. Recently the behavioural part 
of the CS (further referred to as behavioural CS) has been proven to be a reliable and 
valid instrument to assess postoperative pain in neonates and infants aged 0-3 years 1415 
The behavioural CS includes six behavioural items: alertness, calmness, respiratory 
response for ventilated or crying for non-ventilated children, physical movement, muscle 
tone, and facial tension. VAS scores were assigned after every 2-minute observation 
period in which the behavioural CS was scored. VAS scores ;o: 4 are supposed to reflect 
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moderate to severe pain. Every time the nurse scored a VAS :::4, the child was given an 
additional 5 flglkg dose of morphine, repeated every 10 minutes when required. 
Respiratory insufficiency was defined by the presence of apnoea or arterial PaC02 values 
::: 7.3 kPa in spontaneously breathing neonates. 16 
Arterial blood samples were taken after induction of anaesthesia (baseline), directly after 
surgery, and at 6, 12, and 24 h postoperatively to determine blood gas values and plasma 
concentrations of M and M6G. 
Blood was sampled before an intermittent bolus was given; thus, plasma concentrations in 
the IM group were measured at time points corresponding witb trough plasma morphine 
concentrations. 
Standardized automated laboratory anal ysers measured plasma total bilirubin and 
creatinine concentrations. Plasma levels of M and M6G were measured by high-
performance liquid chromatography (HPLC).17 In serum all calibration graphs were 
linear: for M tbe concentrations ranged from 5 - 90 ng/ml and for M6G from 5 - I 00 
ng/ml. The quantitation limit was 5 ng/ml forM and M6G. However, in individual 
samples, the chromatogram allowed for a lower threshold. In this concentration range, the 
intra- and inter-day coefficients of variation were less than 10 % for all compounds and 
the accuracy was about 5 %, implying a high degree of precision. 
Statistical Analysis 
In order to be able to analyse the effects of age, we distinguished between neonates aged 
:; 7 days and > 7 days. The relations between the need for extra morphine (yes/no) and 
various factors iu the univariate analysis were analysed using Fisher's exact test; 
multivariate analysis was done using logistic regression. Correlation coefficients are 
Spearman's rho. Other tests used are given in the text. P =0.05 (two-sided) was 
considered the limit of significance. 
5.4 Results 
We included sixty-eight patients, of whom 52 were aged:; 7 days, and 16 > 7 days). 
Table I gives their clinical and surgical characteristics. Apart from the age-related 
differences in weight, heart rate (HR), mean arterial blood pressure (MAP), and the 
plasma concentrations of creatinine and bilirubin, the two age groups showed no 
significant differences. 
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Table 1 Patient characteristics and details of surgery 
Postnatal age in days (range) 
Gestational age in weeks 
Study weight in kg 
Birth weight in kg 
No. of boys/girls 
No. of patients receiving CMIIM 
Mean Arterial Blood Pressure baseline (mmHg) 
Heart Rate baseline (b/min) 
Plasma total bilirubin ().lmoVl) 
Plasma bilirubin glucuronide ().lmol/1) 
Plasma creatinine ().lmol/1) 
No. requiring preoperative mechanical ventilation(%) 
No. requiring postoperative mechanical ventilation during >24 h (%) 
Surgical Stress Score 
Surgical procedures (n) 
Congenital diaphragmatic hernia 
Tracheo~oesophageal atresia 
Bronchopulmonary (lobectomy) 
Gastroschisis 
Intestinal atresia/malrotation/colonic "pull through" 
Septic gastro-intestinal a 
Exstrophy of the bladder 
Miscellaneous b 
Age,; 7 days 
n =52 
2 (0-7) 
38.2 (36.1-42.1) 
2.8 (2.4-3.3) 
2.9 (2.4-3.4) 
31121 
24/28 
50 (44-56) 
136 (125-144) 
110 (57-142) 
6.0 (5 0-7.0) 
46 (34-66) 
14 (26%) 
30 (57%) 
9.0 (8.0-1 1.8) 
10 
13 
2 
17 
7 
2 
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Age>7 days 
n = 16 
14 (8-28) 
39.2 (37 3-40.1) 
3.4 (3.1-3.9) 
3.2 (3.0-3.5) 
917 
1115 
58 (52-66) 
147 (133-158) 
38 (15-78) 
6.0 (4.0-13.0) 
24 (16-39) 
5 (31 %) 
7 (43%) 
11.0 (8.0-13) 
4 
5 
4 
Values are median (interquartile range) unless stated otherwise. CM =Continuous Morphine; 
IM =Intermittent Morphine; n = number of patients. 
a intussusception, necrotizing enterocolitis, meconium peritonitis, perforation, ileus. (teratoma, 
h pancreatectomy, Hirschsprung's disease, closure d. omphalo-mesentericus. 
Morphine 
Six patients, all on mechanical ventilation (5 aged S 7 days, 1 aged> 7 days), were 
excluded from morphine analysis, five because of detectable plasma morphine levels at 
baseline [congenital diaphragmatic hernia (n = 4), meconium peritonitis (n = 1)], and one 
because of loss of the arterial line at the end of surgery (n = 1). 
The factors postnatal age, gestational age, sex, body weight, plasma concentration of 
creatinine and total bilirubin, preoperative and postoperative mechanical ventilation, SSS, 
and morphine treatment (CM or IM), were investigated for their relationship with the need 
for additional morphine (yes or no) during the first 24 h after surgery. 
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Table 2 Morphine data at 24 h after surgery, according to treatment and age 
CM (n- 30) IM(n- 32) # 
AgeS7 days Age> 7 days AgeS7 days Age> 7 days 
(n; 20) (n; 10) (n; 27) (n; 5) 
Extra morphine (n) 
Yes 5 8 8 2 
No 15 2 19 3 
M requirement (J..Lg/kg/h) 10.0 (10.0-10.2)* 10.8 (10.2-11.9) 10.0 (10.0-10.4) 10.0 (l 0.0-11.2) 
n 20 10 27 5 
M in plasma (nglml) 23.0 (!7.1-32.0)t 15.3 (7.7-22.6) 15.4 (11.4-19.7) 8.2 
n 19 10 23 2 
M6G in plasma (ng/ml) 16.4 (12.1-20.0) 15.8 (13.3-28.2) 13.5 (10.6-19.2) 7.6 
n 19 10 24 2 
M6G/Mratio 0.6 (0.5-U)t 1.5 (1.0 -2.6) l.l (0.7-1.5) 4.3 
n 18 10 21 2 
CM = Continuous Morphine; IM =Intermittent Morphine; M =Morphine M6G = morphine-6-
glucuronide; n =number of patients.# Note: trough values in the IM group. 
In CM: *Lower in neonates 5:7 days vs. > 7 days ( P < 0.001 ); t higher in neonates :::;7 days vs. 
>7 days (P; 0.027); fLower in neonates :07 days vs. >7 days (P; 0.018) (Mann-Whitney test). 
Values are number or median (interquartile range). 
In multivariate logistic analysis, only age [13/47 s 7 days (27%) vs. 10/15 > 7 days 
(66 %); P = 0.006], and preoperative mechanical ventilation [1/13 ventilated (7 %) vs. 
22/48 non-ventilated ( 46 % ); P = 0.014] were significant predictors of the need for 
additional morphine. Postoperative mechanical ventilation did not significantly influence 
the need for extra morphine. 
Table 2 lists for each age group the morphine requirement and the plasma concentrations 
of M and M6G in CM and IM at 24 h after surgery. 
Morphine requirement (related to body weight) was significantly lower in the younger 
neonates on CM (P < 0.001, Mann Whitney U test). 
Morphine plasma concentrations 
Median plasma concentrations of morphine at 24 h after surgery were significantly higher 
in neonates aged S 7 days as compared with the older neonates in the CM group 
(P = 0.027) (Table 2). There were no significant differences in plasma morphine levels 
between neonates with or without extra morphine at any time point. 
Figure 1 shows the plasma concentrations according to age (S 7 days and> 7 days) and 
treatment (CM and IM), at 6 h (left panel) and 12 h (right panel) after surgery. 
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Fig. 1 Morphine plasma concentrations at 6 hours (left panel) and 12 hours (right panel) after 
surgery, according to age (.::;7 days or> 7 days of age) and treatment group [continuous 
morphine (CM) or intermittent morphine (IM)]. Plasma levels of patients who did not 
need extra morphine during next period (6~12 hat the left and 12-24 hat the right) are 
indicated by circles. Plasma levels of patients who did need extra morphine during next 
period are marked with triangles. 
Morphine plasma concentrations varied widely and were not indicative for additional 
morphine need in the postoperative period following these measured values. 
Neonates who were mechanically ventilated for longer than 24 h postoperatively (n = 37) 
had significantly higher morphine plasma concentrations than the non-ventilated patients 
(n = 15) at 12 and 24 h after surgery (29.1 vs. 13.1 ng/ml and 26.9 vs. 12.0 ng/ml, 
respectively; both P < 0.001). This difference in morphine plasma levels was not related 
to age or treatment regimen (CM vs. !M). Morphine requirements did not significantly 
differ between ventilated and non-ventilated neonates. 
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Table 3 Physiological responses and pain scores during the first 24 hours after surgery 
Age n HR MAP cs VAS VAS ;:,4 
(%) 
$ 7days 49 137* (13) 49* (7) 12.6 (2.6) 1.3 (0.7) 5.1 
>7days 16 151 (12) 58 (9) 13.3 (2.1) 1.7 (0.7) 7.8 
HR =Heart rate (blmin); MAP =Mean arterial blood pressure (mmHg); CS = COMFORT 
behavioural Score; VAS= Visual Analogue Score (means of measurements at 3, 6, 9, 12, 15, 18, 
21 and 24 h after surgery); VAS ~4, as percentage of total VAS scores during 24 h; n =number 
of patients. 
*HR and MAP lower in neonates aged 57 vs. > 7 days (P < 0.001) (Mann- Whitney test). 
Values are mean (SD) 
Morphine-6-glucuronide plasma concentrations 
M6G was detectable in the plasma of all neonates from 6 h after surgery. M6G plasma 
concentratious did not significautly differ between the younger and older neonates. 
The median M6G/M ratio was significantly lower in the younger neonates at 6, 12 and 24 
h after surgery (all P < 0.04) (Table 2).Although the plasma concentrations ofM6G did 
not significantly differ between ventilated and non-ventilated neonates, the M6G/M ratio 
was significantly lower in postoperative mechanically ventilated neonates at 12 h and 24 h 
postoperatively (0.7 vs. 1.6 and 0.7 vs. 1.4, respectively; both P < 0.02). The M6G/M 
ratios in neonates ventilated for less than 24 hours (n = 10) were in between those of the 
ventilated and non-ventilated neonates. 
Physiological and behavioural responses 
Table 3 gives the mean values (SD) of HR, MAP and pain scores for the first 24 h 
postoperatively. Hemodynamic data could not be analysed in 3/68 neonates due to loss of 
the arterial line during the study. 
In multiple regression analysis mean HR was significantly higher with higher age and 
body weight (both P < 0.05). 
MAP was only dependent on age and was significantly lower in neonates aged ,<; 7 days, 
even after adjusting for baseline values (P < 0.001). 
Mean COMFORT and VAS scores correlated significantly with each other (r = 0.7; P < 
0.001). Pain scores did not significantly differ between neonates aged,<; 7 and> 7 days or 
between different morphine treatment. Frequencies of VAS scores ;:, 4 (indicating pain) 
ranged from 0 to 3, and were not related to age, plasma concentrations of morphine or 
M6G, specific diagnoses, or type of surgery performed. 
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Respiratory depression 
The number of spontaneously breathing neonates increased from 15 at 6 h (9 aged,; 7 
days, 6 aged> 7 days) to 22 at 24 h postoperatively (14 ,0:7 days, 8 > 7 days). Only one of 
them (duodenal atresia) showed increased PaC02levels amounting to 8.9, associated with 
high morphine (trough) concentrations of 55 ng/ml at 6 after surgery. Four others 
(morphine trough plasma levels varying from 8 to 23.9 ng/ml) required intubation and 
mechanical ventilation: failed extubation after repair of oesophageal atresia (n=2); apnoea 
after repair of exstrophy of the bladder (n = 1) and after jejunal atresia (n = 1). All these 
five neonates were on IM and aged ,0: 7 days; none of them had received additional 
morphine in the postoperative period. Although the four infants who needed reintubation 
were on IM, the difference between CM and !M was not significant (P > 0.1 ). 
Remarkably, two other young neonates on IM with morphine trough plasma levels of 29 
and 59 ng/ml, respectively, at 6 h postoperative, did not manifest either hypercarbia or 
hypoventilation. 
Other adverse effects 
Hypotension related to the administration of morphine was not observed. Urinary 
retention could not be monitored because most of the neonates had a urinary catheter in. 
As all had undergone major abdominal or thoracic surgery, it could not be established 
whether either surgery or morphine therapy had altered gut motility. 
5.5 Discussion 
This randomized, controlled trial aimed at evaluating the effects of age on morphine 
metabolism in full term newborns. After surgery, neonates aged ,0: 7 days required fewer 
additional morphine doses, maintained higher plasma morphine levels, and converted less 
morphine to M6G (lower M6G/M ratios) than older neonates. The higher morphine 
plasma concentrations might, in part, result from a smaller volume of distribution at this 
age. While a meta-analysis showed that the morphine volume of distribution is not 
dependent on age, 18 in other studies the volume of distribution tended to be somewhat 
smaller in neonates aged,; 7 days compared with older infants, but this difference was not 
statistically significant.7.1° A morphine loading dose of 50 ).lg/kg does probably suffice for 
neonates aged ,0: 7 days, whereas 100 ).lg/kg is mostly necessary for older infants. 
From a meta-analysis, an initial morphine infusion of 7 1-'g/kg/h was calculated to be 
sufficient for postoperative pain treatment in full term neonates. 18 An adjustment was 
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suggested with regard to cmdiac and non-cardiac surgery (5 ~g/kg/h and 10- 15 ~g/kg/h, 
respectively). 19 In our study, only 27 % of the neonates,; 7 days of age required extra 
morphine compared with 66 % of those> 7 days, suggesting that postoperative pain in 
some of the younger neonates could have been adequately treated with less morphine than 
the minimal dose used. 
Findings from our study suggest that concentrations between 15 and 20 ng/ml are 
effective in postoperative neonates up to 4 weeks of age. However, as documented earlier, 
morphine plasma concentrations ranged widely, and no significant correlation was found 
between plasma levels and the need for extra morphine during the following hours. In a 
study comparing the effects ofiM versus CM in non-ventilated infants (including 14 
neonates< 1 month of age) 7% of the infusion group had respiratory problems even 
when adjusted to a tmget morphine plasma concentration of 20 ng/ml20 Although in the 
present study median morphine plasma concentrations were higher in neonates~ 7 days, 
none of the spontaneously breathing neonates in the CM group had respiratory problems. 
Five neonates, all on IM, showed respiratory depression. In only one of them this could be 
attributed to the morphine therapy, because periods of apnoea started 30 min after a 
morphine bolus dose. In the others the respiratory problems largely resulted from surgical 
complications. This suggests that morphine plasma concentrations alone are not 
necessarily indicative of ventilatory depression. 
In tbe present study, mechanical ventilation was associated with higher plasma morphine 
levels, similar plasma M6G levels and lower M6G/M ratios. In five neonates, who were 
on ventilation preoperatively and had been without morphine therapy> 6 h, morphine was 
still detectable at the time of surgery. Data on the clinical cousequences of mechanical 
ventilation on portal hemodynamics and renal function are conflicting.2J.22 However, 
although morphine metabolism is more dependent on the glucuronidation capability, a 
slower morphine metabolism and a longer elimination time may be the result of a 
decreased hepatic and renal pelfusion due to positive endexpiratory pressure (PEEP). A 
decreased M6G production, combined with a reduced renal clearance, can explain the 
similar M6G plasma concentrations and higher morphine in mechanically ventilated 
neonates. Bearing in mind the individual variability of morphine clearance, at this young 
age, a 6-hour period is apparently too short to effectively clear plasma of morphine, 10 
especially under conditions of mechanical ventilation. This phenomenon can also explain 
why neonates who had been mechanically ventilated before surgery needed less morphine 
after surgery. 
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Postoperative ventilation did not influence the need for additional morphine. However, in 
spite of the non-significant differences in morphine requirements between postoperatively 
ventilated and non-ventilated neonates, the mechanically ventilated neonates proved to 
have higher plasma concentrations of morphine. 
The clinical effect of morphine also relies on the formation of its active metabolite M6G. 
Morphine is largely metabolized by the age-dependent isoform Uridine 5' -Diphophate 
Glucuronosyltransferase (UGT)-2B7 to M6G and M3G.23 In this study the M6G/M ratio 
was significantly lower in the neonates aged :S 7 days, probably as a result of the low 
UGT activity at this age. 
Remarkably, the hemodynamic variables (HR and MAP) showed no significant 
correlation with pain scores. This questions the reliability of HR and MAP as parameters 
for pain measurement in this age group. 24 
5.6 Conclusions 
In conclusion, findings from the present study suggest that in neonates> 7 days of age a 
morphine dosage of 10 11glkg/h is sufficient for postoperative analgesia after non-cardiac 
major surgery. Hepatic and renal disturbances, however, may require adjusted dosages. 
For neonates :S 7 days of age an initial morphine infusion of 5-10 11g/kg/h is suggested, 
after a loading dose of 50 11g/kg. Further research into morphine requirements in this age 
group is needed. Morphine plasma concentrations varied widely. We found no 
consistency between morphine plasma levels and analgesia, or between plasma levels and 
respiratory depression. In neonates on mechanical ventilation, morphine plasma 
concentrations increased with unchanged M6G plasma levels, probably owing to a 
decreased hepatic and renal function. Although in the present study the CM and IM 
groups showed no significant differences in safety, the intermittent morphine regimen did 
not provide any advantage. Morphine given as a continuous infusion is more feasible and 
might be regarded as safer in neonates. 
Further findings from this study suggest that neonates on mechanical ventilation have a 
slower morphine metabolism than spontaneously breathing neonates. Behavioural 
observation can be used as indication for tapering off the morphine infusion, thus 
preventing overdosing with its associated risks. 
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6.1 Summary 
A randomized double-blind clinical trial compared the efficacy of l 0 11glkg/h morphine 
continuous intravenous infusion (CM) with that of 30 11g/kg morphine (IM) every 3 h after 
major abdominal or thoracic surgery, in 181 infants aged 0-3 years. Efficacy was 
assessed by the caregiving nurses with the COMFORT 'behaviour' and a visual analogue 
scale (VAS) for pain, every 3 h in the first 24 hours after surgery. Random regression 
modeling was used to simultaneously estimate the effect of randomized group assignment, 
actual morphine dose (protocol dosage plus extra morphine when required), age category, 
surgical stress, and the time-varying covariate mechanical ventilation on COMFORT 
'behaviour' and the observational VAS rated pain, respectively. Overall, no statistical 
differences were found between CM and IM morphine administration in reducing 
postoperative pain. A significant interaction effect of condition with age category showed 
that the CM assignment was favorable for the oldest age category (l - 3 years old). The 
greatest differences in pain response and actual morphine dose were between neonates and 
infants aged 1 - 6 months, with lower pain response in neonates who were on average 
satisfied with the protocol dosage of lO rg/kg/h. Surgical stress and mechanical 
ventilation were not related to postoperative pain or morphine doses, leaving the inter-
individual differences in pain response and morphine requirement largely unexplained. 
6.2 Introduction 
Reports on pediatric postoperative pain advocate good pain management comprising both 
pain assessment by validated instruments and adequate analgesic treatment (Berde, 1989; 
Beyer and Bournaki, 1989; Cohen, 1993; Glass, 1998; Goddard and Pickup, 1996; 
Morton, 1997). To accomplish this, more evidence-based knowledge about postoperative 
pain and related issues in pediatric samples is needed (McGrath, 1998; Mcintosh, 1997). 
One area of research examines the psychometric properties of (newly developed) 
postoperative pain instruments (Boelen et al., 1999; Buchholz et al., 1998; Buttner and 
Finke, 2000; Gilbert et al., 1999; McGrath et al., 1985; Merkel et al., 1997; Tarbell et al., 
1992; van Dijk et al., 2000). These studies suggest that behavioural pain measures are the 
preferred substitute measures when self-report is not possible, as is the case in preverbal 
infants. Another area of research describes the efficacy and safety of analgesic treatments 
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after surgery in infants. After major surgery, opioids (especially morphine) are the most 
frequently employed analgesics. The efficacy and safety of intravenous (i .v.) continuous 
morphine after major surgery in children was examined in three studies. (Beasley and 
Tibbals, 1987) found that 20- 25 !lglkg/h morphine was effective after major surgery in 
121 non-ventilated children 0 to> 14 years of age. Millar et al. (1987) concluded that 14-
21 !lglkg/h morphine was effective in 85% of 20 children, 3 months to 12 years of age. 
Finally, Esmail et al. (1999) evaluated the efficacy of morphine after major surgery in 110 
non-ventilated children aged 3 months to 16-year-old children, with infusion rates ranging 
from 10 to 40 !lgikg/h; the 65.5% inadequate analgesia in the latter study was related to 
the lower infusion rates. In all three studies, pain was the major outcome variable, 
assessed by either the visual analogue scale (VAS) or graphic rating scale (GRS) (Scott 
and Huskisson, 1976) in the studies of Beasley and Tibbals (1987) and Millar et al. 
(1987), and age-appropriate validated pain instruments in the study of Esmail et al. (1999). 
Clinical signs of ventilatory depression, a safety outcome of major importance, were not 
observed in these latter studies. All three studies have some methodological drawbacks. 
Firstly, they include children of all ages, making it difficult to establish age-related 
differences in pain and morphine requirement. Secondly, because of a lack of standardized 
protocols, the rationale for varying doses remained unclear. Thirdly, because ventilated 
infants were excluded, neonates were undenepresented in these studies, which is 
unfortunate because, nowadays, infants with congenital anomalies are often operated on at 
an early age (Jona, 1998). 
Studies comparing different routes of administration in pediatric samples, reported that 
i.v. morphine administration gives better pain relief than intramuscular morphine 
injections (Bray, 1983; Hendrickson eta!., 1990).ln addition, needle pain and fear for 
needles make intramuscular injections an undesirable route of administration 
(Hendrickson et al., 1990). 
To our knowledge, there are no double-blind randomized clinical trials which have 
compared the efficacy of i.v. morphine administration and that of intennittent i.v. 
morphine administration in both neonates and infants. Besides comparing the efficacy of 
these two modes of administration, it is of clinical importance to examine patient or 
procedural characteristics that might explain individual differences. First, there may be 
large age-related differences in response to standardized levels of morphine. Second, the 
efficacy of morphine after major surgery is often determined without considering 
100 Chapter 6 
differences in surgical procedures. One study described slower morphine clearance after 
cardiac than after non-cardiac surgery in neonates and infants (Lynn eta!., 1998), which 
may imply that smaller morphine doses may be required in cardiac surgery. Although 
there are no objective measures to detennine the painfulness of a surgical procedure, there 
is a measure developed for assessing the severity of surgical stress (SSS) in neonates 
(Anand and Aynsley-Green, 1988). To date, the relationship between postoperative pain 
and surgical stress has not been explored. Third, the effects of mechanical ventilation on 
postoperative pain assessment are unknown. 
This study addressed the postoperative analgesic efficacy of two modes of morphine 
administration, i.e. equal doses of morphine either through continuous i. v. infusion or 
through i.v. bolus injections every 3 h following major abdominal or thoracic surgery. 
In addition, we examined the impact of age, severity of stress, and mechanical ventilation 
on the individual pain responses. 
6.3 Methods 
Patients 
Between March 1995 and September 1998 a total of 204 children aged 0 - 3 years, 
admitted for major abdominal or thoracic surgery to the Sophia Children's Hospital 
Rotterdam, entered the study after informed consent of the parents was obtained. 
Included were: neonates (2: 35 weeks gestation and bodyweight 2: 1500 g) and infants aged 
up to 3 years. 
Exclusion criteria were: use of analgesic or sedative co-medication (e.g. acetaminophen or 
midazolam) influencing the measured amount or potency of morphine, use of 
neuromuscular blockers, hepatic or renal dysfunction, seriously compromised neurological 
status, or altered muscle tone. 
The Medical Ethical Committee of the Hospital approved the study. 
6.4 Assessment instruments 
COMFORT scale 
Pain was assessed with the behavioural part of the COMFORT scale (further referred to as 
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COMFORT 'behaviour'). This scale has proved a reliable and valid instrument to assess 
postoperative pain in !58 neonates and infants, using trained nurses as observers (van Dijk 
eta!., 2000). Prior to this study, 39 nurses were trained to assess the COMFORT scale and 
VAS. The linearly weighted Cohen's kappa, as a measure for the interrater reliability, 
ranged from 0.54 to 0.93 for the individual COMFORT items. The COMFORT 
'behaviour' score encompasses six behaviour items: alertness, calmness, muscle tone, 
movement, facial tension, and either respiratory response (for ventilated children) or 
crying (for non-ventilated children), all of them with response categories ranging from 1 
(low distress/no pain) to 5 (high distress/pain). The total score thus ranges from 6 to 30. 
Visual Analogue Scale 
In addition, the nurses completed an observational VAS for a clinical rating of pain in 
each child. The VAS is a horizontal continuous 1 0-cm line with the anchors 'no pain' on 
the left side and 'extreme pain' on the right side. The score ranges from 0 to 10 (Lawrence 
eta!., 1993; McGrath eta!., 1985; Taddio et al., 1995; Tarbell et al., 1992). 
Surgical Stress Score 
The SSS (Anand and Aynsley-Green, 1988) was developed to assess the severity of 
surgical stress in neonates and includes the following items: amount of blood loss (score 
range 0- 3); site of surgery (score range 0- 2); amount of superficial trauma (score range 
1 - 3); extent of visceral trauma (score range 1 - 4); duration of surgery (score range I - 5); 
associated stress factors: a) hypothennia (score range 0- 3), b) infection (score range 0-
3). The items prematurity and cardiac surgery were not applicable in our study and 
therefore the score could range from 3 to 22. These items are clearly described in the 
scoring list; information needed for sc01ing of the SSS is obtained from the surgical and 
anesthesia records. The SSS was scored jointly by the attending anesthesiologist and 
surgeon immediately after surgery in accordance with the original description of the SSS 
(Anand and Aynsley-Green, 1988). 
Design 
A randomized double-blind clinical trial was carried out to compare the efficacy ofi.v. 
continuous morphine (CM) and i.v. intermittent morphine (IM) after major abdominal or 
thoracic surgery in infants aged 0- 3 years. Patients were stratified into four 
developmentally relevant age categories: neonates (2: 35 weeks gestation and weight 
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:> 1500 grams), younger infants (1 - 6 months), older infants (7- 12 months) and toddlers 
(1 - 3 years). Infants within these age categories were randomly assigned to CM or lM 
administration. The hospital pharmacist prepared the study drugs; the randomization 
schedule was known to the pharmacist only and retained until the end of the trial. 
Pain was assessed prior to surgery, after return to the Pediatric Surgical Intensive Care 
unit (PSJCU), and every 3 h during the first 36 h postoperative. Pain assessment, blood 
sampling, administration of the morphine or placebo bolus and handling of the child was 
consistently done in this order. 
Procedure 
Anaesthetic management was standardized. Perioperative fluids were standardized to 
maintain a glucose infusion rate between 4 and 6 mg/kg/rnin; body temperature was kept 
within normal ranges. A peripheral artery was cannulated and the measured mean arterial 
blood pressure (MAP) and heart rate (HR) data were used as peroperative baseline values. 
After the first arterial blood sample (baseline), patients received a second dose of S fig /kg 
of fentanyl before surgical incision. Additional doses of 2 flg /kg of fentanyl were 
administered when HR and/or MAP were 15 %above baseline value. The mechanical 
ventilation was continued in patients who required ventilatory assistance after surgery. At 
the end of surgery, all patients were given an i.v. loading dose of 100 fig/kg morphine. 
Protocol morphine dosage, following the loading dose, was administered in the following 
way. The CM group started with a morphine infusion of 10 fig/kg/h, combined with a i.v. 
placebo bolus (saline) every 3 h. The IM group received a continuous placebo infusion 
(saline), combined with a i.v. morphine bolus of 30 fig/kg every 3h. The first intermittent 
bolus (morphine or placebo) was given 3 h after surgery. Morphine boluses were 
administered within the span of approximately 30 s. When children were considered to be 
in pain, an observational VAS pain was scored after which additional morphine could be 
given according to the following decision rules. 
The first hour after surgery when VAS:> 4: 30 ,ug/kg morphine(= approximately one-third 
of the loading dose), to be repeated when VAS remained:> 4 every 15 min. More than 1 h 
after surgery and VAS:> 4: S fLglkg morphine may be given, to be repeated every I 0 min. 
If this did not result in adequate pain control, the anesthesiologist was consulted for 
additional analgesic treatment. 
Mechanical ventilation was continued after surgery in neonates < 37 weeks 
postconceptional and after repair of esophageal atresia or congenital diaphragmatic hernia. 
Efficacy of continuous versus intermittent morphine administration after major surgery 
In older age categories, postoperative ventilation was applied depending on the surgical 
procedure. 
Statistical analysis 
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The outcome variables COMFORT 'behaviour' and observational VAS rated pain were 
skewed to the right and logtransformed (base l 0) to achieve normality. Actual morphine 
dose was highly skewed to the right and therefore divided into three categories (1= lO 
!lgikg/h, 2 = >10 to :C 15 !lgikg/h and 3 = > 15 !lgikg/h). 
Random regression modeling, using SAS 6.12 for Windows, was used to simultaneously 
estimate the effect of randomized group assignment, actual morphine dose (protocol 
dosage plus extra morphine when required), age category, SSS and the time-varying 
covariate mechanical ventilation on COMFORT 'behaviour' and observational VAS rated 
pain, respectively. Random regression modeling has many advantages: it allows for 
missing data and an unequal number of data for each subject, and for the inclusion of 
fixed and time-varying covariates. Furthennore, a realistic covariance structure (as 
opposed to compound symmetry or independence between repeated measures) can be 
implemented (Gibbons et al., 1993). 
6.5 Results 
Initially, 204 infants were allocated to this trial. However, five were lost to follow up; one 
infant died within the first hours after surgery due to irreversible pulmonary hypertension, 
three patients had a failing arterial line, and one patient experienced clinical signs of 
ventilatory depression. In addition, 18 patients were excluded because they did not comply 
with the inclusion criteria: three required muscle relaxants, seven received midazolam, 
four received acetaminophen or diclophenac, and four received both midazolarn and 
acetaminophen. 
Table I gives the background characteristics of the sample (n = 181) and the excluded 
cases (n = 23) 
The excluded infants did not significantly differ with regard to background characteristics, 
except age. This is primarily due to the low number of excluded neonates. 
Furthermore, the surgical stress score tended to be higher for the excluded infants. The 
two randomized groups were comparable with respect to age and gender. 
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Table 1 Background characteristics of the original sample and the group completing the 
trial 
Completed trial (n = 181) Excluded cases (n = 23)a 
ll Percentage n Percentage 
Randomized group assignment 
Continuous morphine 88 49 J3 56.5 
Intennittent morphine 93 51 10 43.5 
Age categories 
Neonates 65 36 I 4 
1-6 months 54 30 13 56 
6- 12 months 27 15 4 17 
1-3 years 35 19 5 22 
Age in days 
Median (IQR) 84 (5-279) 163 (61-301) 
Gender 
Boys 104 57.5 15 65 
Girls 77 42.5 8 35 
Location of surgery' 
Superficial 12 7 4 
Low abdominal 86 48 5 22 
High abdominal 53 29 9 39 
Thoracic 24 13 7 31 
Thoracic + abdominal 6 3 4 
Mechanical ventilation Postoperative 
Yes 75 41 10 43 
No 106 59 12 57 
Severity of surgical stress 
Median (IQR) 9(8-11) 11 (9-13) 
p 
0.47 
0.01" 
0.05 
0.48 
0.07b 
0.72 
0.06 
Lost to follow-up: n = 1 deceased within 3 h after surgery, n = 3 failing arterial line, n = 1 ventilatoy 
depression; excluded because of non-compliance with criteria: n = 7 received midazolam, n = 4 
received acetaminophen or diclofenac, n = 4 received both midazolam and acetaminophen, n = 3 
requiring muscle relaxants. 
Exact test. 
Supe1jicial surgery: comprised nephrectomy, ureter reimplantation, pyeloplasty, exstrophy of the 
bladder, sacroteratoma, yolk sac tumor, pull-through, incarcerated hernia. Low abdominal: Rehbein 
resection, closure entero!colostoma, gastrointestinal operations such as for atresia, intussusception, 
malrotation, necrotizing enterocolitis, and meconium peritonitis. High abdominal: comprised 
diaphragmatic hernia/paresis, duodenal atresia, subtotal pancreatectomy, Nissen fundoplication, hepatic 
and choledochal surgery, (ad)renal surgery, stomic peiforation. Thoracic surgery: Trachea-oesophageal 
atresia, lobectomy, pneumectomy, Blalock and vessel loop. Thoracic + abdominal : Colon interposition, 
operation for oesophageal/anal atresia. 
Table 2 shows the summary statistics for pain assessments, morphine dosage and 
postoperative mechanical ventilation for the two randomized groups. 
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a CM = continuous morphine, IM = intermittent morphine; JQR = Interquartile range 
b Assessed nine times in the first 24 h. 
c Maximum dosage 36.9 in the CM assignment, 26.7 in the IM assignment. 
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In the CM assignment, 26 of the infants (29 %) were without pain with the 10 flg/kg/h 
morphine as opposed to 36 (39 %) in the IM assignment (Fig. 1). This difference was not 
statistically significant. (X2 y,,,- oorr'"'' = 1.31, P = 0.26, two-sided). Extra boluses of 
morphine, according to the decision rules of the protocol, were given once or more, to 119 
infants (66% of the sample). Of these, 39 infants received extra morphine within the first 
hour after surgery, which consisted of one-third of the loading dosage. Within the first 6 
hours after surgery 92 infants received extra morphine. Another 20 infants received their 
first extra bolus between 6 and 12 h after surgery. Only seven children received a first 
extra bolus of morphinel2 h after surgery. 
The effects of the predictor variables on COMFORT 'behaviour' and observational VAS 
rated pain as outcome variables are given in Tables 3 and Table 4, respectively. Both 
models incorporated random intercepts and random slopes. 
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Mean and SE of COMFORT 'behaviour' scores for the four age groups split by 
median morphine dosage: 77 % of the neonates (50 of 65) had morphine dosage 
<=median, 30% of young infants (16 of 54), 33 % of the older infants (9 of 27) and 
46% of the toddlers (16 of 35). 
The randomized group assignment did not have differential effects on the repeated 
COMFORT 'behaviour' or observational VAS rated pain scores. However, actual 
morphine dose was significantly related to observational VAS rated pain, after observing 
that the 
> 15 )lgikg/h category had significantly higher VAS scores than the two lower dosage 
morphine categories. Age category significantly predicted both outcome variables, 
indicating that the l - 6 months infants had significantly higher pain scores than the 
neonates. The interaction between age categories and randomized group assignment was 
significant for observational VAS rated pain behaviour. This was explained by the 
difference between neonates and toddlers, with the CM condition being more favorable 
than the IM condition for the toddlers, but not for the neonates. 
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Table 3 Predictability of COMFORT 'behaviour' (n~181)' 
Outcome variable : COMFORT 'behaviour' 
Jl SE of Jl t p 
Morphine condition O.QI5 0.04 0.36 0.72 
Morphine dosageb 
10 ~g/kg/h -0.06 0.03 -1.89 0.06 
>I 0 to :S 15 ).lg/kg/h -0.01 0.03 -0.22 0.82 
Age categoryc 
I - 6 months 0.09 0.03 3.85 0.0001 
6- 12 months 0.05 0.03 1.82 0.07 
I - 3 years -0.01 0.03 -0.29 0.77 
Morphine condition * age category 
Condition * l - 6 months -0.04 0.03 -1.27 0.20 
Condition * 6- 12 months 0.004 0.04 0.11 0.91 
Condition * I - 3 years 0.05 0.03 1.48 0.14 
Morphine condition * morphine dosage 
Condition * 10 )..lg/kg/h 0.001 0.04 0.02 0.99 
Condition * > 10 !-lglkg/h -0.005 0.04 -0.14 0.89 
Linear time trend 0.001 0.001 0.09 0.93 
Surgical Stress Score -0.003 0.002 -1.49 0.14 
Mechanical ventilation -0.003 0.01 -0.24 0.81 
a Random regression modelling for repeated measurements. 
b Morphine dosage category: 1 = 10 J-lglkg/h and 2 = >10 to S 15 jig/kg/h compared to 3 = > 
15 jlglkg/h (reference category). 
cAge categories I- 6 months, 6- 12 months and 1-3 years compared to neonates (reference 
group) Significant predictor variables (P < 0.05) are given in italics. 
The interaction between randomized group assignment and morphine dose was not 
significant, indicating that the relation between the actual morphine dose and the level of 
observational VAS rated pain and COMFORT 'behaviour' scores did not depend on the 
randomized group assignment. 
The observational VAS rated pain score significantly decreased over time, whereas the 
COMFORT 'behaviour' score showed no significant time trend. 
The SSS and mechanical ventilation did not significantly predict the levels of COMFORT 
'behaviour' and observational VAS rated pain. 
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Fig. 2 Mean and SE of VAS pain scores for the four age groups split by median morphine 
dosage: 77% of the neonates (50 of65) had morphine dosage <~median, 30% of young infants 
(16 of 54), 33 %of the older infants (9 of27) and 46% of the toddlers ( 16 of 35). 
The most significant predictor variables are shown in Figs. I and 2, which give the means 
and standard errors of COMFORT 'behaviour' and observational VAS rated pain scores 
over time for the four age categories, split by the overall median dose of morphine(l0.7 
f.lglkglh). As was confirmed by the random regression analyses, average levels of 
COMFORT 'behaviour' and observational VAS rated pain were different for the 'high' vs. 
'low' morphine groups. Age effects were clearly seen, especially when comparing 
neonates and young infants. The observational VAS rated pain showed a moderate decline 
in scoring over time. The toddlers showed a slight increase in COMFORT 'behaviour' 
scores, with limited differences between those below and above the overall median 
morphine dose level. 
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Table 4 Predictability of observational VAS pain (n = 181)' 
Outcome variable : observational VAS pain 
ll SE of ll t p 
Randomized group assignment -0.06 0.07 -0.88 0.38 
Morphine dosageb 
10 flg/kglh -0.27 0.05 -4.89 0.0001 
>10 to S 15 f!g/kglh -0.11 0.05 -2.33 0.02 
Age categor~l 
I - 6 months 0.10 0.04 2.65 0.01 
6- 12 months 0.05 0.04 1.20 0.23 
I - 3 years -0.09 0.04 -2.15 0.03 
Randomized group assignment age category 
Assignment * I - 6 months -0.04 0.05 -0.76 0.44 
Assignment* 6- 12 months -0.01 0.06 -0.20 0.84 
Assignment * 1 - 3 years 0.16 0.05 3.12 0.002 
Randomized group assignment * morphine dosage 
Assignment * 10 ~g/kg/h 0.09 0.07 1.38 0.17 
Assignment* >10 to S 15 f!g/kglh 0.06 0.06 0.98 0.33 
Linear time trend -0.01 0.001 -6.23 0.0001 
Surgical Stress Score 0.001 0.003 0.24 0.81 
Mechanical ventilation -0.03 0.02 -0.99 0.32 
a Random regression modelling for repeated measurements. 
b Morphine dosage category I = 10 JLglkglh and 2 = >10 to S 15 JLglkglh compared to 3 = > 15 
JLg/kglh (reference category) 
cAge categories 1 - 6 months, 6 - 12 months and 1 - 3 years compared to neonates (reference 
group) 
Significant predictor variables (P < 0.05) are given in italics. 
6.6 Discussion 
This randomized double-blind controlled trial showed that for 29 % of the infants in the 
CM assignment and 36 % of the infants in the IM assignment, a dosage of 10 ).!gikglh 
morphine was effective to prevent postoperative pain. Therefore, we conclude that the 
(in)effectiveness did not statistically differ between the two morphine conditions. Only for 
the 1- to 3-year-old infants, the CM assignment was somewhat favorable. This can be 
explained by the fact that the half-life of morphine reaches adult values with half-life of 
2 h ± 1.8 for infants older than 2 months (Kart eta!., 1997). The 3-h period between i.v. 
morphine bolus injections in the IM assignment could therefore, result in morphine 
plasma levels below the therapeutic range in the 1- to 3-year old age category. 
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A recent study by Lynn compared continuous morphine infusions after surgery to 
intermittent i.v. boluses as needed in 83 infants of 0- I year of age (Lynn eta!., 2000). l.v. 
morphine infusions resulted in better analgesia, corresponding to higher total morphine 
dosing compared to the intermittent group. However, the continuous infusion rates were 
set to meet a targeted morphine concentration of 20 ng/ml and all infants received 
additional acetaminophen which hampers the comparison to our results. 
The unexpected equal results for the two routes of morphine administration in relation to 
postoperative pain are promising, especially for clinical settings with a limited availability 
of infusion pumps (e.g. developing countries). Furthermore, opposed to intermittent 
boluses, continuous morphine infusions will require a larger fluid volume to be given to 
small neonates, thus limiting fluid volume available for postoperative nutrition. The 
difference in nursing workload and costs between the two routes of administration has not 
been established to our knowledge. 
Age was related to pain and actual morphine dosage, although not in a linear way. 
Neonates had lower COMFORT 'behaviour' scores and observational VAS rated pain 
scores compared to infants aged I - 6 months. Neonates tend to metabolize morphine 
slower than older infants do (Kart eta!., 1997; Lynn eta!., 2000; Lynn eta!., 1998) which 
might explain the lower pain scores of the neonates. Furthermore, the majority of neonates 
(75 %) in this study was at least 37 weeks gestational age. Therefore an increased 
sensitivity to pain and lower pain thresholds (Anand, 2000; Fitzgerald, 1993) as seen in 
premature neonates is of limited relevance in this study. Why the young infants ( l - 6 
months) had the most pain could not be explained by surgery-related characteristics 
However, upon closer inspection it appeared that the 1-6 months-old infants differed in 
two aspects from the ueonates: surgical experience and prematurity at birth. Almost all of 
the neonates (97 %) underwent their first procedure under anesthesia in this trial, whereas 
of the I - 6 months old infants only 35 % had no prior surgical experience. In addition, 30 
% of the I - 6 months old infants was born before 35 weeks gestational age opposed to 
none in the neonatal group. Considering the extensive literature on increased pain 
sensitivity and windup in premature neonates (Anand, 2000; Fitzgerald, 1993) undergoing 
many painful procedures, surgical history and prematurity may be relevant factors. 
A matter of consideration with infants and toddlers is the problem of differentiating 
between pain, anger, and anxiety. With increasing age, infants are likely to become more 
aware of their environment and to respond in their unique way. Furthermore, infants 
become more active when they feel better, which might unintentionally increase the 
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behavioural pain scores. This could explain the slight increase in COMFORT 'behaviour' 
scores across time for the toddlers (Fig.!), and the non-significant time trend for 
COMFORT 'behaviour'. When nurses are trained in using the COMFORT scale, it should 
be emphasized to score distress behaviour only. The observational VAS rated pain is less 
sensitive for such misinterpretation as it asks directly to assess the pain intensity. On the 
other hand, the quality of the observational VAS rated pain depends strongly on the 
observer's experience and knowledge of infants in pain. By contrast, the COMFORT 
'behaviour' is based solely on a 2-min behavioural observation and its reliability can be 
improved by training. 
Ofthe 62 infants who received 10 llglkg/h morphine after surgery, 42 were neonates (CM: 
n = 20; IM: n = 22). Only one neonate was included in the group who received> 15 - 36.9 
!lglkg/h morphine. For term neonates, 10 flg/kg/h, and for infants 15 flg/kg/h, seem 
adequate doses to begin with after major surgery. In the literature, recommended dosages 
for morphine i.v. infusion range from 10 to 40 flg/kg/h, mostly depending on age. In a 
review by Kmt et a!. (I 997b) the recommended dosage for term neonates was calculated 
to be 7 fjg/kg/h and for infants 20 fig/kg/h. Considering the variability within the age 
categmies in the present study, our results confirm the current opinion that dosages should 
be determined or adjusted for each individual separately (Kmt eta!., 1997b; Pokela eta!., 
1993). Another explanation for the inter-individual variability could lie in the genetic 
heterogeneity in morphine metabolism, as was pointed out for the glucuronide pathway 
(Coffman eta!., 1998). 
In our study, the severity of surgical stress was not significantly related to postoperative 
pain. In other studies, postoperative metabolic and hormonal stress responses were 
positively correlated with the SSS in neonates (Anand and Ward Platt, 1988), and 
metabolic and hormonal stress responses decreased thanks to analgesic treatment after 
surgery in premature neonates (Anand eta!., 1987). An explanation for the apparent lack 
of association between SSS and pain response might be that the SSS in our study was 
relatively low with limited variability across patients, pmtly due to the exclusion of 
premature neonates and cardiac surgery. Since ours is the first study to relate SSS to 
behavioural pain measures, we may conclude that more research is required to establish 
knowledge about the stress-pain relationship (Aynsley-Green, 1996). 
In the cmrent study, the time-varying covariate mechanical ventilation did not predict the 
repeated pain assessments. In our sample 42% (75 of 182 cases) required postoperative 
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ventilation, equally divided across the two conditions. The majority of the ventilated cases 
were neonates (51 of 75 cases). Ventilated cases are usually excluded, either because 
safety is an outcome variable or because pain assessment in these cases is too complex. 
Although the safety of morphine for the ventilated cases could not be determined, pain 
assessment for the ventilated cases was not a problem in our study, because we used the 
COMFORT 'behaviour' which has one item specifically developed for ventilated cases 
that replaces the item 'crying' used for non-ventilated cases. In the present study, one 
patient with clinical signs of ventilatory depression was excluded from the trial. The 
inclusion of ventilated cases in our study had the advantage that our findings may be 
generalized to the population of the PSICU. 
Side effects of morphine, such as pruritis, vomiting and nausea, were not observed in this 
study. Because of the high incidence of gastrointestinal surgery and urinary catheters, gut 
motility and urinary retention were not documented. Side effects caused by the bolus 
administration of 30 11glkg were neither observed. 
Fifteen infants (7 %) were excluded from this trial because they received sedatives and/or 
other analgesics than morphine. Although this may be seen as a drawback of the current 
study, in our opinion, a minority of infants remains difficult to be treated adequately for 
pain in clinical practice. Healthcare providers find it difficult to decide whether agitation 
is caused hy for instance 'fighting the ventilator', distress or pain (Ramelet, 1999). As a 
result, treatment is based on 'trial and error', rather than evidence-based treatment 
(Stevens and Koren, 1998). 
In summary, the results of this study show that continuous and intermittent i.v. morphine 
administration after major surgery were equally (in)effective in infants up to I year of age. 
Differences in pain response and morphine dosage were most prominent between neonates 
and infants 1 - 6 months old, with lower pain responses in neonates (who were on average 
satisfied with the protocol dosage of 10 !lglkglh) and higher pain responses in infants aged 
1- 6 months, who required higher dosages of morphine. Individual differences in pain 
response and morphine requirement remained largely unexplained. Surgical stress score 
was not related to postoperative pain or morphine dosages. 
These findings expand our knowledge on postoperative pain and may contribute to better 
postoperative pain management for infants aged 0- 3 years after major surgery. 
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7.1 Abstract 
Objective 
To evaluate postoperative pain management in neonates from 1985 to 2002. 
Design 
Retrospective study. 
Setting 
Paediatric Surgical Intensive Care Unit in a level Ill children's hospital. 
Patients and Interventions 
Chapter 7 
Four different periods of pain management were identified: A (1985- 1990) morphine as 
needed, intermittently; no validated pain score (PS), B (1990- 1995) morphine 
continuously; no validated PS, C (1995- 1998) morphine continuously, developing 
validated PS, D (1998- 2002) morphine continuously, validated PS combined with 
algorithm. 
Over the period 1985 - 2002, we evaluated in eighty-one neonates who had undergone a 
primary anastomosis of an isolated oesophageal atresia and closure of the trachea-
oesophageal fistula, how the introduction of continuous morphine infusions and a 
validated pain score combined with an algorithm, effected 
a) the amounts of morphine used and the duration of mechanical ventilation during the 
first 3 days after surgery, and 
b) the relation between prescribed and actually administered morphine dosages. 
Results 
In period A neonates received significantly less morphine than in the periods B, C and D 
(all P < 0.005), no differences were found between the latter three periods. The proportion 
of patients mechanically ventilated after surgery increased from 84 % in period A, to 90 
% in period B, and to l 00 % in the periods C and D. The duration of mechanical 
ventilation after surgery increased during periods A, B and C [median ( 10 - 90'h 
percentile)] from 24 (0- 78), to 47 (1 - 96), to 48 (20- 109), respectively, and decreased 
in the last period to 34 (15- 145) hours. Overall, the total duration of postoperative 
mechanical ventilation did not significantly differ between the four periods. To evaluate 
the effect of a validated pain score combined with an algorithm (period D), we completed 
a "subgroup analysis". The odds of being given greater or lower amounts than the median 
morphine dose did not differ between the periods C and D. However, the odds to be 
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mechanically ventilated longer than the median duration of 45 h was 4.5 times lower in 
period D than in period C (95 % Cl: 0.05- 0.94). There was no significant association 
between the prescribed and the actually administered amounts of morphine in period A. 
However, in the three later periods the correlation was significant and increased from r = 
0.58 (P = 0.007) in period B, tor= 0.91 and 0.88 (both P < 0.001) in period C and D, 
respectively. 
Conclusion 
The change from personal interpretation of postoperative pain to individual assessment 
based on objective pain scores resulted in optimal morphine dosages with an acceptable 
duration of mechanical ventilation, and a high correlation between prescribed and 
administered analgesia. 
7.2 Introduction 
Pain management in children has changed significantly during the last decades. 
Analgesics used to be given on demand, when pain was proven, but opioids were seldom 
used and only in children ventilated mechanically. 1-5 Fear for adverse effects of opioids 
and ignorance of pain perception and pain experience prevented medical and nursing staff 
from prescribing and administering analgesics as standard practice. Despite all reports of 
undertreatment, this attitude did not change till Anand et al. reported the deleterious 
effects of inadequate analgesia during and after surgery in pretenn neonates. Patients 
without analgesia exhibited not only significant stress responses (increased epinephrine, 
norepinephrine, glucose, and decreased insulin levels), but also increased morbidity and 
I . 6 7 marta rty. · 
Fear for respiratory depression of morphine and lack of efficacy data made anaesthetists 
reluctant to administer large amounts of morphine in small children. 8 From the mid-1980s 
several studies regarding the pharmacokinetics and safety of opioids were performed in 
neonates and infants.9- 16 For safety reasons most of these studies were canied out in 
mechanically ventilated infants. 
Gradually pain management after major surgery changed from "on demand" into pain-
preventing therapy, so-called pre-emptive analgesia, and morphine administered as a 
continuous infusion became standard care. Unfortunately, from lack of validated pain 
measurements for non-verbal children, it was impossible to evaluate the effects of the 
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different morphine therapies or to determine optimal analgesic doses for different age 
groups. 
In the 1990s a number of studies provided anaesthetists and paediatricians with validated 
tools for assessment of postoperative pain in non-verbal children. 17-29 Next it was shown 
that age, kind of surgery and method of morphine administration all effect surgical stress 
responses and morphine requirements.30-35 From that time onwards paediatric pain 
. d 36 management Improve . 
The purpose of the present study was to evaluate different periods of pain management 
from 1985 to 2002, from nurse-biased to standard care. In one diagnostic category of 
surgical neonates, i.e. neonates with an isolated oesophageal atresia treated by primary 
anastomosis, we evaluated the effects of a protocol of continuous morphine infusion and a 
validated pain score combined with an algorithm for postoperative pain management, on 
a) morphine requirements, b) duration of mechanical ventilation and c) the relation 
between prescribed and actually administered amounts of morphine. 
Table 1 Per- and postoperative management on the surgical PICU of the Sophia Children's 
Hospital 
Period 
A (1985-1990) ll (1990-1995) c (1995-1998) D (1998-2002) 
Anaesthetic Halothane/ Halothane/ Isoflurane/ Isoflurane/ 
procedure N 20/02/air/ N20/02/air/ N20/0iair/ N20/02/air/ 
pancuronium atracurium atracurium atracurium 
awake intubation fentanyl 3 ~g/kg FentanyllO !lglkg FentanyllO !lglkg 
Postoperative pain 1M (IV/RC). only CM, 10-20 )..lg/kg/h, Cl\1/IM, initial dose: CM, initial dose: 
treatment during mechanical during mechanical 10 )lg/kglh, during 5-10 )lglkg!h, during 
ventilation ventilation and SR mechanical ventilation mechanical ventilation 
andSR andSR 
Loading dose Never/rare Not standardized Always, 100 )lgfkg Always, 100 )lg!kg 
Algorithm No No No Yes 
Additional pain Personal Personal VAS:o>4 VAS:o>4 
relief interpretation interpretation 
Adjusting Personal Personal According to protocol Based on pain scores 
morphine dosage interpretation interpretation 
Pain assessment Not standardized Not standardized COMFORT and VAS COMFORT and VAS 
Mechanical On indication/rare On indication Yes Yes 
Ventilation after 
surgery Yes/No 
IM = intermittent morphine,' CM = continuous morphine,' IV= intravenously; RC= rectally; SR= 
spontaneous respiration, 
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7.3 Patients and methods 
This changing attitude regarding pain and pain management was also found on the 
surgical paediatric intensive care unit (PICU) in the Sophia Children's Hospital, allowing 
us to distinguish four different periods from 1985 till now (Table 1). 
Table 1 gives details about the anaesthetic procedures and postoperative management, i.e. 
mechanical ventilation yes/no, pain assessment and pain treatment, applied during these 
periods. 
In period A), postoperative pain was treated with intennittent morphine rectally or 
intramuscularly foHowing nurses' judgement. Mechanical ventilation after surgery was 
only stmted on indication. 
In period B) patients received continuous morphine infusions preventing personal bias 
regarding morphine administration. However, no validated scales for measurement of 
postoperative pain were available, and the infusion rates were adjusted by personal 
interpretation of pain. 
In period C) in a RCT comparing the effects of postoperative continuous and interntittent 
morphine, the COMFORT Scale (CS) was validated for postoperative pain measurement 
in non-verbal children. The behavioural pm1 of the CS has been proven to be a valid, 
reliable and feasible instrument for assessment of pain in neonates and infants aged 0 to 3 
years after major surgery.26 ln this study all neonates and infants received an initial 
morphine dose of 10 ~g /kg/hJ, according to the results of other studies 9 •13 ·37 
From that time onwards patients after oesophageal surgery were routinely mechanically 
ventilated. 
In period D), as result of the above study,34 postoperative morphine was given as a 
continuous infusion. Neonates and infants> 7 days received an initial dosage of 10 
).lg/kg/h, neonates,; 7 days 5 ~g!kg/h, after a loading dose of 100 ).lglkgmorphine. 
The behavioural CS was now pmt of standard daily care, to evaluate the effects of 
analgesia and to adjust dosages according to an algorithm, what was developed 
consequently (Fig 1). 
Figure I shows the algorithm, providing instructions for pain management, based on 
COMFORT and VAS scores. 
Algorithm PSICU 
-.J After each bolus VAS and 
COMFORT to be repeated I 
VAS;::: 4 
COMFORT behaviour ;:.. 17 Bolus morphine every 10 min, max. 
1 J-
3 tll11c~ per h 
~ investigate causes < 3 months old + 10 [lg/kg No improvement in scores 
,; _,.. eonsultation IC 0 VAS~4 > 3 months old _,.. 15 ~Lglicg physician 
COMFORT behaviour < 17 
I I) VAS ~ 
j 2)COMFORT Restlessness: M idazolam 0. 05-0.1 
investigate the causes V mglkg bolus c.q. infusion (after -VAS<4 consultation IC physician) 
COMFORT behaviour :?: 17 
Hunger, positioning non-
pharmacological interventions 
VAS<4 
No direct action 
COMFORT behaviour < 17 iJ. repeat score.~ during 
regular care 
Fig. 1 Algorithm giving instructions for rain management in the paediatric surgical intensive care unit 
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7.4 Methods 
A single-centre analysis in a level !II children's hospital was carried out. 
Inclusion and exclusion criteria 
We identified all neonates, admitted to the paediatric surgical intensive care unit (P!CU) 
after a primary anastomosis of an oesophageal atresia and closure of the trachea-
oesophageal (TE) fistula, during the period 1985 - 2002. Patients with gestational age < 
35 weeks, those who were complicated by cardiac, hepatic, neurologic or renal disorders 
(including major associated anomalies), or other surgical procedures, and those who were 
treated postoperatively with sedatives, muscle relaxants or other analgesics than 
morphine, were excluded (n = 90). 
The surgical procedure included a right-sided thoracotomy, using a retropleural approach 
followed by an end-to-end anastomosis with closure of the TE fistula. 
Variables 
The following data were collected: age, sex, the dosage of morphine for the first 24 h 
prescribed by the anaesthetist, the dosage of morphine actually administered during the 
first, second and third 24 h after surgery, the route of analgesic administration, and the 
duration of mechanical ventilation. When the route of administration was rectally, the 
rectal dose was converted to an intravenous one by halving the dose (rectal bioavailability 
of morphine varies from 10- 60 % ). 
Procedure 
The data were collected retrospectively as well as prospectively, depending on the period 
when the operation was carried out. The data of patients operated upon before 1995 were 
collected retrospectively, using the following sources: patient histories, medication charts, 
anaesthetic reports, and Therapeutic Intervention Scoring System (TISS) scores38 Most of 
the patients in period C and D participated in clinical trials. In these trials morphine 
requirement, pain scores, and the duration of mechanical ventilation were prospectively 
registered, to determine morphine phannacokinetics in different age groups. 
Data analysis 
The children were stratified into one of four groups depending on the period of operation. 
To find out whether the groups differ, One Way ANOV A was performed, after which 
Student t-test was used to compare each pair of group. Pearson Correlation Coefficient 
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was used to assess the association between prescribed and actual given amounts of 
morphine. If the data showed strong skew distribution, their non-parametric variants (i.e. 
Kruskall Wallis, Mann Whitney U Test, and Spearmann's Rank Correlation) were used. 
7.5 Results 
A total of 171 infants were identified, 81 of which were included. Twenty-five during 
period A), 20 during period B), 17 during period C), and 19 during period D). 
Kruskall Wallis demonstrated that the median age in period A was significantly lower 
than that in B, C and D (P < 0.005). In all periods more boys than girls were included (all 
P = 0.001). Table 2 presents, besides the patients' characteristics, the amounts of 
morphine used each day and the total duration of mechanical ventilation for the four 
different periods. 
Morphine 
Kruskall Wallis analysis showed significant group differences in the total amount of 
morphine administered during 72 hours after surgery. In period A neonates received 
significantly less morphine than in the periods B, C, and D (all P < 0.005), no differences 
were found between the latter three periods. 
Figure 2 shows the median doses of morphine during the first, the second and the third 
day after surgery, in the four periods. 
Mechanically ventilation after surgery 
From 1985 - 2002 the percentage of patients mechanically ventilated after surgery 
increased from 84% in period A, to 90% period B, and to 100% in the periods C and D. 
The duration of mechanical ventilation after surgery increased during periods A, B and C 
[median (10- 90th percentile)] from 24 (0- 78), to 47 (I- 96), to 48 (20- 109), 
respectively, and decreased in the last period to 34 (15- 145) hours (Table 2). Overall, the 
total duration of postoperative mechanical ventilation did not significantly differ between 
the four periods. 
Period C versus D 
To evaluate the effect of combining a validated pain score with an algorithm 
(accomplished in period D), we completed a "subgroup analysis" estimating whether 
neonates in period D had a greater or lower odds to have a larger morphine requirement 
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and a longer duration of mechanical ventilation than neonates in period C. For this 
purpose the variables "morphine requirement" and "duration of mechanical ventilation" 
were discriminated into: a) getting more or less than the median morphine requirement for 
the first 72 hours and b) needing mechanical ventilation more or less than the median 
duration of ventilation. To assess these two medians the data of both periods C and D 
were combined; medians were 7.3 flg/kg/b and 45 h. respectively. The odds of receiving 
greater amounts of morphine (i.e. 2: 7.3 fig /kg/h) did not differ between the two periods. 
However. the odds to be mechanically ventilated for> 45 h was 0.22 (95% Cl: 0.05-
0.94); i.e. 4.5 times lower in period D than in period C. 
Figure 3 shows the proportions of patients in need of postoperative mechanical ventilation 
in the four periods. with duration ranging from 0 to > 48 h. 
Fig. 2 
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Table 2 Patient characteristics, morphine dosages and duration of postoperative mechanical ventilation 
- r•~-·-·-·-•~ ''~'~"' ~'""'"~'"'' " " ' -~-----" --~-- ----.. ---~ 
A B c D P value 
1985-1990 1990-1995 1995-1998 1998-2002 
__________ ,_ 
-- - ------- ----~~--- .. ·--" -----
No. of patients 25 20 17 19 
Postnatal age in days 1 (0-2)* 1 (1-4) 2 (1-7) I (0-5) *A vs. all < 0.005 
Gestational age in weeks 40 (36-42) 39 (36-42) 38 (35-42) 39 (36-41) 
Weight in kg 2.9 (2.1-3.8) 2.5 (1.8-3.5) 2.9 (2.0-3.6) 3.0 (2.0-3.6) 
No. of boys/girls 16/9 12/8 16/1 13/6 
% of patients receiving morphine at day 1 100 100 100 100 
day 2 64 80 92 94 
day 3 8 25 38 19 
Morphine dosage during 72 h atler surgery (]tg/kg/h) 3.0 [ 1.2-7.8]* 8.0 [3.3-16.2] 8.3 [5.7-14.6] 7.3 [3.5-13.7] *A vs. all P < 0.05 
Morphine dosage (~tg/kg/h) at day l 7.0 [3.0-17.4] 15.0 [10.0-23.7] 14.0 [13.8-24.8] 14.0 [9.0-24.0] 
day 2 3.0 [0-8.0] 6.5 [0-19.1] 6.0 [3.2-14.4] 5.0 [1.5-10 OJ 
day 3 0 [0-0.8] 0 [0-9.9] 0 [0-10.0] 0 [0-5.0] 
% of patients mechanically ventilated after surgery 84 90 100 100 
No. of hours of mechanical ventilation after surgery 24 [0-78] 47 [1-96] 48 [20-109[ 34 [15-145] 
Values are median (range), median [10- 90111 percentile}, or percentage. 
Day 1 =the first 24 h after surgery; day 2 = 24- 48 h after surgel)l; day 3 = 48- 72 h after surge1)r. 
Evaluation of pain management in neonates after oesophageal atresia 
Morphine prescribed and administered 
Figure 4 shows a scatter plot of the prescribed morphine doses and the actual given 
amounts of morphine during the first 24 h after surgery in the four periods. 
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Spearmann Rank Correlation testing demonstrated no significant association between the 
prescribed and the actually administered amounts of morphine in period A. However, the 
three later periods showed significant correlation, increasing from r = 0.58 (P = 0.007) in 
period B, tor= 0.91 and 0.88 (both P < 0.001) in periods C and D, respectively. 
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7.6 Discussion 
From 1985 to 1998, i.e. in the first three periods studied, the increased attention given to 
pain, including the changeover from intermittent to continuous therapy and the use of a 
loading dose, resulted in increased use of morphine and, as expected, longer duration of 
postoperative mechanical ventilation. During the last period (1998- 2002) the lower 
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initial morphine doses, and the use of an objective, validated pain scale combined with an 
algorithm for pain management as standard daily care, did not result in significantly lower 
morphine doses over the first 3 days after surgery. However, the risk to be mechanically 
ventilated for more than the median length of 45 h was significantly reduced. 
Although the duration of mechanical ventilation after oesophageal surgery is not only 
dependent on the morphine dosage, but especially on the severity of tracheomalacia, this 
confounding variable was consistent during all periods. All other potential confounding 
variables such as major associated anomalies or other surgical procedures were excluded. 
Misconceptions and lack of information on pain and pain management in children explain 
the little attention given to these subjects in the past. Fear of respiratory depression, in 
view of the fact that children seemed to have higher opioid sensitivity compared with 
adults,39 fear of addiction, ignorance about the maturity of the neonate's nervous system, 
they all influenced the clinical practice. Medical treatment was predominantly focussed 
on the survival of the child, i.e. fighting against low blood pressure and heart rate, as one 
was still unaware of the deleterious effects of surgical stress6 •7 Apart from shmt-term 
effects, untreated pain is associated with long-term sequelae. Experiments in animals 
suggest that the effects extend into adulthood. They disrupt the predetermined maturation 
process of the central nervous system, which result in sprouting of axons into new areas 
of the dorsal horu40.41 These neurophysiological alterations are associated with increased 
pain sensitiveness in chi!dhood 42-45 Adequate management of pain in early infancy 
prevents children from developing an altered pain threshold46 
Morphine, ordered as needed, was often interpreted as "as little as possible", and was on! y 
given during mechanical ventilation. Following the Royal Children's Hospital of 
Melbourne, the way of morphine administration in the surgical PICU was changed into 
i.v. continuous morphine, and, if necessary, morphine was continued when patients were 
off the ventilator. 
In that period a morphine dosage of 10 flg/kg/h, seemed to be a minimally required dose 
for postoperative pain treatment at all ages, taking into account the possibility of 
additional doses, on the published amounts varying from 20 to I 00 flg/kgfh for neonates 
and infants9 •10·15•16·37 The results of a clinical trial on our PICU35 made it likely that a 
lower dose of morphine would have sufficed for the young neonates. Consequently, from 
that time onwards neonates S: 7 days received an initial dose of 5 flg/kgfh and neonates> 
7 days 10 flg/kg/h. 
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The improvement in pain management over the consecutive periods is evident in the 
scatter plot giving the amounts of morphine prescribed and actually administered. The 
increasing correlation between prescription and administration from period A to C shows 
the growing uniformity in pain management, whereas the slightly reduced correlation in 
the last period shows the influence of validated pain assessment. With the use of a 
validated pain protocol, morphine infusions in non-verbal children can be increased, or 
tapered off, providing tailored analgesia. 
There is general agreement that validated pain scales are necessary for adequate pain 
management, and hence an abundance of pain scales have been and are still being 
developed. However, as far as we know, no studies are published evaluating the effects of 
the introduction of a validated pain scale on postoperative pain management in non-verbal 
children following major surgery. 
The introduction of a pain scoring system was not easily accepted in tbe PICU. It was 
considered a redundant activity, seeing that experienced PICU-nurses thought they could 
estimate the amount of pain by personal interpretation. Only after the introduction of a 
protocol, including a validated pain scale combined with an algorithm for pain 
management, the pain assessment with pain measurements was found effective and 
became standard care. 
This study shows the usefulness of an objective pain score in non-verbal children. 
Following proper training, even non-experienced caregivers are able to adequately assess 
pain in this vulnerable group of patients, taking into account inter-observer vmiability. 
However, an alg01ithm, including instructions for additional analgesia, is an essential part 
of the pain protocol. 
Witb this validated and feasible guideline for pain management, we were able to start new 
studies in post-surgical neonates and infants47 and have developed an infrastructure for 
future evaluation of analgesic protocols and pain assessment instruments. 
7.7 Conclusion 
Postoperative pain management in neonates and infants has improved during the last 
decades. The change from personal interpretation to individual assessment based on 
objective pain scores resulted in optimal morphine dosages with an acceptable duration of 
mechanical ventilation, and a higher correlation between prescribed and administered 
analgesia. 
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General discussion and future directives 
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8.1 Evolution of pain management in general 
Pain management in children has changed significantly during the last decades. 
Before 1987 no serious attention was given to this subject. In 1968, Swafford and Allen! 
repmted that only 2 of the 60 postoperative children needed analgesia, for, as they wrote, 
"children tolerate discomfort well and need seldom medication for relief of pain". Eland2 
was the first in !977, followed by others,3-5 to report the undertreatment of children 
compared with adults after comparable surgery. Analgesics were given on demand, when 
pain was proven, but opioids were seldom used and only in children ventilated 
mechanically6 Fear for adverse effects of opioids and ignorance of pain perception and 
pain experience prevented medical and nursing staff from prescribing and administering 
analgesics as standard practice. Despite all reports of undertreatment, this attitude, 
denigrating the importance of adequate pain relief, did not change till Anand et al. 
reported the deleterious effects of inadequate analgesia during and after surgery in 
preterm neonates. Patients without analgesia exhibited not only significant stress 
responses (increased epinephrine, norepinephrine, glucose, and decreased insulin levels), 
but also increased morbidity and mortality7 ·8 
End of the eighties 
Although these studies convinced anaesthetists and paediatricians that neonates do feel 
pain and that pain has to be treated, fear for adverse effects of morphine and lack of 
efficacy data made them reticent to administer large amounts of morphine in small 
children9 From this period several studies regarding the pharmacokinetics and safety of 
opioids were performed in neonates and infants. I0-!7 For safety reasons most of these 
studies were carried out in mechanically ventilated infants. 
Half-way the nineties 
The above pharmacokinetic studies convinced many paediatric anaesthetists and 
intensivists that opioids are not harmful for neonates and children, not even when they 
breath spontaneous! y, and that they should be administered to protect infants from the 
adverse effects of surgical stress. 18 From that time onwards, pain management after major 
surgery changed from "on demand" into pain-preventing therapy, so-called pre-emptive 
analgesia, and morphine administered as a continuous infusion became standard em-e. 
Unfortunately, from lack of validated pain measurements for non-verbal children, it was 
impossible to evaluate the effects of the different morphine therapies or to detennine 
optimal analgesic doses for different age groups. 
General discussian and future directives 
Several studies were set up to develop validated instruments for assessment of 
postoperative pain in non-verbal children, and to assess the most efficacious dose of 
morphine in neonates and infants after major surgery. However, combining pain 
assessment and analgesia was by no means common practice. 
End of the nineties 
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Although McGrath had already stm1ed to develop pain measurements for postoperative 
children in the eighties, 19 later studies provided anaesthetists and paediatricians with 
validated tools for assessment of postoperative pain in non-verbal children20-31 Later it 
becomes known as well that factors such as age, kind of surgery and method of morphine 
administration all influence surgical stress responses and morphine requirements. 32-37 
8,2 Evolution of pain management on the paediatric surgical intensive care unit 
(PICU) ofthe Sophia Children's Hospital 
This changing attitudes regarding pain and pain management were also reflected on the 
surgical PICU in the Sophia Children's HospitaL Accordingly we may discern four 
different periods over the span from 1985 till 2002. 
In period A), (1985 - 1990), postoperative pain was treated with intermittent morphine 
rectally or intramusculm-ly following nurses' judgements_ Mechanical ventilation after 
surgery was started only on indication. 
In period B), (1990 - 1995), following the Royal Children's Hospital of Melbourne, the 
prefeiTed route of morphine adn:rinistration became i.v. continuous morphine. If 
necessary, morphine was continued when patients were off the ventilator. A paediatric 
pain group was set up which developed the first protocols for pain management_ 
Validated scales for measurement of postoperative pain were not yet available, morphine 
infusion rates were adjusted by personal interpretation of pain. One of the reasons for the 
scarcity in paediatric pain studies was the lack of instruments for the assessment of 
continuing pain in non-verbal children. 
In period C), (1995- 1998), in a RCT comparing the effects of postoperative continuous 
and intern:rittent morphine, the COMFORT Scale (CS) was validated for postoperative 
pain measurement in non-verbal children_ The behavioural part of the CS has been proven 
to be a valid, reliable and feasible instrument for assessment of pain in neonates and 
infants aged 0 to 3 years after major surgery.38 In this period a morphine dosage of 10 
~g/kg/h seemed to be a minimal required dose for postoperative pain treatment for all 
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ages, based on reported amounts varying from 20 to 100 flg/kglh for neonates and infants, 
ki . h 'b'l' f dd' . l d 10 16 17 39 ta ng mto account t e poss1 1 1ty o a 1t10na oses. · · · 
From that period on patients after oesophageal surgery were rontinely mechanically 
ventilated. 
From the results of our studies,29'36'37 we concluded that a lower dose of morphine likely 
would have sufficed for the young neonates. 
In period D), (1998- 2002), as a consequence of the above studies, postoperative 
morphine was given as a continuous infusion, for neonates and infants > 7 days an initial 
dosage of 10 flg/kg/h/, neonates :S 7 days 5 flglkg/h, after a loading dose of 100 11g/kg of 
morphine. 
From that time onwards application of the behavioural CS was part of standard daily care, 
enabling to evaluate the effects of analgesia and to adjust dosages according to an 
algorithm developed next. 
Against tbis background, the studies in this thesis have a threefold aim: 
l. To develop a valid objective pain scale for the measurement of postoperative pain in 
neonates and infants 
2. To compare the effects of continuous morphine, which is the commonest route of 
administration, with those of intermittent morphine, which was used before, in 
neonates and infants after major surgery. Attention was focussed on a) hormonal 
metabolic stress responses, b) age-related morphine requirements, c) morphine 
metabolism and d) the correlation with objective pain assessment. 
3. To evaluate the effects of the evolution in pain management on a) postoperative 
morphine requirement and duration of mechanical ventilation in a single-diagnosed 
group of surgical neonates, and b) the relation between prescribed and actually 
administered morphine doses. 
8.3 The next section ontlines the results and conclusions of our studies and gives 
future directions. 
I. Hormonal and metabolic stress responses after major surgery in children 
aged 0-3 years: a double-blind , randomized trial comparing the effects of 
continuous versus intermittent morphine.Br J Anaesth 2001;87:390-399. 
The results of this study prompted us to reject our primary hypothesis that continuous 
infusions of morphine produce would improve postoperative analgesia and lower 
hormonal-metabolic responses. Clinical bias was eliminated by the double-blind study 
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design, and total morphine consumption was comparable between the two randomized 
groups. Only in the older infants, aged I - 3 years, we noted greater degrees of stress in 
the intermittent morphine group than in the continuous morphine group, which may be 
caused by the relatively greater plasma clearance of morphine in this age group. Thus, it is 
likely that the longer duration of opioid effect following intermittent morphine boluses in 
the younger age groups resulted in clinical and physiological effects that were comparable 
to those of a continuous infusion. 
The pattern of surgical stress responses differed significantly between the neonates and 
the older age groups. In tbe neonates, developmental differences were found for the 
postoperative changes in hmmonal-metabolic variables (plasma adrenaline, noradrenaline, 
insulin and lactate), cardiovascular responses, behavioural parameters, and postoperative 
morphine consumption. In the older age groups, we found comparable patterns of 
hormonal-metabolic responses, behavioural responses and postoperative morphine 
consumption. 
We found significantly higher adrenaline and noradrenaline plasma concentrations after 
upper abdominal surgery than after thoracic or superficial surgery. Significantly higher 
plasma concentrations of noradrenaline occurred following a blood transfusion in 
neonates as compared with neonates without transfusion, at 6, 12 and 24 h after surgery. 
These differences were not found in the other age groups. 
In this study we have shown that neonates and infants up to I year of age may receive 
intermittent morphine doses, thereby avoiding the excessive fluid intake and the need of 
infusion equipment. Older infants (I - 3 years) may require either a continuous infusion, 
or more frequent dosing regimens (every 1 - 2 hours) or judicious increases in the 
intermittent doses used for postoperative morphine analgesia. We speculate that combined 
therapy with different classes of analgesics and sedative drugs will provide more effective 
control of physiological and behavioural responses, especially in toddlers 1 - 3 years of 
age, who may have a high level of anxiety in the PICU environment. Further studies are 
needed to establish the efficacy and safety of such combinations, i.e. morphine combined 
with midazolam, paracetamol or a NSA!D. These studies will not only provide a scientific 
framework for the postoperative management of neonates and young infants, but may also 
provide clues to elucidate the development of pain and stress-responsive systems in the 
developing brain. 
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II. Therapeutic requirements and plasma concentrations of morphine and its 
metabolites in postoperative neonates and infants aged 0-3 years, submitted. 
We investigated a) the effects of potential confounding variables on morphine 
requirements in neonates and infants after major surgery, and b) the age-related changes 
in morphine and metabolite concentrations. 
Our studies revealed that age is the most important factor determining optimal doses, 
differentiating dose requirements between neonates and infants older than 4 weeks. 
Because concentration is directly proportional to dose, we need to determine clearance in 
order to predict dose. 
Dosage 
Morphine requirement was not significantly different between the treatment groups. Most 
ofthe neonates had adequate analgesia through the minimal dose of 10 flg/kg/h. The older 
children needed significantly more morphine, with requirements ranging from (median) 
10.9 to 12.3 flg/kg/h. Extra morphine dosages, given in a nurse-controlled way, based on 
observational validated pain scores, resulted in similar plasma concentrations in the 
continuous and intermittent morphine group from 12 h after surgery. Even with the 
additional morphine, the required dose was lower than the recommended dosage of 20 
/k /h 3' 40 41 H . h. 1 . f h d. d . d )lg g . -· · owever, m t 1s meta-ana ys1s most o t e stu 1es were not es1gne as 
randomized clinical trials. 
Plasma concentration 
Morphine plasma concentrations were significantly dependent on age, bearing in mind 
that patients with renal impairment were not included. Tbe wide "analgesic range" in 
reported plasma morphine concentrations results from the various pain stimuli or sedation 
end-points, differences in pain perception and pain assessment, and variations in the 
children's clinical state. 15' 16,42.43 To report adequate doses for postoperative analgesia more 
studies with large numbers are needed in well-defined groups of patients (i.e. age, severe 
illness, mechanical ventilation, in need of sedation or analgesia, tolerance, cardiac or non-
cardiac surgery, method of treatment, race, pain assessment, etc.). 
Metabolites 
The clinical effect of morphine also relies on the formation of its active metabolite M6G. 
Morphine is largely metabolised by the age-dependent isoform Uridine 5'-Diphophate 
Glucuronosyltransferase (UGT)-2B7 to M6G and M3G.44 The highest plasma 
concentrations of morphine-3-glucuronide (M3G) and morphine-6-glucnronide (M6G) 
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were found in the neonates, signifying that neonates were able to glucuronidate morphine. 
High morphine plasma levels and low M3G- and M6G-morphine ratios were the result of 
a low renal function, which was confirmed by the significant correlation between serum 
creatinine and M6G in the neonates. The decreased clearance of morphine explains its 
increased analgesic effect in neonates, contributed by the active metabolite M6G. While 
the M3G-morphine and M6G-morphine ratios increased with advancing age, indicating 
improved morphine metabolism, the M3G and M6G plasma concentrations decreased 
with advancing age, indicating improved renal excretion.33 
Plasma concentrations of morphine and morphine metabolites did not only significantly 
differ between neonates and the older children, but also between infants aged 4 weeks to 6 
months and I to 3 years. The major changes in morphine metabolism and elimination 
apparently take place between 6 and 12 months of age. The M6G/ M3G ratios were 
relatively constant at all ages, suggesting that 3- or 6-glucuronidation of morphine was 
dependent on similar regulatory mechanisms. 
Safety 
Only three children older than 4 weeks (two on continuous and one on intermittent 
morphine) showed respiratory depression and needed reintubation in the first 24 h after 
surgery. In all cases it had to be considered as a complication of their surgical operation. 
Conclusion 
Age is the most important factor in morphine dosage and morphine metabolism. By 
stratifying for age and carefully monitoring the children's behaviour, we were able to give 
more precise dosages for postoperative morphine after major non-cardiac surgery. Extra 
morphine dosages, given in a nurse-controlled way, based on observational validated pain 
scores, resulted in similar plasma concentrations. Used in this way, both treatments are 
equally effective and safe. However, because morphine given intermittently does not 
provide preventive analgesia, continuous morphine infusions are more effective, 
especially in older infants. 
III. Postoperative pain in the neonate: age-related differences in morphine 
requirements and metabolism, submitted. 
To investigate the effect of developmental maturation on morphine metabolism in full 
term neonates after major non-cardiac surgery, we performed a sub-analysis in the 
neonatal group. In this group we distinguished between neonates aged :S 7 days and > 7 
days, because hepatic and renal physiology change prominently in the first week after 
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birth. The analysis included a) age-related aspects, i.e. analgesia, morphine requirement, 
morphine and morphine-6-glucuronide (M6G) concentrations; and b) effects of other 
clinical factors, i.e. apnoea, mechanical ventilation, intennittent versus continuous 
morphine. 
Neonates aged :S 7 days required fewer additional morphine doses, maintained higher 
plasma morphine levels, and converted less morphine to M6G (lower M6G-morphine 
ratios) than older neonates. Pain scores did not differ between age groups or morphine 
treatment groups. 
Dosage 
Only 27 % of the neonates :S 7 days of age required extra morphine compared with 66 % 
of those > 7 days, so a lower dose of morphine than the minimal dose of 10 ~g/kglh, 
would likely have sufficed for the younger neonates. From a meta-analysis, an initial 
morphine infusion of 7 ~g/kg/h was calculated to be sufficient for postoperative pain 
treatment in full term neonates, and a dose of 2 ~g/kg/h was recommended for preterm 
neonates. 40.41 
Morphine plasma concentrations 
The higher morphine plasma concentrations in the young neonates might, in part, result 
from a smaller volume of distribution at this age. While a meta-analysis40.4 1 showed that 
the morphine volume of distribution is not dependent on age, in otber studies the volume 
of distribution tended to be somewhat smaller in neonates aged :S 7 days compared with 
older infants, but this difference was not statistically significant. J0.4S A morphine loading 
dose of 50 ~g/kg does probably suffice for neonates aged :S 7 days, whereas 100 11glkg is 
mostly necessary for older infants. 
Metabolites 
The M6G-morphine ratio was significantly lower in the neonates aged :S 7 days, probably 
as a result of the low UGT activity at this age. 
Safety 
None of the spontaneously breathing neonates in the continuous morphine group had 
respiratory problems. Five neonates, all on intermittent morphine and all :S 7 days of age, 
showed respiratory depression, four needed reintubation in the first 24 h after surgery, but 
in only one of them this could be attributed to the morphine therapy. In the others the 
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respiratory problems largely resulted from surgical complications. Morphine plasma 
concentrations were not correlated with respiratory depression. 
Conclusion 
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Findings from our study suggest that concentrations between 15 and 20 ng/ml are 
effective in postoperative neonates up to 4 weeks of age. However, as documented earlier, 
morphine plasma concentrations ranged widely, and no significant correlation was found 
between plasma levels and the need for extra morphine during the following hours, based 
on validated pain scores, or between plasma levels and respiratory depression. 
IV. Morphine pharmacokinetics using the allometric model 
The use of the 'per kilogram size' model (mllminlkg) has confused interpretation of 
morphine developmental pharmacokinetics; an overestimation occurs as size decreases. 
Anderson et al. corrected available clearance data from different age groups using a % 
power allometric size model to demonstrate that adult values for clearance are reached at 
about 6 months 46 The data of morphine and metabolite serum concentrations in children 
0-3 years old given either intermittent boluses or morphine infusion (the above studies) 
were investigated using a population based approach that included size as the primary 
covariate in an effort to disentangle age related factors fi·om size related factors. 
Population parameter estimates were obtained using a non-linear mixed effects model 
(NONMEM). 
The volume of distribution of morphine increased exponentially with a maturation half-
life of 2 weeks from 72 l/70kg at birth; formation clearance to M3G and M6G increased 
with a maturation half-life of 78.7 days fi·om 5.8 and 0.6 llh/70kg at bitth to predicted 
values of 25 aud 3 l/b/70kg at 3 years respectively. At 6 months formation clearances 
were 87 % of those predicted in children at 3 years. Formation maturation of both 
metabolites was the same. Serum bilirubin concentration was inversely related to 
metabolite formation clearances. 
M3G is the predominant metabolite of morphine in young children, and total body 
morphine cleaxance is 87 % that of older children at 6 months. Metabolite elimination 
clearauce of M3G and M6G increased with a maturation half-life of 131 days from 1.53 
and 1.1 l/b/70kg at birth to predicted values of 7.2 and 5 llh/70kg at 3 years respectively. 
This maturation curve closely approximated that described for the maturation of 
glometular filtration rate in infants. Clearance predictions can be used to calculate 
morphine hydrochlmide infusion rates required attaining steady-state serum 
concentration. Infusion rate is a product of clearance and desired concentration. Derived 
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from this pharmacokinetic analysis using the allometric model, recommended initial 
morphine doses for different ages are given at the end of this chapter. 
V. Efficacy of continuous versus intermittent morphine administration after 
major surgery in 0-3-year-old infants; a double-blind randomized controlled 
trial. Pain2002;98:305-313. 
Efficacy of both therapies was assessed by nurses with the COMFORT "behaviour" and 
visual analogue scale (VAS) for pain, every 3 h in the first 24 h after surgery. Overall, no 
significant differences were found between continuous and intermittent morphine therapy 
in reducing postoperative pain. Only the oldest age group, children aged I - 3 years, had 
lower pain responses with continuous morphine. The lowest pain responses were found in 
the neonates, whereas infants 4 weeks to 6 months had the highest pain scores. Surgical 
stress scores and mechanical ventilation were not related to postoperative pain. 
Conclusion 
Continuous morphine and intermittent morphine were equally (in)effective in neonates 
and infants up to I year of age. Differences in pain response were most prominent 
between neonates and infants 1 - 6 months old. 
VI. Evolution of pain management in neonates after oesophageal atresia 
Over the period 1985 till 2002, which could be broken down into four different periods of 
pain management, we evaluated in eighty-one neonates, who had undergone a primary 
anastomosis of an isolated oesophageal atresia and closure of the trachea-oesophageal 
fistula, the effects of the introduction of continuous morphine infusions and a validated 
pain score combined with an algorithm, on a) the used amount of morphine and the 
duration of mechanical ventilation during the first 3 days after surgery, and b) the relation 
between prescribed and actually administered morphine dosages. 
The duration of mechanical ventilation after surgery increased tilll998, and decreased in 
the last period. Analysing the effect of the use of a validated pain score in combination 
with an algorithm (introduced in the last period D), morphine requirements did not 
significantly change. However, the odds to be mechanically ventilated longer than the 
median duration of 45 h was significantly lower in the last period than in period C. 
Conclusion 
The change from personal interpretation to individual assessment based on objective pain 
scores resulted in optimal morphine dosages with an acceptable duration of mechanical 
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ventilation, and in a higher correlation between prescribed and administered analgesia. 
Even non-experienced caregivers are able to adequately assess pain in this vulnerable 
group of patients, following appropriate training and taking into account inter-observer 
variability. 
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However, an algorithm, including instructions for additional analgesia, is an essential part 
of the pain protocol. 
8.4 Continuous or intermittent morphine 
Investigating the effect of continuous morphine and intermittent morphine on surgical 
stress responses, infants aged I - 3 years in the intermittent morphine group showed 
greater stress than those in the continuous morphine group. Morphine requirement was 
not significantly different between both treatments. Combining the results of the different 
studies, we conclude that morphine given intermittently does not provide any clinical 
advantage, and that a continuous morphine infusion is favourable because it is more 
feasible, acts analgesic preventive, is possibly safer in neonates, and more effective in 
older infants. To maintain analgesic plasma concentrations and prevent overdosing careful 
observation supported by validated pain scores is compulsory. 
8.5 Surgical Stress Score (SSS) 
Although in the above studies the SSS did not significantly differ between age or 
treatment groups, multiple regression analysis showed that the SSS significantly affected 
the required morphine dose. Because the SSS was developed for preterm and full term 
neonates after cardiac surgery,"7 a new version for infants and children after non-cardiac 
surgery might improve the utility. A more detailed SSS, including age, high or low 
abdominal surgery, blood transfusion yes or no, earlier experiences of pain, etc., may help 
to assess the need for postoperative morphine. 
8.6 Mechanical ventilation 
Of particular interest is the effect of mechanical ventilation on analgesic requirement. 
In this thesis significant differences were found between mechanically ventilated and non-
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ventilated children. Most of the mechanically ventilated children were found among the 
neonates and the infants aged 4 weeks to 6 months of age. 
Stress responses 
The significantly higher plasma concentrations of noradrenaline at baseline in the 
ventilated versus non-ventilated neonates might be explained by the withdrawal of 
sedative and analgesic drugs prior to surgery (according to the study protocol) in a limited 
number of patients. The higher plasma concentrations of noradrenaline in patients aged 1-
6 months, who were mechanically ventilated after surgery, probably result from distress 
induced by fighting the ventilator. 
Morphine metabolism 
In this thesis, mechanical ventilation in neonates was associated with higher plasma 
morphine levels, similar plasma M6G levels and lower M6G-morphine ratios. 
In some neonates, who were on ventilation preoperatively and had been without morphine 
therapy > 6 h, morphine was still detectable at the time of surgery. Bearing in mind the 
individual variability of morphine clearance at this young age, a 6-hour period is 
apparently too short to effectively clear plasma of morphine. 
Data on the clinical consequences of mechanical ventilation on portal hemodynamics and 
renal function are conflicting48-50 A decreased M6G production, combined with a reduced 
renal clearance, can explain the similar M6G plasma concentrations and higher morphine 
in mechanically ventilated neonates. Although morphine metabolism is more dependent 
on the glucuronidation capability, a slower morphine metabolism and a longer elimination 
time may be the result of a decreased hepatic and renal perfusion due to positive 
endexpiratory pressure (PEEP). This phenomenon can also explain why neonates who had 
been mechanically ventilated before surgery needed less morphine after surgery. 
Postoperative ventilation did not influence the need for additional morphine over the first 
24 h after surgery. However, in spite of the non-significant differences in morphine 
requirements between postoperatively ventilated and non-ventilated neonates, the 
mechanical! y ventilated neonates proved to have higher plasma concentrations of 
morphine. 
Conclusion 
It is evident that neonates and infants need analgesia and/or sedation during artificial 
ventilation in order to control catecholamine responses. We expect that a combined 
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therapy with different classes of analgesic and sedative drugs will provide more effective 
control of physiological responses, but further research is needed. 
Although clinical consequences of mechanical ventilation are conflicting, the results of 
our studies would suggest that mechanical ventilation exerts an influence on morphine 
metabolism in neonates. No such information is available for older infants, because most 
of the older children were breathing spontaneously. 
8. 7 Advised morphine dosages for neonates and infants 
Morphine plasma concentrations varied widely. We found no consistency between 
morphine plasma levels and analgesia, or between plasma levels and respiratory 
depression. 
The morphine and metabolite plasma concentrations, the morphine requirements, and the 
results of the pharmacok:inetic morphine study using the allometric model, allowed us to 
give well-defined morphine dosages for different age groups. A mean steady-state serum 
concentration of 20 ng/ml can be achieved in children after non-cardiac surgery in an 
intensive care unit with a morphine hydrochloride infusion of 8.5 ).lg/kglh at birth (term 
neonates), 15 ).lg!kglh at I month, 22 llgikglh at 3 months, 27 ).lgikg/h at 12 months 
postnatal age and 25 ).lg!kg/h for I - 3 year old children. 
According to the pharmacok:inetic results, the volume of distribution of morphine 
increased exponentially with a maturation half-life of 2 weeks from 72 1170kg at birth. 
Besides the lower glucuronidation capability and reduced renal function, the smaller 
volume of distribution of morphine at birth might partly be responsible for the higher 
morphine plasma concentrations in neonates S 7 days of age, and hence, a loading dose of 
50 J.lg/kg is probably sufficient for this age group. 
At 6 months the production of both metabolites, M3G and M6G, was 87 % of that 
predicted in children at 3 years. Serum bilirubin concentration was inversely related to 
metabolite formation clearances. Renal clearance of M3G and M6G closely approximated 
that described for the maturation of glomerular filtration rate in infants. Hence, hepatic 
and renal disturbances may require adjusted dosages. 
Fortunately, during the last decades paediatric pain has drawn much attention. We are 
now getting to know that chronic exposure to (non-) noxious stimuli during 
hospitalisation contributes to an altered pain response and that neurophysiological 
a1terations are associated with increased pain sensitiveness in childhood. 51-57 On the other 
hand, more information should be collected about physical morphine dependency and 
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addiction. During prolonged treatment with morphine physical dependency is difficult to 
avoid. Opioid dependency, however, is not the same as addiction. Opioid withdrawal 
symptoms can be prevented by tapering off the morphine dosage over the therapy, or can 
be treated by adding clonidine or benzodiazepines. 58 However, more clinical trials are 
needed to determine adequate doses. 
Although the mauagement of paediatric pain has been improved, in other groups of 
patients, such as the extremely low-birfh-weight infauts, the mentally handicapped, the 
elderly, or the terminal patients dying at home, the know-how to asses and to treat pain is 
still lacking. This manifestation of "unheard pain" deserves more attention from doctors, 
nurses and other caregivers, possibly through inclusion of this subject in curriculums. 
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9.1 Summary 
One of the reasons for the scarcity in paediatric pain studies was the lack of instruments 
for the assessment of continuing pain in non-verbal children. Tbe introduction of 
continuous morphine infusions about a decade ago without proper evaluation of its effects, 
together with the evolution of pain assessment instruments prompted us to design a study 
with tbe following research questions: 
1. How reliable, valid and feasible is the multidimensional COMFORT scale to assess 
postoperative pain in neonates and infants< 3 years of age? 
The COMFORT scale was adapted for the Netherlands and its behavioural part has been 
proven to be a valid instrument for measurement of postoperative pain in neonates and 
infants after major surgery (PhD thesis M. van Dijk). 
2. Is there an improved efficacy and safety of postoperative analgesia with continuous 
morphine infusions compared with intermittent doses, in neonates and infants after major 
surgery? 
Hence, the aim of this study, which was sponsored by NWO (grant nr. 940-31-031), was: 
1. to compare the effects of continuous morphine, as the most used method of 
administration, with intermittent morphine, which was used before, in neonates and 
infants after major surgery, regarding a) hormonal metabolic stress responses, b) age-
related morphine requirements, c) morphine metabolism and d) the correlation with 
objective pain assessment 
2. to evaluate the effects of the evolution in pain management on a) postoperative 
morphine requirement and duration of mechanical ventilation in a single-diagnosed group 
of surgical neonates, and b) the relation between prescribed and actual administered 
morphine doses. 
Study design: 
After approval of the study protocol by the hospital medical ethical committee and after 
written consent from the parents, we included children aged 0 to 3 years, admitted to the 
paediatric surgical intensive care unit (PICU) following non-cardiac thoracic and 
abdominal surgery. 
Patients were excluded if they had received analgesic or sedative drugs < 6 b prior to 
surgery, if they were receiving neuromuscular blockade, or if they suffered from hepatic, 
renal, or neurologic disorders or an altered muscle tone. 
Patients were stratified for age into 4 groups: !. 0- 4 weeks, II. 4 - 26 weeks, III. 6 - 12 
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months, IV. 1 - 3 years, and were randomly assigned to receive either intravenous 
continuous morphine (CM) or intermittent morphine (IM). The pharmacists prepared all 
study dmgs and strata-specific schedules for randomisation, and clinical staff were 
blinded to the study group allocation until the data collection was complete. 
Anaesthetic management was completely standardized in all patients. Anaesthesia was 
induced intravenously with thiopentone 3-5 mg/kg or by inhalation with halothane in 
oxygen. Fentanyl 5 fig/kg was given before orotracheal intubation, which was facilitated 
with atracurium 0.5- I mg/kg or suxamethonium 2 mg/kg. Ventilation was controlled and 
anaesthesia was maintained with isoflurane 0.5 MAC in 60 % nitrous oxide in oxygen or 
air in oxygen. Peri operative fluids were standardized to maintain a glucose infusion rate 
between 4 - 6 mg/kg/min; body temperature was kept within normal ranges. A peripheral 
artery was cannulated and the measured mean arterial blood pressure (MAP) and heart 
rate (HR) data were used as preoperative baseline values. After the first arterial blood 
sample (baseline), patients received a second dose of 5 fig/kg of fentanyl before surgical 
incision. Additional doses of 2 fig/kg of fentanyl were administered when HR and/or 
MAP were 15 % above baseline value. At the end of surgery, the neuromuscular block 
was antagonized and the tracheal tube was removed, or the artificial ventilation was 
continued in patients who required ventilatory assistance after surgery. 
Directly after surgery all patients received an intravenous loading dose of morphine HCl 
(100 11g/kg in 2 min) followed by a morphine infusion of 10 fig/kg/h for children in the 
CM group, combined with three-hourly intravenous placebo (saline) boluses. Children in 
the 1M group received a continuous placebo infusion (saline), combined with three-hourly 
intravenous morphine HCJ doses of 30 11g/kg. The first intermittent bolus (morphine or 
placebo) was given at 3 h after surgery. Additional analgesia was given by the PICU 
nurse when there were signs of pain, indicated by VAS scores :2 4. During the first hour 
after surgery, one-third of the loading dose of morphine HCJ could be repeated every 15 
min, and thereafter 5 fig/kg of morphine HCl could be given every 10 min if required. No 
other analgesic or sedative drugs were used. 
Arterial blood samples were taken after induction of anaesthesia, at the end of surgery, 
and at 6, 12, and 24 h after surgery to determine blood gases, plasma concentrations of 
adrenaline, noradrenaline, insulin, glucose, lactate, morphine (M) and the metabolites 
morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). From 24 - 36 h after 
surgery, urine was collected for determination of the 3-methyl histidine/creatinine molar 
ratio (3MHICR), as a measure of protein breakdown. 
156 Chapter 9 
After the surgical procedure, the Surgical Stress Score (SSS) was computed by the 
surgeon and anaesthetist. PICU nurses performed regular assessments prior to surgery 
(baseline) and every 3 h up to 36 h after surgery. Nursing interventions included pain 
assessment using a visual analogue scale (VAS) and COMFORT scale (CS) blood 
sampling (as indicated), giving the intermittent bolus (placebo or morphine), and then 
nursing as needed. Thus, plasma concentrations of hormonal and metabolic stress 
responses were measured at time points corresponding with trough plasma morphine 
concentrations in the IM group. 
The SSS consists of 7 items: amount of blood loss, site of surgery, amount of superficial 
trauma, extent of visceral trauma, duration of surgery, associated stress factors 
(hypothermia, localized or generalized infection and prematurity), cardiac surgery. The 
total scores in this study (excluding cardiac surgery and prematurity < 35 weeks) could 
range from 3 to 24, and were used to classify the degree of surgical stress. 
The Visual Analogue Scale (VAS) was used as an observational instrument. VAS scores 
range from 0 to I 0, scores < 4 indicated absent or mild pain and scores ~ 4 indicated 
moderate to severe pain. 
The COMFORT "behaviour" scale has been proven to be a valid, reliable and feasible 
instrument for assessment of pain in neonates and infants aged 0 to 3 years after major 
surgery as a measure of postoperative pain in this age group. This scale consists of six 
behavioural items: alertness, calmness, respiratory response for ventilated or crying for 
non-ventilated children, movement, muscle tone, and facial tension. Total scores range 
from 8 to 40. 
Chapter 2 reports the efficacy of continuous morphine versus intermittent morphine 
through hormonal-metabolic responses (plasma concentrations of epinephrine, 
norepinephrine, insulin, glucose, lactate), and hemodynamic responses (heart rate, mean 
arterial pressure) to postoperative pain in children aged 0-3 years. Safety was determined 
by the incidence of respiratory depression, because this is the most dangerous 
complication of opioid therapy. 
Minor differences occurred between the randomized treatment groups, with the oldest li\1 
group (aged 1-3 years) showing higher blood glucose concentration (P = 0.003), mean 
arterial pressure (P = 0.02), and COMFORT score (P = 0.02) than the CM group. 
Ontogeny of the surgical stress response was illustrated by several differences between 
the stratified age groups. In the neonates, preoperative plasma concentrations of 
noradrenaline (P = 0.01) and lactate (P < 0.001) were significantly higher, while the 
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postoperative plasma concentrations of adrenaline were significantly lower (P<O.OOl) and 
plasma concentrations of insulin significantly higher (P < 0.005) than in the older age 
groups. Postoperative pain scores (P < 0.003) and morphine consumption (P < 0.001) 
were significantly lower in the neonates than in the older age groups. Our results show 
that continuous infusion of morphine does not provide any major advantages over 
intermittent morphine boluses for postoperative analgesia in neonates and infants. These 
data further illustrate the ontogeny of hormonal-metabolic responses to surgical stress, 
with important differences between neonates and older infants in the patterns of plasma 
catecbolamines, insulin and lactate concentrations postoperatively. 
Chapter 3 describes the effects of treatment (continuous morphine versus intermittent 
morphine) and the effects of age on morphine metabolism by analysis of plasma 
concentrations of morphine (M), morphine-3-glucuronide (M3G), morphine-6-
glucuronide (M6G) and the ratios of M3G/M, M6G/M and M6G/M3G. Clinical variables 
such as gestational age, sex, birth weight, study weight, the therapeutic regimens used, 
and the need for preoperative or postoperative mechanical ventilation may affect 
morphine requirements and plasma concentrations of morphine and its metabolites in 
neonates and infants undergoing surgery. 
Multiple regression analysis of different variables revealed that age was the most 
important factor affecting morphine requirements and plasma morphine concentrations. 
Significantly fewer neonates required additional morphine doses as compared with all 
other age groups (P < 0.001). Method of morphine administration (intermittent vs. 
continuous) had no significant influence on morphine requirements. Neonates had 
significantly higher plasma concentrations of morphine, M3G and M6G (all P<O.OO!), 
and significantly lower M6G/M ratio (P<0.03) than the older groups. The M6G/M3G 
ratio was similar in all age groups. 
Neonates require a narrower therapeutic window for postoperative morphine analgesia 
than older age groups, with no differences in the safety or effectiveness of intermittent 
doses compared to continuous infusions in any of these age groups. 
Chapter 4 describes the developmental pharmacokinetics of morphine and its metabolites 
in neonates, infants and young children. In an effort to disentangle age-related factors 
from size-related factors, a population-based approach was used that included size as the 
first covariate. 
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The formation clearances of morphine base to its glucuronide metabolites as well as 
metabolite elimination clearances were estimated using non-linear mixed effects models. 
Population parameter estimates and their variability(%) for a one compartment, first 
order elimination model were as follows: volume of distribution 115 I (54), formation 
clearance to M3G 24.3 (91) 1/h, formation clearance to M6G 2.9 (87) 1/h, elimination 
clearance ofM3G 7.2 (65) 1/h, elimination clearance ofM6G 5.0 (76) 1/h; standardised to 
a 70 kg person using allometric '14 power' models. Clearance by other routes contributed 
50 % of total body clearance. The volume of distribution increased exponentially with a 
maturation half-life of 2 weeks from 72 1170kg at birth; formation clearance to M3G and 
M6G increased with maturation half-life of 79 days from 5.2 and 0.6 l/h/70kg respectively 
at birth. Serum bilirubin concentration was inversely related to metabolite formation. 
Metabolite clearance increased with age (maturation half-life 131 days) with a time 
course similar to that described for glomerular filtration rate in infants. 
M3G is the predominant metabolite of morphine in young children and total body 
morphine clearance is 87 % that of older children at 6 months. A mean steady-state serum 
concentration of 20 ng/ml can be achieved in children after non-cardiac surgery in an 
intensive care unit with a morphine hydrochloride infusion of 8.5 f.lg/hlkg at birth (term 
neonates), 15 j.lg/h/kg at I month, 22 f.!g/h!kg at 3 months, 27 j.lg/h/kg at 12 months 
postnatal age and 25 j.lg/h/kg for I - 3 year old children. 
Chapter 5 describes the age-related differences in morphine requirements and 
metabolism in the postoperative neonate. In this study we investigated the effect of 
developmental maturation on morphine metabolism in full term neonates after thoracic or 
abdominal surgery. We distinguished between neonates (defined as aged< 28 postnatal 
days) aged S 7 days and> 7 days, because hepatic and renal physiology change 
prominently in the first week after birtb. The analysis included a) age-related aspects, i.e. 
analgesia, morphine (M) need, morphine and morphine-6-glucuronide (M6G) 
concentrations; and b) effects of other clinical factors, i.e. apnoea, mechanical ventilation, 
intermittent versus continuous morphine. 
Sixty-eight neonates (52 aged S 7 days, 16 aged> 7 days), admitted to Paediatric Surgical 
Intensive Care Unit, following abdominal or thoracic surgery, received morphine 100 
j.lg/kg after surgery, and were randomly assigned to either continuous morphine (CM, 10 
j.lg/kg/h) or intermittent morphine boluses (lM, 30 f.!g/kg/3 h). 
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Neonates aged,; 7 days differed significantly from neonates > 7 days in morphine 
requirement [median 10 vs. 10.8 [.lg!kg/h, (P < 0.001)], morphine plasma concentration 
[23.0 vs. 15.3 ng/ml, (P = 0.027)], and M6G/M ratio [0.6 vs. 1.5, (P = 0.018)]. Pain scores 
did not differ between age groups or morphine treatment groups. 
Neonates who were mechanically ventilated> 24 h (n = 37) had significantly higher 
morphine plasma concentrations than the spontaneously breathing neonates (n = 15) at 12 
and 24 h after surgery (29.1 vs. 13.1 ng/ml and 26.9 vs. 12.0 ng/ml, respectively; both P < 
0.001). 
Morphine plasma concentrations were not correlated with effective analgesia or 
respiratory depression. Five neonates showed respiratory insufficiency, all on IM, 
however the difference between CM and IM was not significant. Neonates aged,; 7 days 
require significantly less morphine postoperatively than older neonates do. Mechanical 
ventilation decreases morphine metabolism and clearance. Both intravenous morphine 
regimens (CM and IM) were equally effective and safe. 
Chapter 6 describes the efficacy of postoperative intermittent and continuous morphine 
through behavioural responses (VAS and COMFORT scale) to postoperative pain in 
children aged 0-3 years. The repeated COMFORT "behaviour" and VAS pain scores were 
compared between the two treatment groups. 
Efficacy was assessed by the caregiving nurses with the COMFORT "behaviour" and 
VAS for pain, every 3 h in the first 24 h after surgery. Random regression modelling was 
used to simultaneously estimate the effect of randomized group assignment, actual 
morphine dose (protocol dosage plus extra morphine when required), age category, 
surgical stress, and the time-varying covariate mechanical ventilation on COMFORT 
"behaviour" and the observational VAS rated pain, respectively. Overall, no statistically 
differences were found between CM and IM morphine administration in reducing 
postoperative pain. A significant interaction effect of condition with age category showed 
that the CM assignment was favourable for the oldest age category (I - 3 years old). The 
greatest differences in pain response and actual morphine dose were between neonates 
and infants aged 1 - 6 months, with lower pain response in neonates who were on average 
satisfied with the protocol dosage of 10 [.lg/kg/h. Surgical stress and mechanical 
ventilation were not related to postoperative pain or morphine doses, leaving the 
interindividual differences in pain response and morphine requirement largely 
unexplained. 
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Chapter 7 describes the process of changing postoperative pain treatment in the 
paediatric surgicallCU of the Sophia Children's Hospital, from 1985 up to the present. 
Four different periods of pain management were identified: A ( 1985 - 1990) morphine as 
needed, intermittently; no validated pain score (PS), B (1990- 1995) morphine 
continuously; no validated PS, C (1995- 1998) morphine continuously, developing 
validated PS, D (1998- 2002) morphine continuously, validated PS combined with 
algorithm. 
Over the period 1985- 2002, we evaluated in eighty-one neonates who had undergone a 
primary anastomosis of an isolated oesophageal atresia and closure of the trachea-
oesophageal fistula, how the introduction of continuous morphine infusions and a 
validated pain score combined with an algorithm, effected a) the amounts of morphine 
used and the duration of mechanical ventilation during the first 3 days after surgery, and 
b) the relation between prescribed and actually administered morphine dosages. 
ln period A neonates received significantly less morphine than in the periods B, C and D 
(all P < 0.005), no differences were found between the latter three periods. The proportion 
of patients mechanically ventilated after surgery increased from 84 % in period A, to 
90% in period B, and to 100% in the periods C and D. The duration of mechanical 
ventilation after surgery increased during periods A, Band C [median (10- 90th 
percentile)] from 24 (0- 78), to 47 (1- 96), to 48 (20- 109), respectively, and decreased 
in the last period to 34 (15- 145) hours. Overall, the total duration of postoperative 
mechanical ventilation did not significantly differ between the four periods. To evaluate 
the effect of a validated pain score combined with an algorithm (period D), we completed 
a "subgroup analysis". The odds of being given greater or lower amounts than the median 
morphine dose did not differ between the periods C and D. However, the odds to be 
mechanically ventilated longer tban the median duration of 45 h was 4.5 times lower in 
period D than in period C (95 % CI: 0.05- 0.94). There was no significant association 
between the prescribed and the actually administered amounts of morphine in period A. 
However, in the three later periods the correlation was significant and increased from 
r = 0.58 (P = 0.007) in period B, tor= 0.91 and 0.88 (both P < 0.001) in period C and D, 
respectively. 
The change from personal interpretation of postoperative pain to individual assessment 
based on objective pain scores resulted in optimal morphine dosages with an acceptable 
duration of mechanical ventilation, and a high correlation between prescribed and 
administered analgesia. 
Chapter 8 contains a general discussion and options for future pain management. 
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9.2 Samenvatting 
Een van de redenen dat er weinig onderzoek werd gedaan naar pijn bij kinderen was het 
gemis aan betrouwbare methodes om aanhoudende pijn te meten, met name bij kinderen 
die zelf hun pijn nog niet onder woorden konden brengen. Ongeveer 10 jaar geleden werd 
in bet Sophia Kinderziekenbuis bet beleid voor pijnbestrijding na grote operaties 
veranderd. Morfine werd niet meer voorgeschreven op een "zo nodig" basis, wat vaak 
gelnterpreteerd werd als "zo weinig mogelijk", maar als een continu infuus. Het gemis 
aan een betrouwbaar instrument om bet effect van beide methodes te vergelijken en bet 
feit dat in deze periode wei vee! methodes ontwikkeld werden om kortdurende pijn bij 
jonge kinderen te meten, zoals de reactie na bet geven van een bielprikje, noopten ons om 
een onderzoek op te zetten met de volgende vragen: 
L Hoe betrouwbaar, valide en praktiscb in gebruik is de multidimensionele COMFORT 
schaal voor bet beoordelen van postoperatieve pijn bij baby's, peuters en ldeuters in de 
leeftijd van 0- 3 jaar? 
De COMFORT schaal werd aangepast voor Nederland en er is aangetoond dat bet dee! 
met gedragsitems een betrouwbaar instrument is om postoperatieve pijn te meten bij 
pasgeborenen, peuters en kleuters na grate operaties (Proefschrift Monique van Dijk). 
2. Is er een verhoogde effectiviteit en veiligheid in postoperatieve pijnbestrijding met een 
continu morfine-infuus, vergeleken met intermitterende morfinedoseringen, bij 
pasgeborenen, peuters en kleuters na grate operaties? 
Doe! van dit onderzoek, wat werd mogelijk gemaakt door een subsidie van NWO (nr. 
940-31-031) was: 
1) een vergelijking van bet effect van continue morfine toediening, als meest gebruikte 
methode, met intermitterende morfine giften, wat voorheen gebruikelijk was, bij 
pasgeborenen en jonge kinderen na grote operaties, wat betreft a) honnonaal en metabole 
stress reacties, b) leeftijdsgerelateerde morfinebehoefte, c) morfinemetabolisme en d) de 
correlatie met een objectieve pijnscore. 
2) een evaluatie van bet effect van de ontwikkeling in pijnbehandeling op a) bet 
morfinegebruik en de beademingsduur bij pasgeboren na operatie van een gelsoleerde 
oesofagusatresie en b) de relatie tussen voorgeschreven en daadwerkelijk toegediende 
hoeveelheden morfine. 
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Hoofdstnk 2 beschrijft het effect van continu morfine vergeleken met intermitterend 
morfine, wat betreft honnonaal-metabole reacties (plasmaspiegels van adrenaline, 
noradrenaline, insuline, glucose en lactaat) en hemodynamische reacties (hartfrequentie, 
gemiddelde arteriele bloeddruk), op postoperatieve pijn bij kinderen van 0 tot 3 jaar _ De 
veiligheid van beide methodes werd bepaald door de frequentie van 
adembalingsdepressie, daar dit de gevaarlijkste complicatie is bij behandeling met 
opio!den. 
Slechts kleine verschillen werden gevonden tussen beide behandelmethodes, waarbij de 
oudste g:roep (I - 3 jaar) met intermitterend morfine hogere glucosespiegels (P = 0.003), 
hogere gemiddelde arteriele bloeddruk (P = 0.02) en hogere COMFORT scores (P = 0.02) 
had dan de groep met continue morfine. De ontstaansvorm van de chirurgische stress 
reactie werd duidelijk uit de verschillen tussen de leeftijdsgroepen. Bij de pasgeborenen 
waren de plasmaspiegels van noradrenaline (P = 0.01) en lactaat (P < 0.001) voor operatie 
significant hager, maar na operatie waren de plasmaspiegels van adrenaline (P < 0.001) 
significant lager en van insuline significant hoge:r (P < 0.005) dan bij de oudere 
leeftijdsgroepen. 
Postoperatieve pijnscores (P < 0.003) en morfinegebruik (P < 0.001) waren signif1cant 
lager bij de pasgeborenen dan bij de oudere kinderen. Onze resultaten tonen aan dat een 
continu morfine infuus geen voordelen biedt boven intennitterende morfine doseringen 
als postoperatieve pijnbestrijding bij pasgeborenen en jonge kinderen. Daarnaast geven 
deze resultaten meer informatie over het ontstaan en de ontwikkeling van de hormonaal-
metabole reacties op chirurgische stress, met belangrijke verschillen tussen pasgeborenen 
en oudere kinderen, zichtbaar in de postoperatieve catecholamines, insuline en lactaat 
con centra ties. 
Hoofdstnk 3 beschrijft de effecten van behandeling ( continu tegenover intermitterend 
morfine) en de effecten van leeftijd op het morfinemetabolisme door bet analyseren van 
plasmaconcentraties van morfine (M), morfine-3-glucuronide (M3G) en morfine-6-
glucuronide (M6G) en de M3G-, M6G- en M3G/M6G-ratio's. Klinische variabelen zoals 
zwangerschapsduur, geslacht, gewicht bij geboorte en tijdens onderzoek, de methode van 
morfinetoediening, de behoefte aan pre- of postoperatieve beademing kunnen invloed 
hebben op bet morfinegebruik en de plasmaconcentraties van morfine en 
morfinemetabolieten. 
Met behulp van multipele regressie analyse werd vastgesteld dat leeftijd de belangrijkste 
factor was qua invloed op de morfinebehoefte en de morfine plasmaconcentraties. 
Significant minder pasgeborenen hadden extra morfine nodig vergeleken met aile andere 
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leeftijdsgroepen (P < 0.001). De behandelmethode (intermitterend versns continu) had 
geen significante invloed op de morfinebehoefte. Pasgeborenen hadden significant hogere 
plasmaspiegels van morfine, M3G en M6G (aile P < 0.001) en een significant lagere 
M6G/M ratio (P < 0.03) dan de oudere leeftijdsgroepen. De M6G/M3G ratio was gelijk in 
aile leeftijdsgroepen. 
De therapeutische breedte wat betreft postoperatieve morfine toediening is bij 
pasgeborenen kleiner dan bij oudere kinderen. Vanaf de leeftijd van 1 maand word! 
analgesie bereikt met een morfine infuus van 10.9 tot 12.3 ~g/kg/h, bij plasma 
concentraties van < 15 ng/ml. 
In a! deze leeftijdsgroepen werd geen verschil gevonden in veiligheid of effectiviteit 
tussen continue of intermitterende morfine toediening. 
Hoofdstuk 4 beschrijft de ontwikkeling in farmacokinetiek van morfine en 
morfinemetabolieten in pasgeborenen en jonge kinderen. In een paging om 
leeftijdsgebonden factoren te ontrafelen van grootte, c.q. gewichtsgebonden factoren, 
werd een op de populatie gebaseerde benadering gebruikt met grootte als eerste co-
variant. 
De klaring van morfine door omzetting naar glucuronides en de klaring van de 
metabolieten door renale eliminatie werden beraamd aan de hand van non-linear mixed 
effects models. 
Populatie gemiddelden and variabiliteit (%) voor een een-compartiment, eerste orde 
eliminatie model, waren als volgt: distributievolume 115 I (54), omzetting van morfine 
naar M3G 24.3 (91) 1/h, omzetting van morfine tot M6G 2.9 (87)1L/h, renale eliminatie 
van M3G 7.2 (65) 1/h, renale eliminatie van M6G 5.0 (76) 1/h; gestandaardiseerd voor een 
70 kg persoon gebruik makend van bet allometrische ''4 power' model. Klaring via 
andere routes droeg voor 50 % bij aan de totale morfineklaring. Het distributievolume 
nam exponentieel toe met een halfwaardetijd van 2 weken beginnend met 72 L/70kg bij 
de geboorte; omzetting tot M3G en M6G nam toe met een halfwaardetijd van 79 dagen 
beginnend met respectievelijk 5.2 en 0.61/hJ70kg bij de geboorte. De bilirubine 
plasmaconcentratie was omgekeerd evenredig met de omzetting tot metabolieten. De 
klaring van metabolieten narn toe met de leeftijd (halfwaardetijd 131 dagen) in een 
tijdsverloop overeenkomend met dat beschreven voor de glomerulaire filtratiesnelheid bij 
kinderen. 
M3G is de vooruaamste morfinemetabo!iet bij jonge kinderen en de totale morfineklaring 
op de leeftijd van 6 maanden is 87 % van die van oudere kinderen. Bij kinderen op een 
intensive care unit na niet-cardiochirurgische ingrepen kan een gemiddelde steady-state 
164 Chapter 9 
serumconcentratie van 20 ng!ml worden bereikt met een morfine HCI infuus van 8.5 
fl.g/kg/h bij geboorte (a terme pasgeborenen), 15 fl.g/kg/h op de leeftijd van 1 maand, 22 
fl.g/kg/h bij 3 maanden, 27 fl.g/kg/h bij 12 maanden en 25 f!g/kg/h voor kinderen van 1 tot 
3jaar. 
Hoofdstuk 5 beschrijft de effectiviteit van postoperatief interrnitterend en continu 
toegediende morfine aan de hand van gedragsuitingen van pijn (VAS en COMFORT 
schaal) bij kinderen van 0- 3 jaar. Voor dit doe! werd door de verpleegkundigen 
gedurende de eerste 24 uur na de ingreep elke drie uur de COMFORT 'gedragscore' en de 
VAS bepaald. Met random regressie analyse werd het effect van de wijze van 
morfinetoediening en de hoeveelheid toegediende morfine op COMFORT 'gedrag' en 
VAS pijn geschat, rekening houdend met de leeftijdsgroep, de "Chirurgische Stress 
Score" en het we! of niet kunstmatig beademd zijn. Globaal bleken CM en 1M even 
effectief postoperatieve pijn te verrninderen, hoewel voor de leeftijdsgroep van I tot 3 jaar 
CM enigszins effectiever bleek te zijn. De wijze van morfinedosering en de leeftijdsgroep 
waren beide voorspelbaar voor de mate van postoperatieve pijn. De grootste verschillen in 
pijnreactie en daadwerkelijke morfinedoseringen kwamen voor tussen pasgeborenen en 
zuigelingen van I tot 6 maanden, met lagere pijnscores bij pasgeborenen. Voor de meeste 
pasgeborenen volstond de dosering van 10 fl.g/kg/h volgens het protocol. "Chirurgische 
Stress Score" en kunstmatige beademing waren niet gerelateerd aan postoperatieve pijn of 
morfinedoseringen, hetgeen de individuele verschillen in pijnrespons en morfinebehoefte 
grotendeels onverklaard laat. 
Hoofdstuk 6 evalueert de effecten van continue of intennitterende toediening van 
morfine voor de behandeling van postoperatieve pijn bij kinderen van 0- 3 jaar met 
behulp van gedragsobservaties (VAS en Comfort schaal). 
Het beloop in de tijd van de Comfort "gedrag" en de VAS pijnscores werd vergeleken 
voor de beide behandelmethodes. Door de voor de patient verantwoordelijke 
verpleegkundige werd elke 3 uur, gedurende de eerste 24 uur na de operatie, de 
werkzaamheid van morfine gescoord met behulp van de Comfort "gedrag"- en VAS 
pijnschaal. 
Met behulp van randonn·egressie-analyse werd het effect bepaald van de randornisatie 
(intermitterend versus continu), de hoeveelheid morfine (volgens protocol en extra 
morfine), de leeftijd, de chirurgische stress, en de tijdafhanke!ijke co-variabele 
kunstmatige beademing, op de Comfort "gedrag"- en de VAS pijnscore. Er werden geen 
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statistisch significante verschillen vastgesteld tussen continue en interrnitterende morfine 
toediening. 
Een belangrijk leeftijdseffect was aanwezig. Continue morfine toediening had de 
voorkeur in de groep kinderen van I tot 3 jaar. 
Het grootste verschil in pijnreactie en morfinebehoefte werd vastgesteld tussen 
pasgeborenen en kinderen van I tot 6 maanden. 
De pasgeborenen vertoonden minder pijn en waren in het algemeen tevreden met de 
dosering volgens het protocol, 10 f,lglk/b. 
Er werd geen duidelijke relatie gevonden tussen de morfinebehoefte en de mate van 
postoperatieve pijn en de chirurgische stress of de kunstmatige beademing. 
Hoofdstnk 7 beschrijft het proces van verandering in pijnbehandeling op de 
kinderchirurgische intensive care afdeling van het Sophia Kinderziekenhuis, vanaf 1985 
tot heden. Vier verschillende periodes van pijnbehandeling konden worden 
onderscheiden: A (1985 - 1990) morfine werd gegeven op een "zo nodig" basis, op 
intermitterende wijze; geen hetrouwbare pijnscores, B (1990- 1995) morfine als continu 
infuus; geen betrouwbare pijnscores, C (1995- 1998) rnorfine als continu infuus, 
ontwikkeling van een betrouwbare methode voor bet meten van pijn, D (1998- 2002) 
morfine als continu infuus, gebruik makend van een betrouwbare pijnschaal 
gecombineerd met een algoritme. 
In de peri ode 1985 tot 2002, werden 81 pasgeborenen geselecteerd, die allen een primaire 
anastomosis hadden gekregen voor een gelsoleerde oesofagusatresie met sluiting van de 
l:racheo-oesofageale fistel. Het effect van de introductie van continue morfine toediening 
en een betrouwbare pijnschaal gecombineerd met een algmitme werd beoordeeld op a) 
het morfinegebmik gedurende de eerste 3 dagen na de ingreep en de duur van de 
kunstmatige beademing, en b) de relatie tussen de voorgeschreven en daadwerkelijk 
gegeven hoeveelheid morfine. In periode A ontvingen de pasgeborenen significant minder 
morfine dan in de periodes B, C enD (aile P < 0.005), terwijl er geen verschillen werden 
gevonden tussen de latere peri odes. Het percentage patienten dat postoperatief beademd 
werd groeide van 84 % in peri ode A tot 90 % in peri ode B en tot l 00 % in de peri odes C 
en D. De duur van de postoperatieve beademing nam toe in de periodes A, B en C 
[mediaan (10- 90'" percentiel)] van respectievelijk 24 (0- 78), tot 47 (1 - 96), tot 48 (20-
109) uur en nam af in de laatste periode tot 34 (15- 145) uur. Globaal was er tussen de 
vier periodes geen significant verschil in totale beaderningsduur. Ter beoordeling van het 
effect van een gevalideerde pijnscore gecombineerd met een algoritme (peri ode D), werd 
een subgroepanalyse uitgevoerd in periode C en D. Het risico om meer of minder dan de 
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mediane morfinedosis te krijgen was niet verschillend in periode C of D. Echter, het risico 
om postoperatief !anger dan de mediane duur van 45 uur beademd te worden was 4,5 keer 
zo laag in periode D dan inC (95 % CI: 0.05 - 0.94). In periode A was er geen 
significante correlatie tussen de voorgeschreven en daadwerkelijk toegediende 
hoeveelheden morfine. In de drie latere periodes was de correlatie echter significant en 
nam toe van r = 0.58 (P = 0.007) in periode B, tot respectievelijk r = 0.91 en 0.88 (beide 
< 0.001) in de periodes C en D. De verandering van persoonlijke interpretatie van 
postoperatieve pijn in een individuele beoordeling gebaseerd op objectieve pijnscores, 
resulteerde in optimale morfinedoseringen met een acceptabele duur van postoperatieve 
beadenting en een hoge correlatie tussen voorgeschreven en toegediende analgetica. 
Hoofdstuk S bestaat uit een algemene discussie met suggesties voor toekomstig 
pijnbeleid. 
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Dankwoord 
Nadat ik enige tijd werkzaam was op de afdeling Anesthesiologie van bet Sophia 
Kinderziekenhuis werd, mij al snel duidelijk dat bet onderwerp "Pijn bij kinderen" een 
ondergeschoven kindje was. De belangstelling voor behandeling van pijn had ik opgedaan 
in de verpleging en tijdens mijn anesthesistenopleiding bij Prof. Spierdijk. Na mijn 
verblijf op de afdeling Anesthesiologie en Intensive Care in bet Royal Children's Hospital 
te Melbourne, waar ik Anneke Meursing nog steeds dankbaar voor ben, kwam ik bij 
terugkomst een jaar te werk op de chirurgische IC van bet SKZ bij Dick Tibboel en Bert 
Bos. Aanvankelijk werd mijn speciale aandacht voor pijn bij kinderen welwillend 
bekeken en toegelaten, zo ook de omzetting van intermitterende morfine giften naar 
continue infusie. Onderzoek naar pijn kwam echter niet van de grond, totdat Dick Tibboel 
op een bijeenkomst Sunny Anand had horen spreken. Tot mijn grote verbazing nodigde 
hij mij vervolgens uit om samen 1net hem onderzoek te gaan doen naar pijn en 
pijnbehandeling bij kinderen. 
Dick, mijn enthousiasme heeft in de daarop volgende jaren heel wat deukjes opgelopen, 
maar steeds lukte bet je weer mij te motiveren om door te gaan. Dank voor je geduld, wat 
niemand achter jou zou zoeken, en voor je vertrouwen. Dank zij jouw geweldige 
stimulans heeft bet Sophia nu een onderzoekslijn naar pijn bij kinderen en !opener nu 
vele projecten. Proficiat' 
A! mijn col! ega's anesthesiologen en in bet bijzonder Jeanne Bezstarosti, dank ik voor 
hun medewerking aan de totstandkoming van dit proefschrift. Dank zij de bereidheid van 
de collega' s om ook in diensttijd mee te werken aan de uitvoering van bet onderzoek lukte 
het om het gewenste aantal patienten in de studie op te nemen. 
Jeanne, door jouw organisatietalent kon ik de tijd klijgen om te schrijven, ik heb dit 
bijzonder gewamdeerd. Wie is de volgende? 
Prof. Erdmann en Prof. Klein, hoogleraren Anesthesiologie, dank ik beiden voor de 
mogelijkheid die geboden werd om onderzoek te gaan doen. Ge!ukkig wordt naast 
klinische zorg, steeds meer aandacht gegeven aan klinisch onderzoek. 
Verder dank ik aile collega' s chirurgen en alle anesthesie- en chirurgiemedewerkers voor 
bet geduld dat zij moesten opbrengen wanneer een patient dee! nam aan het 
"pijnonderzoek". Wachten voor bet inbrengen van een arterielijn kan soms heel lang 
duren. 
Prof. Molenaar, emeritus hoogleraar kinderchirurgie, betrokken bij het onderzoek in de 
beginfase, dank ik voor zijn kritische opmerkingen. 
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Alle medewerkers van de chirurgische intensive care afdeling dank ik voor hun inzet en 
betrokkenheid bij bet onderzoek: de intensivisten die vaak het voorwerk deden door 
toestemming voor deelname te vragen aan de ouders, de verpleegkundigen die met de 
COMFORT Score moesten leren omgaan en vervolgens op vaste tijden de patienten 
moesten scoren, ook in tijden van weinig personeel. Zander jullie medewerking was het 
niet gelukt, 
Patricia van Deventer, dankzij jouw doorzettingsverrnogen is bet scoren van pijn bijna in 
bet gehele Sophia ingevoerd. Onderzoek doen is een, de uitvoering of wei de 
implementatie van de resultaten is twee. Voorts had je altijd even tijd voor een kopje 
koffie, wanneer bet mij weer eens tegen zat Bedankt voor je support. 
Samen met Monique van Dijk ben ik aan het onderzoek begonnen, met even het idee om 
samen te promoveren. AI snel had ik door dat ik naast bet geven van anesthesie haar 
tempo niet Icon bijhouden en mijn eigen weg moest gaan. Monique, met dank heb ik 
gebruik gemaakt van aile databestanden die door jou zijn ingevoerd. Onder jouw 
bezielende leiding zullen nog veel projecten worden uitgevoerd. 
Verder dank ik Jeroen Peters, bij wie ik met vragen op het gebied van statistiek of de 
computer altijd terecht kon. 
Ik dank Wim Hop, voor aile uurtjes met koffie en sigarettenrook, voor het mooie uitzicht 
vanuit de Hoogbouw, voor de eindeloze analyses waar altijd weer wat nitkwam, voor bet 
geduld iets uit te leggen aan een non-statisticus. 
Aile medewerkers van het klinisch chemisch laboratorium dank ik voor bet verwerken 
van de bloedmonsters en voor de verzorging van het transport naar andere laboratoria. 
Ko Hagoort en Laraine Visser-Isles, dank voor jullie onmisbare hulp om van mijn Engels 
Engels te maken. 
Verder dank ik de mensen die kritisch naar mijn artikelen hebben gekeken: 
Josien de Boer, betrokken bij het onderzoek in de beginfase, ik dankje voor je kritische 
opmerkingen en voor je optimisme op een goede afloop. 
Brian Anderson, thank you for your advices and for your important contribution to this 
thesis, and of course there will be een "feestje". 
Sunny Anand, you inspired me to start research on this subject. Thanks to you, surgical 
neonates and infants are treated in a human way. 
John van den Anker, jouw enthousiasme is erg aanstekelijk. Bedankt voor je adviezen en 
je bijdragen. 
Margo Terlouw, onze samenwerking was kort maar zeer intens. Dankzij jou heeft het 
proefsduift een professioneel aanzien gekregen. Dank voor de bijzonder prettige 
samenwerking. 
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lk dank Antoinette van Nierop en Michie! van Ormondt, dat zij mijn paranimfen willen 
zijn. lk hoop dat onze jarenlange vriendschap nog lang zal voortduren. 
Adrie, het is zover, het "boekje" is af1 Je hebt er altijd in geloofd. Nu eindelijk weer tijd 
voor andere diugen. Een weekend zal straks weer zijn waar het voor bedoeld is, genieten 
van de buitenlucht en daarna een heerlijk glas wijn. Proost! 
Last but not least, dank ik de ouders van de kinderen die dee! genomen hebben aan het 
onderzoek. Als ouder van een ziek kind staat je hoofd er allerminst naar om ook nog eens 
onderzoek te Iaten uitvoeren. lk bewonder de ouders die dit wei konden opbrengen. 
Dankzij hun medewerking kunnen andere kinderen profiteren van de resultaten van dit 
onderzoek. 
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